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ABSTRACT 
 
The analysis of degraded DNA can be problematic. Recent advances in the identification 
and analysis of single nucleotide polymorphisms (SNPs) have demonstrated the advantage 
of these markers over short tandem repeats (STRs) in that they only require small 
amplicons. However, before applying to casework, it is important to develop allele 
frequency databases from relevant populations. The main aim of the study is to 
characterize three Malaysian major ethnic groups; Malay, Chinese and Indian, using 52 
autosomal SNP markers that have been identified in the SNPforID project.    
Sanchez et. al., 2006 reported a multiplex of 52 SNP markers in one PCR reaction with two 
single base reaction (SBE) in the detection of SNPs using capillary electrophoresis (CE). The 
amplicons for PCR ranged from 59 bp to 115 bp.  Whilst for SBE reactions ranged from 16 
nt to 92 nt.  In their study, full complete profile was obtained from 500 pg DNA input.  The 
study was carried out on three major populations: African, Asian and European. 
As in this study, a total of 325 Malaysian samples (109 from Malays, 107 from Chinese and 
109 from Indians) were genotyped.  In order to genotype the population samples reliably 
and robustly, four sets of 13-plex SNPs were developed. Internal validation was carried out 
using both genetic analyzers, ABI PRISM® 310 and 3500 Genetic Analyzer. Sensitivity and 
reproducibility studies demonstrated that the assays were highly sensitive, requiring as 
little as 30 pg of DNA.  Full, complete and clear profiles were generated. Data were 
collected and evaluated statistically for forensic usefulness.  
Across the three ethnic groups, few significant departures from HWE, at p values <0.05 
were observed at 3 SNP markers in Malays, 4 SNP markers in Chinese and 9 SNP markers 
in Indian samples. Five markers (rs2107612, rs722098, rs2076848, rs907100 and 
rs1528460) in the Indians and one marker (rs1528460) in the Chinese, showed the lowest 
p value, that is p=0.0. However, after Bonferroni correction at p <0.00096 significant 
deviation(s) from HWE was observed at 1 SNP marker (code marker 26) in the Malays, 2   
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SNP markers (code marker 46 and 54) in the Chinese and 5 SNP markers (code marker 12, 
21, 36, 38 and 54) in the Indians.  In addition, a pair of loci (at code markers 3 and 53) was 
found to be associated in the Malays after the Bonferroni correction (at p <0.0000377). 
As for forensic parameters, the combined mean match probabilities for the 52 SNPs of 
Malay, Chinese, and Indian were 1 in 3.9654e-19, 5.3964e-18, and 1.7459e-19, corresponding 
to a combined power of discrimination of  >99.99999999%, respectively.  Paired Fst values 
obtained in the study showed, as expected, that Malay group is closely related to the 
Chinese population, with the Indian population being more distant.   
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INTRODUCTION 
 
1.1. GENETIC MARKERS IN THE FORENSIC DNA ANALYSIS 
Since the introduction of DNA profiling in 1985, a broad spectrum of genetic markers and 
human identity-typing systems has emerged for forensic use.  The core aim of forensic 
DNA testing is to generate a genetic signature that could either exclude or establish that 
there is an extremely high probability to infer a link between individual(s) and evidential 
material(s).  Since the Colin Pitchfork murder investigation (Jeffreys et al. 1985), forensic 
science has successfully implemented a lot of molecular biology tools.  
Today, a common set of standardized STR markers are widely used in forensic genetic 
casework. A large number of STR loci have been characterized but only around 20 are 
commonly analyzed in forensic casework (Goodwin et.al. 2011). Both Applied Biosystems 
and the Promega Corporation has become big providers of STR kits that permit robust 
multiplex amplification of the STR core markers (Butler 2011). 
With the rapid growth of the human identification applications of STR loci, STRBase 
(http://www.cstl.nist.gov/boitech/strbase) was launched in 1997, to keep the forensic 
scientist up-to-date with the rapidly evolving field of DNA typing. It contains much useful 
information including population data for STR markers, links to other related web pages, 
new microvariants or “off-ladder” STR alleles and others (Butler 2011).    
Various DNA technologies have since evolved, including lineage marker analyses which use 
maternally inherited mitochondrial DNA (mtDNA) hypervariable regions and paternal Y-
chromosome polymorphisms (Y-STR).  In forensic investigation, mtDNA analysis is very 
useful for generating profiles, particularly of human remains that are highly degraded and 
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not amenable to STR typing and also for kinship analysis, such tracing maternally –related 
families (Goodwin et.al. 2011, Coble et al. 2009).  As for Y chromosomal markers, they are 
widely used for the forensic analysis of male DNA, especially in the analysis of mixed 
samples in rape cases (Jobling & King 2004). They are also important in paternity testing, 
historical investigations and exploring human migration patterns (Butler 2011). Another 
lineage marker that recently has gained the forensic scientist’s attention is X-chromosome 
STR typing. This can be helpful in some kinship analysis situations, particularly in deficient 
paternity cases, where one of the parents is not available (Butler 2011).  
There is another complementary technique to standard STR-based analysis which was also 
introduced and implemented in order to obtain DNA profiles from cells and debris 
transferred through skin contact, especially in cases such as snatch theft, housebreaking 
and car theft; this technique is called Low Copy Number (LCN) (Butler 2005). Low copy 
number (LCN) typing, particularly for current short tandem repeat (STR) typing, refers to 
the analysis of any sample that contains less than 200 pg of template DNA. Generally, LCN 
typing simply can be defined as the analysis of any DNA sample where the results are 
below the stochastic threshold for reliable interpretation (Budowle et. al. 2009). 
However, there are several complex and specific challenges in generating DNA profiles 
such as there is no DNA profile or only partial DNA profile is amplified due to DNA 
degradation or the inhibitors of the biological samples. In order to address these problems 
several technologies including “miniSTRs” or reduced-sized PCR products were developed 
and introduced (Butler 2005). Same common STR loci used in commercially available kit 
exceed 400bp in size, but with “miniSTRs” the amplicons size is reduced, ranging from 
50bp up to 280bp (Butler 2011).  
In addition, to overcome PCR inhibitors and successfully generate DNA profiles, many 
more technologies and commercial kits with improved buffers were designed and 
developed by the providers as listed in Table 1-1.   
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Table 1-1: Commercially available multiplex kits, with improved reagents [Taken from 
(Butler 2011)]. 
Kit’s Name Source Release date 
AmpF1STR MiniFiler Applied Biosystems Mar 2007 
AmpF1STR SEfiler plus (improved buffers) Applied Biosystems Nov 2007 
PowerPlex 16 HS (same primers, improved reagents) Promega Mar 2009 
PowerPlex ESX 16 & EXS 17 Promega Sept 2009 
PowerPlex ESI 16 & ESI 17 Promega Sept 2009 
AmpF1STR Identifiler Direct  
(same primers, improved reagents) 
Applied Biosystems Nov 2009 
AmpF1STR Identifiler Plus  
(same primers, improved reagents) 
Applied Biosystems Jan 2010 
AmpF1STR NGM Applied Biosystems Jan 2010 
Investigator ESSplex QIAGEN April 2010 
Investigator Decaplex SE QIAGEN April 2010 
Investigator Triplex AFS QS QIAGEN April 2010 
Investigator Triplex DSF QIAGEN April 2010 
Investigator ESSplex QIAGEN Aug 2010 
Investigator IDplex QIAGEN Sept 2010 
Investigator HDplex QIAGEN Sept 2010 
Investigator Hexaplex ESS QIAGEN Sept 2010 
Investigator Nonaplex ESS QIAGEN Sept 2010 
Investigator ESSplex SE QIAGEN Oct 2010 
AmpF1STR NGM Select Applied Biosystems Dec 2010 
PowerPlex 18D Promega Feb 2011 
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Although the core STR markers and other complementary markers have been extensively 
used in crime casework, yet the forensic DNA scientist often uses additional markers as 
the need arises to obtain more or further information in a particular sample or case 
(Butler 2011).  
The study of single nucleotide polymorphisms (SNPs), has received a lot of attention in 
recent years, due to the abundance of SNPs throughout the human genome. The 
increasing interest in SNP typing in the forensic field, is not only for analyzing the 
geographical origin of samples, by defining Y chromosome or mtDNA haplogroups, but 
also for the potential applications of autosomal SNPs. This interest is growing particularly 
in the analysis of degraded DNA and complicated kinship testing (Sobrino et al. 2005a).   
 
1.2. SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) 
A polymorphism has been defined as existing when at least two different alleles are 
present in a population, and both are present at ≥1% frequency. An allele below the 1% 
frequency used to define a polymorphism is sometimes called a variant, but this term is 
used by others to describe any form of DNA variation, irrespective of frequency or 
phenotypic effect. The literature also contains the frequency-independent term single 
nucleotide variant (SNV), which some have argued should replace single nucleotide 
polymorphism (SNP). Our practice is to use “polymorphism” (including SNP) to indicate ≥1% 
allele frequency, “variant” for any less frequent difference between genome copies, and 
“mutation” to refer to a de novo change (Jobling et. al. 2013). 
Approximately 7 billion people living today carrying about 14 billion genome copies, and, 
with the rare exceptions carried by identical twins, triplets, and so on, all of them are 
different. The differences between genomes encompass a wide range of scales: from 
single nucleotide polymorphisms (SNPs) through to structural variation involving millions 
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of base pairs of DNA sequence. Most differences have no discernible effects on the people 
who carry them, but some result in phenotypic diversity with no obvious deleterious 
effect, and some cause, predispose to, or protect against, serious diseases (Jobling et. 
al.2013). 
The simplest and smallest-scale difference between two homologous DNA sequences is a 
base substitution, in which one base is exchanged for another (Figure 1-1 and Figure 1-2). 
When a pyrimidine base is exchanged for another pyrimidine (for example, C for T), or a 
purine for another purine (for example, A for G), the change is called a transition. When a 
pyrimidine is exchanged for a purine, or vice versa, this is a transversion. These differences 
are examples of single nucleotide polymorphisms, or SNPs (pronounced “snips”). The 
insertion or deletion (indel) of a single base is also included in the category of SNPs—
perhaps unadvisedly, because the mechanisms which underlie these indels, and the ways 
they are analyzed, differ from those for base substitutions (Jobling et. al.2013). 
 
 
Figure 1-1: Examples of mutations affecting a few base pairs, including examples of 
transition and transversion substitutions [Taken from Jobling et.al. 2013]. 
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Figure 1-2: Transition and transversion mutations [Taken from Jobling et.al. 2013]. 
 
1.2.1. SNP Characteristics 
SNPs have a number of characteristics that make them appropriate for forensic studies as 
well as population studies: (i) there are several millions of validated SNPs in the human 
genome; (ii) SNPs can be typed by semi-automated, cost-effective and standardized 
methods; (iii) Polymerase Chain Reaction (PCR) amplicons can be shorter than 100 bp, 
which allows for amplification and unambigous allele calling even from highly degraded 
DNA samples; (iv) they have very low mutation rates compared to short tandem repeats 
(STRs), a feature which is valuable for kinship testing; and, (v) as biallelic polymorphisms, 
SNPs are comparatively easy to validate.  Although, individual SNPs have a discrimination 
power lower than that of individual STRs, it has been shown that 50 unlinked SNP loci with 
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high overall heterozygosity, matches or exceeds the discriminatory power of 15 STRs 
(Sanchez et al. 2006a).  
Figure 1-3 shows mutation rates of micro- and minisatellites are very variable between 
loci. The rates given here reflect ascertainment bias, in that they are those of the mostly 
widely used and polymorphic loci.  The average rates are probably much lower (Jobling et. 
al.2013).  
 
Figure 1-3: Overview of mutation rates (μ) of different classes of polymorphisms [Taken 
from Jobling et.al. 2013]. 
CHAPTER 1  Introduction  
 
 
9 
 
Base substitutions, occurring at an average rate of the order of 10–8 per base per 
generation, are about 10 times more frequent than indels, although this relative 
frequency varies substantially between loci, because it depends on the sequence context. 
Transitions are almost three times more frequent than transversions, despite the fact that 
for a given base there are two possible transversions to only one transition (Figure 1-2)—if 
all mutations were equally probable we would expect a 2:1 ratio of transversions to 
transitions. This deviation from expectation might be explained by influences of efficiency 
of error detection and repair, sequence context, or perhaps by differences in 
misincorporation rates (Jobling et.al. 2013). 
It is important to note that mutation rates of base substitutions are in general so low that 
a given mutation at a particular position is unlikely to have recurred or reverted in the 
small populations of early humans; independent occurrences are therefore not usually 
found today at appreciable frequencies. The low mutation rate also means that base 
substitutions generally belong to the class of binary polymorphisms, also known as 
biallelic, or diallelic polymorphisms, or unique event polymorphisms (UEPs) (Jobling et. 
al.2013). 
Whilst, typical figures for mutation rate estimates from direct approaches are around 10–3 
to 10–4 per polymorphic microsatellite per generation. Application of such rates to the 
dating of past events such as migrations and population expansions is somewhat 
controversial, since when populations with well-documented short-term histories are 
examined the effective mutation rate that explains the accumulated diversity seems to be 
considerably lower (Jobling et.al. 2013). 
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1.2.2. SNP Consortium/Databases 
There are several groups and institutions that have contributed their efforts over the past 
few years in facilitating and characterizing SNPs, including the mapping of the entire 
human genome/ SNPs and also the development of SNP databases. Some of them are 
listed as below. 
 
1.2.2.1. The European DNA Profiling Group (EDNAP) 
EDNAP group (www.isfg.org/EDNAP) was started in 1988 by a group of forensic scientists 
from various parts of European with the main aim of harmonizing DNA technology for 
criminal investigations.  This working group was accepted in 1991, at the Congress of the 
ISFG (International Society for Forensic Genetics). Since then, this group has been working 
together and collaborates in many forensic DNA research projects and analyses.  
 
1.2.2.2. The SNP Consortium Ltd. (TSC) 
TSC was established in 1999, a collaboration between major pharmaceutical companies, 
the Wellcome Trust, and five leading academic and genome sequencing centers 
(http://snp.cshl.org).  TSC has produced several million mapped and characterized human 
SNP markers, in samples from African, European and Asian populations (Thorisson & Stein 
2003, Butler 2005). TSC is one of the biggest contributors to the HapMap Project. 
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1.2.2.3. HapMap Project  
The International HapMap Project, launched in 2002, is a partnership of scientists and 
funding agencies from Canada, China, Japan, Nigeria, the United Kingdom and the United 
States to identify and catalog genetic similarities and differences in human beings.  
The aim of the International HapMap Project was to characterize patterns of genetic 
variation and LD in a sample of 269 individuals from four geographically defined 
populations with ancestry in Africa, Europe, and Asia, thus facilitating the design of 
efficient genome wide association studies for common disease. The study began in 2002, 
and by 2007 had published a haplotype map based on over 3.1 million SNPs (Jobling et. 
al.2013). 
The HapMap Web site provides researchers with a number of tools that allow them to 
analyze the data as well as download data for local analyses. In phase I of the project, 
more than 1.1 million SNPs were genotyped in 269 individuals from four worldwide 
populations (Yoruba, Japanese, Chinese and European) (Thorisson et al. 2005).  
In Phase II, over 3.1 million human SNPs were characterized and genotyped from those 
269 individuals. Data shows that 10–30% of pairs of individuals within a population share 
at least one region of extended genetic identity arising from recent ancestry and that up 
to 1% of all common variants are untaggable, primarily because they lie within 
recombination hotspots. The recombination rates found varied systematically around 
genes and between genes of different function (Frazer et al. 2007).  
The International HapMap Project 3 together with the Human Genome Project and the 
SNP Consortium has also successfully identified 10 million common DNA variants, 
primarily SNPs, in a limited set of DNA samples. Knowledge of these SNPs and their 
linkage-disequilibrium (LD) patterns enabled genome-wide association studies, which have 
successfully identified hundreds of novel genomic loci that influence human diseases 
(Altshuler et al. 2010). Linkage disequilibrium (LD) is the association of alleles because of 
CHAPTER 1  Introduction  
 
 
12 
 
reduced recombination between them, which can reflect either physical distance, or 
variable recombination activity (Jobling et. al.2013). 
The results of HapMap demonstrate an extremely non-uniform distribution of 
recombination in the genome, reflected in a discontinuous block-like structure of LD. 
These haplotype blocks can contain many SNPs that are highly correlated with one 
another, and display the limited haplotype diversity that is expected from relatively few 
historical recombination events. The breakdown of LD between blocks is often abrupt, 
reflecting the occurrence of most human recombination events within hotspots. 
Computational methods allow the local recombination rate to be calculated from the 
population-scale genotypic data across the whole genome: rates vary greatly, and from 
HapMap Phase II data approximately 33,000 hotspots showing greatly elevated 
recombination could be identified, with a mean width of 5.5 kb (constrained by SNP 
density— most empirically determined hotspots are considerably smaller). About 60% of 
recombination occurred within these hotspots, yet they comprised only ~6% of sequence 
(Jobling et.al.2013). 
In phase III, an extended set of 1,184 samples from 11 populations were studied which 1.6 
million common SNPs were genotyped. The additional populations were from African 
ancestry in the southwestern USA (ASW), Chinese in metropolitan Denver, Colorado, USA 
(CHD), Gujarati Indians in Houston, Texas, USA (GIH), Luhya in Webuye, Kenya (LWK), 
Maasai in Kinyawa, Kenya (MKK), Mexican ancestry in Los Angeles, California, USA (MXL), 
and Tuscans in Italy (Toscani in Italia, TSI) (Altshuler et al. 2010).  
 
1.2.2.4. HGDP-CEPH Diversity Panel Database 
This panel database (V3.0) is designed to receive and store polymorphic marker genotypes, 
copy number variant (CNVs) calls, and Sanger DNA sequences generated by users of the 
DNAs of the HGDP-CEPH Diversity Panel. There are 11 data sets in this panel and the data 
are publically accessible via this website (http://www.cephb.fr/en/hgdp/).   
CHAPTER 1  Introduction  
 
 
13 
 
This panel was initiated by a group of scientists at Stanford University that collaborated 
with the Center for the Study of Human Polymorphism (CEPH) at the Fondation Jean 
Dausset in, Paris. They have studied a large scale of genetic diversity in human populations. 
Genomic DNA was analyzed from more than 1,000 individuals from 52 different 
populations, determining their genotypes at more than 650,000 SNP loci, with the Illumina 
BeadStation technology. The collection of these DNA is also referred to as the "HGDP-
CEPH Human Genome Diversity Cell Line Panel". The indigenous populations involved are 
from Africa, Europe, the Middle East, South and Central Asia, East Asia, Oceania and 
America (Cann et al. 2002, Rosenberg et al. 2002, Cavalli-Sforza 2005, Li et al. 2008). 
Many investigators and researchers have been using these cell lines to carry out their 
studies. In order to establish a 34-plex ancestry-informative marker (AIM) assay, a group 
of scientists (Phillips et al. 2007b) have used three main population-group HGDP-CEPH 
samples of geographically-known origin to estimate the misclassification rates by 
statistical means in predicting ancestral origin of the training sets populations (60 
Mozambican, 60 Somali, 60 Galician, 60 Danish, 60 Mainland Chinese and 60 Taiwanese). 
In addition, several reference population of HGDP-CEPH were also used in the revision of 
an established 34 SNP forensic ancestry and for comparison in analyzing four U.S. 
populations which show a range of admixture patterns (Fondevila et al. 2013a). 
 
1.2.2.5. 1000 Genomes 
The 1000 Genomes Project is an international collaboration to produce an extensive public 
catalog of human genetic variation, including SNPs and structural variants, and their 
haplotype contexts. The goal of the 1000 Genomes Project is to find most genetic variants 
that have frequencies of at least 1% in the populations studied and to estimate the 
frequencies of the variant alleles, and also identify the haplotype and characterize their LD 
patterns.  
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The 1000 Genomes Project Consortium targeted about 2500 anonymous people from 
about 25 populations around the world which have been sequenced using next-
generation sequencing technologies.  
In Phase 1, the genomes of 1,092 individuals from 14 populations were constructed using 
a combination of low-coverage whole-genome and exome sequencing. The Consortium 
discovered and genotyped 38 million single nucleotide polymorphisms, 1.4 million short 
insertions and deletions, and more than 14,000 larger deletions. 
The project’s pilot phase used population samples collected for the HapMap project and 
comprised three sub-projects as follows: 
• Trio pilot: whole-genome sequencing at high coverage (each base covered on average 42 
times) of two families of African and European origins (YRI and CEU), each including two 
parents and one daughter. 
• Low-coverage pilot: whole-genome sequencing at low coverage (2–6×) of 59 unrelated 
African individuals (YRI), 60 unrelated European individuals (CEU), and 60 unrelated East 
Asian individuals (30 CHB and 30 JPT). 
• Exon pilot: targeted high-coverage (average >50×) sequencing of 8140 exons from 906 
randomly selected genes (total of 1.4 Mb), in 697 individuals from seven populations of 
African (YRI, LWK), European (CEU, TSI), and East Asian (CHB, JPT, CHD) ancestry. 
The data generated by the 1000 Genomes Project not only aid the interpretation of all 
genetic-association studies, but also provide lessons on how best to design and analyze 
sequencing-based studies of disease.  A further 1,500 individuals from 12 new populations, 
including at least 15 high-depth trios; will form the final phase of this project (Altshuler et 
al. 2012). 
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1.2.2.6. The Single Nucleotide Polymorphism Database (dbSNPS) 
The dbSNPs or dbSGV (database of short genetic variations) is a public- domain archive for 
a broad collection of simple genetic polymorphisms and it was developed to complement 
GenBank. This collection of polymorphisms includes single-base nucleotide substitutions 
(also known as SNPs), multi-base deletions or insertions, retro-transposable element 
insertions and microsatellite repeat variations (STRs).  
The SNP database can be queried from the dbSNP homepage by using Entrez SNP, or by 
using the links to the six basic dbSNP search options stated in the NCBI handout 
(ftp://ftp.ncbi.nlm.nih.gov/pub/factsheets/Factsheet_SNP.pdf). By 2008, there were 
about 12.8 million human reference SNPs have been deposited into the public database 
dbSNP build 128 (http://www.ncbi.nlm.nih.gov/books/NBK44423/).  
 
1.2.2.7. The SNPforID Browser (SNPforID Consortium ) 
Several members of the European forensic DNA typing community launched a project in 
2003 known as SNPforID that is developing SNP assays to directly aid forensic DNA 
analysis (Phillips et al. 2004). This group is endeavouring to develop highly multiplexed 
SNP assays using unlinked loci that are well spread throughout the human genome for 
high-throughput forensic identification of individuals. Population data are also being 
gathered to measure SNP allele frequencies in various groups (Butler 2005). The SNPforID 
browser page contains a world map which is clickable at any population selected. There 
are two main sets of SNPs available: SNPforID 52-plex (for individual identification 
markers) and SNPforID 34-plex (ancestry markers). The website page also contains the 
frequencies tab, statistic tabs and download tabs, where users are allowed to retrieve the 
alelle  frequencies and other forensic parameters such as hetereozygosity values, FST etc. 
The SNPforID studies were carried out on populations distributed across Africa, America, 
Europe, East-Asia, Central-South Asia, Middle East and Oceania. 
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In order to facilitate the SNPforID Browser user with multiple databases, which allow the 
user to compare or access them easily, a novel web tool has been developed and termed 
SPSmart (SNPs for Population Studies). These databases include HapMap, Perlegen, CEPH 
(Michigan and Stanford) and 1000 Genomes (Amigo et al. 2008b). 
 
1.2.3. Categories of SNP Markers 
At the 22nd Congress of the International Society of Forensic Genetics (ISFG) which was 
held in Copenhagen, Denmark on 2007, there was a panel discussion on single nucleotide 
polymorphisms (SNPs) and their application in forensic identity and relationship testing.  
During the meeting, the scientists’ experiences in SNPs were presented on their 
developed SNP panels, and they discussed the benefits, limitations and requirements for 
SNP implementation and interpretation (Butler et al. 2008, Budowle, van Daal 2008, Butler 
2011). As a result, the scientists and the panel of experts have decided to classify the SNP 
markers into four general categories, as shown in Table 1-2.  
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Table 1-2: Classifications of SNP markers [Taken from (Butler 2011)]. 
Category Characteristics Examples 
Identity SNPs: 
 
Individual identification 
SNPs (IISNPs) 
 
SNPs that collectively give very low 
probabilities of two individuals 
having the same multi-locus 
genotype. 
FSS 21plex (Dixon et al. 2005) 
SNPforID 52plex(Sanchez et 
al. 2006a) 
Kidd group SNPs(Pakstis et al. 
2010) 
Lineage SNPs: 
 
Lineage Informative SNPs 
(LISNPs) 
 
Sets of tightly linked SNPs that 
function as multi-allelic markers 
that can serve to identify relatives 
with higher probabilities than 
simple bi-allelic SNPs. 
mtDNA coding region SNPs 
(Coble et al. 2004) 
Japanese Y-SNPs (Mizuno et 
al. 2010) 
Haplotype blocks (Ge et al. 
2010) 
Ancestry SNPs: 
 
Ancestry Informative 
SNPs (AISNPs) 
 
SNPs that collectively give a high 
probability of an individual’s 
ancestry being from one part of the 
world or being derived from two or 
more areas of the world 
SNPforID 34-plex (Phillips et 
al. 2007b) 
24 SNPs (Lao et al. 2010) 
FSS YSNPs (Wetton et al. 
2005) 
Phenotype SNPs: 
 
Phenotype Informative 
SNPs (PISNPs) 
 
SNPs that provide a high probability 
that the individual has particular 
phenotypes, such as a particular 
skin colour, hair colour, eye colour, 
etc.  
Red Hair (Grimes et al. 2001) 
“Golden” gene pigmentation 
(Lamason et al. 2005)  
IrisPlex eye colour (Walsh et 
al. 2011) 
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1.2.4. Widely-used SNP Typing Methodologies  
A number of SNP typing methods are available, each with their own strengths and 
weaknesses (Sobrino et al. 2005a).  But among those methods, few are widely-used by the 
researchers or forensic scientist, this could be possibly because most of the forensic 
laboratories are already well-equipped with particular high-throughput instruments, such 
as capillary electrophoresis (CE) and Real-time PCR.  
 
1.2.4.1. Primer extension (PE) 
PE is one of the most frequently used detection methods for SNP genotyping and is also 
known as minisequencing and single base primer extension. The mechanism is based on 
the ability of DNA polymerase to incorporate specific deoxyribonucleotides 
complementary to the sequence of the template DNA.  The product can be detected by 
capillary electrophoresis (CE) analysis as described in the SNaPshot® method (Applied 
Biosystems 2009a).  By using this method, multiplexing of SNPs marker is feasible and 
practicable but a lot of work is needed to optimize the PCR and SNaPshot reaction of each 
set of SNPs. Several studies on autosomal SNPs, Y-SNPs, mtDNA-SNPs and ancestry SNPS 
(Sanchez et al. 2003, Sanchez et al. 2006a, Brión et al. 2005, Tomas et al. 2010, Gusmao et 
al. 2012, Fondevila et al. 2013a, Ballantyne et al. 2012) have been undertaken in different 
forensic laboratories with the analysis of SNPs using this technology (Sobrino et al. 2005a). 
 
1.2.4.2. Oligonucleotide Ligation Assay (OLA)  
OLA is a SNP typing method based on the ability of ligase to covalently join two 
oligonucleotides when they hybridize next to one another on a DNA template.  The OLA 
assay requires that three probes are designed, one common and two allele specific.  The 
CHAPTER 1  Introduction  
 
 
19 
 
common probe anneals to the target DNA immediately downstream of the SNP.  One 
allelic probe has at the 3ʹ end, the nucleotide complementary to one allele, with the other 
allelic probe having the nucleotide complementary to the alternative allele.  These two 
allelic probes compete to anneal to the DNA target adjacent to the common probe. This 
generates a double-stranded region containing a nick at the allele site.  Only the allelic 
probe perfectly matched to the target will be ligated to the common probe by DNA ligase. 
The multiplex capability of several technologies based on OLA is very high, but it is not 
suitable for forensic casework because it requires a high amount of DNA template (37ng) 
(Sobrino et al. 2005a).  Several SNPs studies have been carried out with OLA technology 
such as the SNPlex™ Genotyping system (De La Vega et al. 2005a) and Genplex™ Typing 
system (Phillips et al. 2007a, Tomas et al. 2008, Tomas et al. 2011, Kidd et al. 2012). 
 
1.2.4.3. TaqMan®SNP Genotyping Assays 
The TaqMan®SNP Genotyping Assay is a single-tube PCR assay that exploits the 5ʹ 
exonuclease activity of AmpliTaq Gold®DNA Polymerase.  The assays includes two locus-
specific PCR primers that flank the SNP of interest, and two allele-specific oligonucleotide 
TaqMan® probes.  These probes have a fluorescent reporter dye at the 5ʹ end, and a non-
fluorescent quencher (NFQ) with a minor groove binder (MGB) at the 3ʹ end.  The use of 
two probes, one specific to each allele of the SNP and labeled with two fluorophores, 
allows detection of both alleles in a single tube.  Fluorogenic probes with an MGB produce 
enhanced allelic discrimination, because the MGB stabilizes the double-stranded probe 
template structure, thereby increasing the probe melting temperature (Tm) without 
increasing probe length.  This provides enhanced mismatch discrimination between these 
shorter probes, resulting in improved specificity.  All MGB probes include a non-
fluorescent quencher (NFQ) that virtually eliminates the background fluorescence 
associated with traditional quenchers (De La Vega et al. 2005a). A few studies (Kidd et al. 
2006, Pakstis et al. 2007, Li et al. 2010) have used this approach in screening their SNP 
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marker candidates and others (Phillips et al. 2007a, Harayama et al. 2011, Dulik et al. 
2012) used TaqMan technology as for comparison in data obtained.  
 
1.3. SNPS AS FORENSIC MARKERS 
Often, forensic samples will contain too little template DNA or too degraded DNA and 
require alternate genetic marker analyses or approaches to what is currently used for 
routine casework. Single nucleotide polymorphisms (SNPs) have promising features to 
support forensic DNA analyses, such as the abundance of potential markers, amenability 
to automation, and potential reduction in required fragment length to only 60-80 bp 
(Budowle, van Daal 2008).  
Budowle and van Daal (2008) also suggested that the SNP markers will serve an important 
role in analyzing challenging forensic samples, such as those that are greatly degraded, for 
augmenting the power of kinship analyses and family reconstructions for missing persons 
and unidentified human remains, as well as for providing investigative lead value in some 
cases without a suspect (and no genetic profile match in CODIS).  
 
1.3.1. Degraded DNA 
The primary point of SNPs in the forensic field is the ability to overcome challenges of 
strong inhibitors or samples possessing highly degraded material.  PCR products for SNP 
markers can be small because the target region is a single nucleotide and amplicons are 
usually less than 100 bp in length.  For these reasons, SNPs are likely to contribute more to 
individual identification especially for mass disaster victim identification. For example, 
SNPs have successfully been used on highly degraded samples from victims of the World 
Trade Center disaster of 11 September 2001 (Butler 2005). 
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1.3.2. Human Identification 
Most SNPs are bi-allelic and thus are not as informative on a per-locus basis as the 
forensically selected STR loci. Because all forensic DNA indices, particularly convicted felon 
DNA databases, are well-established and based on STR loci, it is unlikely that SNPs will 
become the primary forensic markers for human forensic identification (Budowle, van 
Daal 2008, Gill et al. 2004).  
However, SNPs do have advantages for forensic analyses in some situations, such as use in 
mass disasters and missing person’s cases where the DNA may be substantially 
fragmented. Lastly, SNPs have relatively low mutation rates which are useful for lineage-
based analyses, such as inheritance cases, missing person cases, and situations where no 
direct reference sample may be available (Budowle, van Daal 2008).  
In order to obtain the same power of discrimination as existing STR multiplex systems, a 
panel of at least 50–100 autosomal SNP loci would be required (Chakraborty et al. 1999, 
Gill 2001). However, creating such large multiplexes that are validated for forensic analysis 
is a challenging task (Budowle, van Daal 2008). 
 
1.3.2.1. SNP panels of 40-100 plex assays for human identification 
Millions of SNPs have been characterized in the human genome; however not all of these 
are suitable for forensic analysis.  Based on selection criteria such as high levels of 
observed heterozygosity (average 0.45) and low FST (average 0.06) between populations 
several sets of markers have been developed for human identification. A number of SNP 
platforms have been developed to be applied for the detection of these SNPs markers.   
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1.3.2.1.1. SNPforID 52plex markers 
A multiplex of 52 SNP markers has been developed and these markers have been reported 
to be polymorphic in European, Asian and African populations. The amplification of all 52 
DNA fragments was carried out in one PCR reaction followed by detection of the SNPs 
with two single-base extension (SBE) reactions, which later detected by Capillary 
Electrophoresis (CE).  In this study, these SNPs were also efficiently used and successfully 
amplified the degraded samples, where previously only partial STRs profiles had been 
obtained (Sanchez et al. 2006a, Sanchez et al. 2006b).   
 
1.3.2.1.2. SNPlexTM Genotyping System 
The SNPlex™ Genotyping system (Applied Biosystems) has been developed for applications 
that require scalable, high-throughput SNP genotyping capabilities.  It utilizes a suite of 
pre-optimized universal assay reagent kits and a set of SNP-specific ligation probes to 
perform genotyping up to a 48-plex level in a single reaction.  This system is based on the 
oligonucleotide ligation/ PCR assay (OLA/PCR) with a universal ZipChute™ probe detection 
for high-throughput SNP genotyping (De La Vega et al. 2005a).  However, this system is no 
longer available commercially.   
 
1.3.2.1.3. GenPlexTM Typing System 
The Genplex™ Typing system 49plex assay has been developed based on the modification 
of SNPlex™ chemistry (both Applied Biosystems; AB SNPlex™ chemistry guide) using oligo-
ligation of pre-amplified DNA and dye-labelled, mobility-modified detection probes. This 
gives highly predictable electrophoretic mobility of the allelic products generated from the 
assay to allow detection with standard CE analyzers.  Few panels of SNPs markers have 
been designed using the GenPlex typing systems, such as the 48 most informative 
autosomal SNPs from the SNPforID core discrimination set supplemented with the 
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amelogenin sex marker. These SNPs are evenly distributed across all 22 autosomes, 
exhibit balanced polymorphisms in three major population groups (African, Asian and 
European) and have been previously shown to be effective markers for forensic analysis 
(Phillips et al. 2007a).  Another two panels of 49 and 41 SNPs were also used to test this 
system (Pakstis et al. 2010, Kidd et al. 2012). However, this system has been discontinued 
and is not available commercially. 
 
1.3.2.1.4. Kidd Group IISNPs 
Initially, Kidd et. al (2006) proposed a preliminary panel of 19 SNPs for the identification of 
humans based on their evaluation of match probabilities. They  tested these 19 SNPs on a 
broad representation of world populations.  This 19-SNP panel is commercially available 
through Applied Biosystems and  has been proven to be high throughput, highly accurate, 
time-efficient and cost-effective (Kidd et al. 2006, Applied Biosystems 2010a).  Later, Kidd 
and colleagues studied 40 SNP markers that were suggested to be suitable candidates for 
the global forensic community for a universally applicable SNP panel for human 
identification (Pakstis et al. 2007).  Kidd and colleagues again extended their panel from 
40 to 92-IISNPs based on the 44 populations studied. However, the final full set of 86-
IISNPs was chosen to be used because no significant Linkage Disequilibrium (LD) was 
found across the 44 populations studied (Pakstis et al. 2010, Kidd et al. 2012).  
 
1.3.3. Estimating ethnic origin of a sample 
With the advent of dense maps of human genetic variation, an increasing amount of 
information is being assembled, which together with new analytical methods, is making it 
possible to explore the recent evolutionary history of the human population (Sabeti et al. 
2007). In many cases, the identification of the population group from which a crime scene 
sample has come from can be valuable intelligence for investigating agencies. Panels 
CHAPTER 1  Introduction  
 
 
24 
 
consisting of mtDNA SNPs and Y SNPs have already been found useful for this purpose but 
are intrinsically limited by the fact that they can only provide information on either the 
maternal or paternal ancestry. Autosomal SNPs that have different frequencies in 
different major population groups can provide valuable information on geographic 
ancestry (Goodwin et.al. 2011). 
 
1.4. APPLICATION OF SNPs MARKERS ON THE MALAYSIAN POPULATIONS AND 
FORENSIC CASEWORK 
 
1.4.1.  Geography and demographic of Malaysia  
The Federation of Malaya, consisting of 11 states in what is now Peninsular Malaysia, 
became independent from British rule in 1957. Sabah, Sarawak and Singapore joined the 
federation to form Malaysia in 1963; Singapore then left the federation to become an 
independent nation two years later. Since then Malaysia comprises Peninsular Malaysia, 
Sabah and Sarawak (Figure 1-4). 
Migration is one of the defining issues of the twenty-first century in Malaysia. The multi-
racial population in Malaysia is evidence of earlier inward migration during the nineteenth 
and the early twentieth century. Colonial rule saw the entry of foreign labour especially 
from China and India to work in the plantations, tin mining and the construction sectors. 
Population distribution varies by state: Selangor is the most populous state (5.46 million), 
followed by Johor (3.35 million) and Sabah (3.21 million). The population share of these 
states to the total population of Malaysia was 42.4 per cent. The least populated states 
were federal territories, Putrajaya (72,413) and Labuan (86,908).   
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Population density of Malaysia stood at 86 persons per square kilometer in 2010 
compared with 71 persons in 2000. Unlike the population distribution, the population 
density revealed a different picture. Selangor, being the most populous state, was only 
ranked fifth in terms of population density with 674 persons per square kilometer. Among 
the most densely populated states were Kuala Lumpur (6,891 persons), Pulau Pinang 
(1,490 persons) and Putrajaya (1,478 persons).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1-4: Population density by state Malaysia, 2010 [Taken from Department of 
Statistics 2010]. 
 
  
Peninsular Malaysia 
East Malaysia 
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1.4.2.  Multi-racial residents in Malaysia  
Malaysia is a multi-racial country with more than 70 identified ethnic groups. These ethnic 
groups are broadly classified into four major groups namely Bumiputera (inclusive of 
Malay and Indigenous), Chinese, Indians and Others (including non-Malaysian citizen). The 
classification of the registered ethnic groups is listed in Table 1-3. 
The population of Malaysia in 2010 was 28.3 million with an annual population growth 
rate of 1.9 per cent. The population is estimated to reach 31.6 million in 2020 (Zarinah 
Mahari 2011). Bumiputera, the main ethnic group constituted 67% per cent of the total 
population followed by Chinese at 24%, Indians 7% and others 0.7% (Department of 
Statistics 2010). 
 
1.4.3.  Forensic Casework in Malaysia  
 
The Forensic Division of Kimia Malaysia is a national leader in the forensic science 
community that provides independent and impartial forensic science services to both 
government agencies and to the private sector. DNA profiling analysis is conducted only in 
the Headquarters in Petaling Jaya, Kuching Branch Laboratory, and Penang Branch 
Laboratory (www.kimia.gov.my). In addition, the Division also provides other scientific 
support including expert opinions, giving lectures and training and is involved in the 
collaboration research with the universities. The Forensic Division has been accredited by 
the ASCLD/LAB® (American Society of Crime Laboratory Directors/ Laboratory 
Accreditation Board) to the international quality standard ISO 17025 since 2005.  
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Table 1-3: Classification of 2010 Census ethnic groups (Department of Statistics 2010, 
JAKOA 2013). 
BUMIPUTERA CHINESE INDIANS 
Peninsular Malaysia 
Malay 
 
Negrito (Kensiu, Kintak, Lanoh, Jahai, Mandriq) 
 
Senoi (Temiar, Semai, Semoq Beri, Jahut, Mahmeri, 
Chewong) 
 
Proto-Malay (Temuan, Semelai, Jakun, Orang Kanaq, 
Orang Kuala, Orang Seletar) 
Foochow 
Hainan 
Henghua 
Hokchia 
Hokchiu 
Hokkien 
Kantonis 
Hakka 
Kwongsai 
Teochew 
Other Chinese 
Malabari 
Malayali 
Punjabi 
Sikh 
Sinhala 
Tamil India 
Tamil Sri Lanka 
Telugu 
Other Indians 
BUMIPUTERA SABAH and W.P.LABUAN BUMIPUTERA SARAWAK 
Melayu 
Melayu Brunei 
Kadazan 
Dusun 
Bajau 
Murut 
Balabak/Molbong 
Bisayah 
Bulongan 
Idahan 
Kadayan 
Lundayuh 
Orang Sungai 
Rungus 
Suluk 
Tidung 
Other Sabah Bumiputera 
Melayu 
Iban 
Bidayuh 
Melanau 
Bisayah Sarawak 
Bukitan 
Iban 
Kadayan Sarawak 
Kanowit 
Kayan 
Kejaman 
Kalabit 
Kenyah 
Lahanan 
Lisum 
Lugat 
 
Penan 
Murut Sarawak 
Punan 
Sabup 
Sekapan 
Sian 
Sipeng 
Tabun 
Tagal 
Tanjong 
Ukit 
Other Sarawak 
Bumiputera 
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1.5. STUDIES RELATED TO MALAYSIA 
 
1.5.1.  Autosomal SNP studies on Southeast Asian and East Asian populations  
The HUGO Pan-Asian SNP Consortium has reported a large-scale study on the autosomal 
variation from various geographic samples of Asian populations. They found that genetic 
ancestry had strong correlation with linguistic associations as well as geography. These 
genome-wide studies of SEA and EA populations’ were carried out using the Affymetrix 
GeneChip HumanMapping 50K Xba Array. Stringently quality-controlled genotypes were 
obtained at 54,794 autosomal single-nucleotide polymorphisms (SNPs) in 1928 individuals 
representing 73 Asian and two non- Asian HapMap populations (The International 
HapMap Consortium 2003).The study showed that about 50% of East Asian (EA) 
haplotypes were found in Southeast Asian (SEA) with only 5% in Central-South Asian (CSA) 
populations. This indicates that SEA is a major geographic source of EA populations.  
The phylogenetic tree shown in Figure 1-5(A), demonstrates that SEA and EA populations 
share a common origin. These observations suggest that the geographic source(s) 
contributing to EA populations were mainly from SEA populations; with rather minor 
contributions from CSA, whilst the CSA populations showed they are sharing ancestry with 
European populations.  
From the maximum likelihood phylogenetic tree (Figure 1-5(B)), the Negritos of the 
Philippines (PI-IR, PI-MW, PI-AT, PI-AG and PI-AE) and Malaysia (MY-KS and MY-JH) differ 
from neighbouring populations. The results suggested that there is substantial genetic 
proximity of SEA and EA populations (Abdulla et al. 2009). A very similar pattern of the 
population tree has been reported by Li et al. (2008) based on their previous study with 
642,690 SNPs (Li et al. 2008) .  
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Figure 1-5: Numbers on the tree branches are bootstrap values. (A) Phylogeny of group 
private haplotypes. EA and SEA private haplotypes demonstrates sharing a common origin. 
Shared haplotypes are found in all EA, SEA, and CSA samples; African haplotypes were 
only used as out-group. (B) Maximum likelihood tree of 29 populations. The tree is based 
on data from 19,934 SNPs. [Taken from (Abdulla et al. 2009)].   
A 
B 
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Other recent studies have investigated the genetic structure of the Malay population in 
Malaysia  using 54,794 genome-wide SNPs genotype data generated from four sub-ethnic 
groups: Peninsular Malaysia (Melayu Kelantan (MY-KN), Melayu Minang (MY-MN), Melayu 
Jawa (MY-JV) and Melayu Bugis (MY-BG)) (Hatin et al. 2011). These data were compared 
to 11 other populations from Indonesia, China, India, Africa and indigenous populations in 
Malaysia, which were obtained from the Pan-Asian SNP database. The results from the 
study suggest the Malay sub-ethnic groups are separated into at least three different 
clusters as shown in Figure 1-6. The MY-JV, MY-BG and MY-MN have a very close genetic 
relationship with Indonesian populations (ID-TR, ID-ML and ID-JV) indicating a common 
ancestral history, while the MY-KN formed a distinct group on the tree indicating that they 
are genetically divergent from the other Malay sub-ethnic groups. In Cluster II, MY-JV was 
also found to be closely related to the Proto-Malays (MY-TM) and Chinese (CN-JN and CN-
WA). Both Chinese populations (CN-JN and CN-WA) were originated from Yunnan, China. 
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Figure 1-6: Neighbour-joining tree on 15 populations based on the FST measurement. 
Malaysia populations: Melayu Kelantan (MY-KN), Melayu Minang (MY-MN), Melayu Jawa 
(MY-JV), Melayu Bugis (MY-BG), Proto-Malay (MY-TM), Jahai Negritos (MY-JH) and Kensui 
Negritos (MY-KS); Indonesia populations: Indonesian Toraja (ID-TR), Indonesian Melayu 
(ID-ML) and Indonesian Jawa (ID-JV); China populations: Chinese Jinuo (CN-JN) and 
Chinese Wa (CN-WA); India populations: Marathi (IN-WL) and Telugu (IN-DR); African: 
Yoruba (YRI) [Taken from (Hatin et al. 2011)]. 
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1.5.2. Theories on migration routes within Asia  
Scientists have produced two basic theories to explain the initial peopling of Asia based on 
the research carried out by the HUGO Pan-Asian SNP Consortium.  As shown in Figure 1-7, 
there are thought to have been two major waves of migration from the Middle East: one 
wave followed a southern coastal route, around the border of India, and continued from 
island to island across Malaysia, Indonesia, and the Philippines to the Pacific (see dark 
green arrows); a second wave is thought to have occurred eastwards across the Eurasian 
steppe turning south through the Asian mainland. A second theory suggests just one initial 
migration: along the coastal route, with populations moving north into East Asia from 
there (Normile 2009). 
 
Figure 1-7: Colored arrows show the genetic diversification of humans after they migrated 
eastward along what is now India’s coast and split into numerous genetically distinct 
groups that moved across Southeast Asia and migrated north into East Asia [Taken from 
(Normile 2009)]. 
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Above figure shows plausible routes of pre-historical migration of Asian human 
populations. According to their study, the most recent common ancestors of Asians 
arrived first in India (aqua-green). Later, some of them migrated to Thailand and South to 
the lands known today as Malaysia, Indonesia, and the Philippines. The first group of 
settlers must have gone very far south before they settled successfully. These included the 
Malay Negritos (brown), Philippine Negritos (purple), the East Indonesians, and early 
settlers of the Pacific Islands (dark green). Thereafter, one or several groups of people 
migrated North, mixed with previous settlers there and, finally, formed various 
populations we now refer to as Austronesian (light green), Austro-Asiatic (red), Tai-Kadai 
(dark blue), Hmong-Mien (light blue), and Altaic (yellow) etc. 
Peninsular Malaysia is a region with a great diversity of human population formed by 
Malays, Chinese, Indian and the minority aboriginal (Orang Asli) populations. The Orang 
Asli of Peninsular Malaysia is separated into three main tribal groups, the Negrito, the 
Senoi and the Proto Malays based on the physical appearance and sociological differences 
(Hood, 2006). Negrito is believed to be the earliest to arrive in Peninsular Malaysia in 
abaout 25, 000 years ago. However, to date, Negrito has the least populations among the 
three Orang Asli groups. The Negritos are physically similar to Andaman Islanders, Aeta in 
the Philippines, Melanesians and Tasmanians. They were predicted to have originated 
from Africa and spread throughout Southeast Asia (Macaulay et. al. 2005). 
Senoi is the largest Orang Asli group in Peninsular Malaysia and estimated to reach 
Peninsular Malaysia during the second wave of migration in about 8,000 years ago from 
South Asia, the mountain areas of Cambodia and Vietnam (Nicholas 1996, Baer 1999). 
They have Mongoloid physical characteristics and speak Khmer dialects. However, some 
believe Senoi are descendants of Australoid from Australia and Veddoid from South India 
(Fix, 1995).  
The second largest race of Orang Asli, the Proto-Malays were separated into six tribes, 
including Jakun/Orang Hulu, Temuan, Semelai, Kuala, Kanaq and Seletar. Fix 1995 had 
categorized the Proto Malays into 3 categories: tribes who speak Malay and wear Malay 
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costume (Temuan), tribes with combination of Proto Malays –Senoi from the linguistic and 
cultural aspects (Senoi) and tribes that settling at coastal areas, mainly Muslim and speaks 
Sumatran dialects.  
Based on archaeology and linguistic findings, it was also suggested that the proto-
Austronesian speakers settled in Taiwan about 4000 B.C. before migrated southwards to 
Southeast Asia region through Philippines into Borneo, Sulawesi, Central Java and Eastern 
Indonesia 2500 years ago (Andaya 2001).  
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1.6. OVERVIEW AND AIMS OF THE STUDY 
The main aim of this study is to investigate the usefulness of SNP markers as a tool for 
working with Malaysian casework samples, which typically exhibit high degrees of DNA 
degradation, due to the high humidity and temperatures.  
In order to carry out the study, the potential core panel of 50 to 100 SNP markers needed 
to be selected. Sanchez and colleagues have reported a multiplex of 52 SNP markers in 
one PCR reaction with two single base extension reactions (SBE) in the detection of SNPs 
using CE. The amplicons for PCR ranged from 59 to 115 bp in length.  The SBE products 
ranged from 16 to 92 bp.  The assay was shown to be robust using 500 pg DNA input. The 
two SBE multiplex comprised one reaction with the first 23 primers (marker code 1 to 23) 
and a second reaction with 29 primers (marker code 24 to 54).  
Many studies were carried out that based on these 52 markers (Barbaro et al. 2012, 
Porras et al. 2009, Santos et al. 2011, Ruiz et al. 2012, Poulsen et al. 2011, Pereira et al. 
2008). However, there were also many studies that used 50 markers (Vullo et al. 2011, 
Schwark et al. 2012a) and 49 markers of these 52 markers (Sharafi Farzad et al. 2013, 
Borsting et al. 2009, Borsting, Morling 2011, Borsting et al. 2012b, Drobnic et al. 2010, 
Tomas et al. 2013). 
In the 50plex assay, 2 SNPs had to be removed: SNP 7 (rs917118) and SNP 48 (rs8037429) 
because they led to C artifacts that hampered the evaluation of other SNPs. Schwark and 
colleagues (2012), generated 2 different multiplex reactions (21- and 29-plex) to obtain a 
satisfactory detection threshold.  
In the 49plex assay, three SNPs (rs1886510/marker 13, rs1463729/marker 35, and 
rs1028528/marker 53) were excluded. Two of them (marker 13 and marker 53) were 
previously known to be difﬁcult to analyze and the cause of many extra experiments, 
because the signals from the SBE products were weak. The SNP rs1463729 (marker 35) 
was excluded because the peak height of the G allele sometimes was 8 times higher than 
the peak height of the A allele. This was an unacceptable peak height ratio because the A 
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allele of a heterozygous individual may not always be detected in weakly ampliﬁed 
samples. In the new design, 49 SNPs are detected in two SBE reactions with 21 and 28 SBE 
primers, respectively. The lengths of the SBE primers vary from 16 to 84 nucleotides 
(Borsting et al. 2009). 
As for this study, SNPforID 52plex loci were chosen as they represented 52 well 
characterized SNP loci with population data available for several worldwide populations 
(Sanchez et al. 2006a). Their study was also supported by the SNPforID Consortium and is 
one of the sets of SNPs that is recognized by the forensic community (Butler et al. 2008) .   
To test these markers the following objectives were defined: 
1. Selection of appropriate SNP genotyping/ detection methods. 
i. To assess the sensitivity and reproducibility of two SNP genotyping 
platforms: TaqMan®SNP Genotyping Assay (Applied Biosystems) using Real-
Time PCR  and SNaPshot® (Applied Biosystems) single base extension 
system using ABI PRISM(R) 310 genetic analyzers.  
 
ii. To optimize and validate both SNP genotyping/detection methods. 
 
2. To develop and optimize a series of multiplexes. In this study, the final four sets of 
13-plex SNPs (designated 13st, 13nd, 13rd and 13th) were developed. 
3. To genotype and characterize approximately 30 unrelated individuals from each 
major ethnic group in Malaysia (Malay, Chinese and Indian) using the newly-
designed 13-plex assays. 
4. To verify and internally validate SNP genotyping with the 13st, 13nd, 13rd and 13th 
assays on the 3500 Genetic Analyzer (Applied Biosysytems). This was to assess the 
sensitivity and reproducibility of the assays before application to larger numbers of 
population samples. This included the use of reduced volumes of reagents and 
template. 
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5. SNP genotyping and characterization of an additional 80 samples from each ethnic 
group.   
6. Determine the SNP typing success of problematic specimens. Ten sets of such 
casework samples were evaluated using the multiplexes designed in order to 
observe the sensitivity of the assays in generating profiles from degraded DNA 
samples. In addition, these assays were also applied on 27 bloodstain samples 
from the same individual but were exposed to the Malaysia’s climate (Day 1 to Day 
27) sometime around August until September. 
7. Perform the multiplex assay for kinship studies. This study used 13 sets of family-
related samples obtained from real casework and two control families with known-
relationships.  This was to assess the multiplex assays’ potential as a useful marker 
set for parentage testing.  
8. Statistical analysis and evaluation of the results obtained from the study.  
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2.1 Sampling  
Throughout the work approval for the use of all Malaysian biological samples was 
granted by the University Health, Safety and Ethics Committee and the Government of 
Malaysia (Appendix A and B). Informed consents were obtained from the volunteers as 
mentioned in Appendix A. In addition, the research was approved by the University of 
Central Lancashire’s Health Safety and Ethics Committee. 
 
2.1.1. Malaysian population samples  
The Malaysian population samples comprised 110 samples from unrelated individuals 
of each of the three major ethnic groups (Malays, Chinese and Indians) living in 
Malaysia. Some of these samples have been used in previous studies looking at 
different forensic markers (Lim et al. 2001, Chang et al. 2002, Seah et al. 2003, Izuan et 
al. 2005, Chang et al. 2007) These samples, obtained from blood donors in Kuala 
Lumpur General Hospital, were provided by the Forensic DNA/Serology Laboratory, 
Department of Chemistry Malaysia. Samples were stored and transported on FTA® 
cards (Whatman® Bioscience, UK). 
 
2.1.2. Environmental Insult samples  
To assess DNA persistence of the blood samples in relation to the environment 
parameters such as humidity and temperature, 27 portions of cotton material sized 3 
cm x 3 cm bearing bloodstains were exposed to the outside environment for 27 days in 
August 2011 and September 2011. The samples were collected each day (Day 1 to Day 
27) and were labelled and then stored immediately at -20 °C until DNA extraction was 
carried out. The environment parameters/climate for days involved in month of August 
and September were supplied by the Meteorology Department of Malaysia (Appendix 
C).  
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2.1.3. Forensic casework samples  
A total of 10 cases, which comprised 51 real casework samples (as shown in Appendix 
D) were used to determine the reliability and reproducibility of SNPs assays designed in 
this study, in generating DNA profiles from the samples. Most of these samples failed 
to generate full DNA profiles during previous analysis at the DNA Laboratory, 
Department of Chemistry, Malaysia. The samples were taken from cases that had 
completed the court trial. 
 
2.1.4. Kinship samples  
A total of 12 kinship cases, particularly from parentage testing, were also used to 
investigate the usefulness and potential of the SNPs assays that had been designed in 
this study. These samples were also taken from cases that had undergone the court 
trial. Two volunteer families’ samples were used as controls in this study.  
 
2.2. Selection of Single Nucleotide Polymorphisms (SNP) markers  
A panel of 52 SNP markers, which were reported to be polymorphic in most 
populations (Sanchez et al. 2006a) was selected to be used in this study (see Table 2.1 
and Table 2.2). These SNP markers were genotyped and validated by The SNP 
Consortium and a small number by Perlegen and HapMap (http://www.hapmap.org) 
genotyping initiatives. The chosen SNP markers were selected based on the criteria as 
mentioned in Sanchez et.al.2006a. 
 
2.3. Quality Control  
Essential practices to minimize and monitor contamination within the laboratory were 
adopted. In all analyses, both positive and negative controls were processed along with 
the samples.   
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Table 2-1: 52 SNP markers positions and coordinates (Sanchez et al. 2006a). 
Individual Identification SNPs 
(IISNPs) 
Genome Coordinates 
Marker Code SNP (rs#) Chromosome NCBI human chromosome 
position 
Arm locations* 
1 rs1490413 1 TSC0724193 p36.32 
2 rs876724 2 TSC0208870 p25.3 
3 rs1357617 3 TSC0496080 p26.3 
4 rs2046361 4 TSC1065282 p16.1 
5 rs717302 5 TSC0039610 p15.33 
6 rs1029047 6 TSC0253802 p25.3 
7 rs917118 7 TSC0229630 p22.2 
8 rs763869 8 TSC0065968 p23.3 
9 rs1015250 9 TSC0097236 p24.3 
10 rs735155 10 TSC0027519 p15.2 
11 rs901398 11 TSC0177752 p15.3 
12 rs2107612 12 TSC1108144 p13.33 
13 rs1886510 13 TSC0904551 q12.11 
14 rs1454361 14 TSC0684657 q12 
15 rs2016276 15 TSC0326920 q11.2 
16 rs729172 16 TSC0028090 p13.3 
17 rs740910 17 TSC0105771 p13.2 
18 rs1493232 18 TSC0729796 p11.32 
19 rs719366 19 TSC0044147 q11 
20 rs1031825 20 TSC0334834 p13 
21 rs722098 21 TSC0050288 q21.1 
22 rs733164 22 TSC0023085 q12.1 
23 rs826472 10 TSC0557086 p15.3 
24 rs2831700 21 NA q21.3 
25 rs873196 14 TSC0202434 q32.2 
26 rs1382387 16 TSC0544547 q23.2 
27 rs2111980 12 TSC1113476 q23.2 
28 rs2056277 8 TSC1082757 q24.23 
29 rs1024116 18 TSC0247167 q23 
30 rs727811 6 TSC0062764 q27 
32 rs1413212 1 TSC0607362 q43 
33 rs938283 17 TSC0357388 q25.3 
34 rs1979255 4 TSC0925231 q35.2 
35 rs1463729 9 TSC0377760 q33.3 
36 rs2076848 11 TSC0022275 q25 
37 rs1355366 3 TSC0491662 q28 
38 rs907100 2 TSC0186810 q37.3 
39 rs354439 13 TSC0700528 q33.2 
40 rs2040411 22 TSC1056845 q13.31 
41 rs737681 7 TSC0033074 q36.3 
42 rs2830795 21 NA q21.3 
43 rs251934 5 TSC0220872 q35.2 
44 rs914165 21 TSC0197658 q22.2 
45 rs10495407 1 NA q43.1 
46 rs1360288 9 TSC0501229 q33.3 
48 rs964681 10 TSC0270699 q26.3 
49 rs1005533 20 TSC0082071 q12 
50 rs8037429 15 NA q21.3 
51 rs891700 1 TSC0162577 q43.3 
52 rs1335873 13 TSC0829150 q12.11 
53 rs1028528 22 TSC0253071 q13.31 
54 rs1528460 15 TSC0798410 q21.3 
Note: *Data were obtained from https://genome-euro.ucsc.edu/cgi-bin.   
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Table 2-2: PCR and SBE primers used in original study (Sanchez et al. 2006a). 
Individual Identification SNPs 
(IISNPs) 
PCR Single base extension (SBE) 
Marker Code SNP (rs#) Final primer 
concentration 
Amplicon 
size 
SNP 
detected 
Final primer 
concentration 
Amplicon 
size 
SNPs 
detected 
1 rs1490413 0.06 68 A/G 0.01 18 T/C 
2 rs876724 0.02 83 C/T 0.04 24 C/T 
3 rs1357617 0.02 90 A/T 0.02 29 T/A 
4 rs2046361 0.03 79 A/T 0.27 78 T/A 
5 rs717302 0.04 86 A/G 0.02 74 A/G 
6 rs1029047 0.06 100 A/T 0.04 54 A/T 
7 rs917118 0.03 87 C/T 0.02 18 G/A 
8 rs763869 0.09 100 C/T 0.03 42 C/T 
9 rs1015250 0.03 95 C/G 0.02 29 G/C 
10 rs735155 0.05 100 A/G 0.02 34 T/C 
11 rs901398 0.02 70 C/T 0.04 46 C/T 
12 rs2107612 0.05 93 A/G 0.02 58 A/G 
13 rs1886510 0.01 86 C/T 0.05 25 G/A 
14 rs1454361 0.02 73 A/T 0.02 62 A/T 
15 rs2016276 0.17 90 A/G 0.02 74 T/C 
16 rs729172 0.02 60 A/C 0.02 70 T/G 
17 rs740910 0.08 87 A/G 0.01 42 A/G 
18 rs1493232 0.07 59 C/A 0.01 66 T/G 
19 rs719366 0.06 105 C/T 0.04 58 C/T 
20 rs1031825 0.03 98 A/C 0.02 50 T/G 
21 rs722098 0.12 81 A/G 0.01 38 A/G 
22 rs733164 0.02 68 A/G 0.01 34 A/G 
23 rs826472 0.04 85 C/T 0.01 46 G/A 
24 rs2831700 0.04 62 G/A 0.03 56 C/T 
25 rs873196 0.03 63 C/T 0.03 52 A/G 
26 rs1382387 0.02 69 G/T 0.03 64 G/T 
27 rs2111980 0.01 72 A/G 0.03 23 A/G 
28 rs2056277 0.03 73 C/T 0.02 92 A/G 
29 rs1024116 0.03 76 A/G 0.03 56 A/G 
30 rs727811 0.03 78 A/C 0.04 72 A/C 
32 rs1413212 0.05 84 A/G 0.05 44 C/T 
33 rs938283 0.03 85 C/T 0.05 22 C/T 
34 rs1979255 0.03 86 C/G 0.05 40 G/C 
35 rs1463729 0.04 87 A/G 0.05 84 A/G 
36 rs2076848 0.04 89 A/T 0.05 27 A/T 
37 rs1355366 0.05 90 A/G 0.03 48 C/T 
38 rs907100 0.04 91 C/G 0.03 27 G/C 
39 rs354439 0.05 93 A/T 0.04 80 A/T 
40 rs2040411 0.03 94 A/G 0.05 68 A/G 
41 rs737681 0.03 96 C/T 0.03 16 C/T 
42 rs2830795 0.02 97 A/G 0.03 44 A/G 
43 rs251934 0.01 98 C/T 0.03 88 A/G 
44 rs914165 0.07 100 A/G 0.05 32 C/T 
45 rs10495407 0.05 102 G/A 0.04 68 C/T 
46 rs1360288 0.04 103 C/T 0.03 16 A/G 
48 rs964681 0.03 106 C/T 0.03 36 C/T 
49 rs1005533 0.03 107 A/G 0.03 36 A/G 
50 rs8037429 0.03 108 C/T 0.03 76 A/G 
51 rs891700 0.04 109 A/G 0.02 32 A/G 
52 rs1335873 0.03 110 A/T 0.04 40 T/A 
53 rs1028528 0.02 113 A/G 0.03 48 A/G 
54 rs1528460 0.06 115 C/T 0.03 60 A/G 
Note: SNP markers 31 and 47 were discarded by the authors.   
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2.4. DNA extraction and purification  
The population samples were extracted and purified using three 
extraction/purification methods; organic solvent and two commercial kits: QIAamp 
DNA Micro kit and QIAamp DNA Investigator Kit (Qiagen GmbH, Hilden, Germany). 
 
2.4.1. Organic Solvent (Phenol/Chloroform/Isoamyl alcohol)  
The organic solvent extraction was carried out as described in previous study 
(Hochmeister et al. 1991). Approximately, 3 mm2 of FTA® card (Whatman) was cut and 
placed into a 1.5 ml microcentrifuge tube. 400 μl of Digest Buffer (10 mM Tris-HCl, 10 
mM EDTA, 50 mM NaCl, 2% (w/v) SDS, pH 7.5) and 15 μl of Proteinase K (10 mg/ml; 
QIAGEN Ltd) were added into the same microcentrifuge tube. The mixture was 
incubated at 56 °C for 18 h or 24 h. After incubation, 400 μl of 
phenol:chloroform:isoamyl alcohol (25:24:1; Sigma Aldrich) were added to the mixture, 
mixed, vortexed and then centrifuged for 5 min at 13,000 rpm (9750 g). The aqueous 
phase (upper layer) was then transferred into a new 1.5 ml microcentrifuge tube. This 
step was repeated twice. To each tube, 1 ml of cold absolute ethanol was added. The 
tubes were inverted few times and then incubated at -20 °C for 1 h. After that, the 
tubes were centrifuged for 20 min at 13,000 rpm. Ethanol was removed by pipetting 
out from the tubes. The tubes caps were left open to allow any residual ethanol to 
evaporate. DNA was re-suspended by adding 30 μl of TE buffer (10mM Tris-HCL, 
0.1mM EDTA, pH 8.0) and was incubated at 56 °C overnight. 
 
2.4.2. QIAamp DNA Micro kit   
The QIAamp DNA Micro kit was used by following the manufacturer’s protocol 
(QIAGEN 2010b). This protocol is for isolation of genomic DNA from blood card 
punches (diameters of approximately 3 mm), bloodstain card or FTA Card (Whatman), 
Guthrie test cards and untreated blood or blood treated with anticoagulants such as 
EDTA, citrate or heparin. Approximately, up to three 3 mm diameter punches from a 
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dried blood spot were placed into a 1.5 ml microcentrifuge tube.  To the tube, 180 μl 
of Buffer ATL and 20 μl of Proteinase K (10 mg/ml) were added into the tube. The 
mixed solution was vortexed thoroughly. The tube was placed in the heated incubator 
at 56 °C for 1 h. During incubation, the solution was vortexed vigorously for 10 s every 
10 min.  After the incubation, the tube was briefly centrifuged to remove drops from 
the inside of the lid. Then, 200 μl of Buffer AL was added and the lid was closed before 
mixed by pulse-vortexing for 10 s. The tube was incubated again at 70 °C for 10 min 
and vortexed for 10 s every 3 min.  The tube was centrifuged briefly before transferring 
the entire lysate into the QIAamp MinElute column without wetting the rim. The tube 
was centrifuged at 8,000 rpm (6000 g) for 1 min. Then, the QIAamp MinElute column 
was placed in a clean 2 ml collection tube, whilst the collection tube containing the 
flow-through was discarded. 500 μl of Buffer AW1 was added to the column, and the 
tube was centrifuged at 8,000 rpm for 1 min.  The filtrate was discarded, and the 
column was placed in a clean collection tube, before 500 μl of Buffer AW2 was added 
into the column. The tube was centrifuged again at 8,000 rpm for   1 min. 
The column was transferred to a clean collection tube and the flow-through solution 
was discarded. Then the column was centrifuged at full speed (13,000 rpm or 9750 g) 
for 3 min to completely dry the column’s membrane. The QIAamp MinElute column 
was transferred in a clean 1.5 ml microcentrifuge tube and the filtrate was discarded. 
To each tube, 25 μl of Buffer AE was added to the centre of the column’s membrane, 
and the column was incubated at room temperature for 1 min. After that the tube was 
centrifuged at higher speed (13,000 rpm) for 1 min.  The filtrate containing the DNA 
was stored at -20 °C. 
 
2.4.3. QIAamp DNA Investigator Kit   
The QIAamp DNA Investigator kit was used by following the manufacturer’s protocol 
(QIAGEN 2010a). Firstly, stained materials were cut out up to 0.5 cm2, then into 
smaller pieces and transferred to a 1.5 ml microcentrifuge tube. To the tube, 300 μl of 
Buffer ATL and 20 μl of Proteinase K were added, and the solution was mixed by pulse-
vortexing for 10 s. The tube was kept in the incubator at 56 °C for 1 h. The solution was 
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vortexed for 10 s every 10 min to enhance the lysis process. After the incubation, the 
tube was centrifuged briefly, and 300 μl of Buffer AL was added. The solution was 
mixed by pulse-vortexing for 10 s, and placed it in the incubator at 70 °C for 10 min. 
Every 3 min, the solution was vortexed for 10 s.  Then, the tube was centrifuged briefly, 
before adding 150 μl of ethanol (96%), and mixed thoroughly by pulse-vortexing for 15 
s. The supernatant was transferred to the QIAamp MinElute column, and was 
centrifuged at 8,000 rpm (6,000 g) for 1 min. The column was placed in a clean 
collection tube, whilst the flow-through was discarded.  To the column, 500 μl of 
Buffer AW1 was added and the tube was centrifuged at 8000 rpm for 1 min.  The 
filtrate was discarded, the column was placed in a clean collection tube, and 700 μl of 
Buffer AW2 was added into the column. The tube was centrifuged again at 8000 rpm 
for 1 min. The column was transferred in a clean collection tube, and the flow-through 
was discarded. After that, 700 μl of ethanol (96%) was added and the tube was 
centrifuged at 8000 rpm for 1 min. The column was transferred again in a clean 2 ml 
collection tube and was centrifuged at full speed (13,000 rpm) for 3 min. The QIAamp 
MinElute column was placed in a clean 1.5 ml microcentrifuge tube, whilst the flow-
through was discarded.  Finally, 25 μl of Buffer ATE was dispensed in the centre of the 
membrane and left to incubate at room temperature for 1 min. Then, the tube was 
centrifuged at full speed (13, 000 rpm) for 1 min. DNA was stored until being used. 
 
2.5. Quantification of DNA samples  
The DNA concentrations were determined using Quantifler® Human DNA 
Quantification kit (Applied Biosystems) run on an Applied Biosystems® 7500 Real-Time 
PCR System. Quantification standards were prepared by serial dilution in TE buffer of 
the 200 ng/μl Human DNA Standard included in the kit. Eight serial dilutions ranging 
from 50 ng/μl to 0.023 ng/μl were used. The procedure was carried out according to 
the manufacturer’s protocol, but instead of using full-scale reactions, the total volume 
of this assay was reduced (Westring et al. 2007). The reduced-scale reaction consisted 
of a 5.25 μl of Quantifiler PCR Reaction Mix, 6.25 μl of Quantifiler Human Primer Mix 
and 1 μl of the DNA sample for a final reaction volume of 12.5 μl. 
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Samples, including the non-template control (NTC) and the DNA standards were 
loaded into MicroAmp® Optical 96-well reaction plate and sealed using Optical 
Adhesive Covers (Applied Biosystems). Each standard dilution was run in duplicate, 
with replicates placed in wells near each other, then followed by DNA samples. 
The sample sheets were set up and the samples were run using the standard thermal 
amplification profile of 95 °C for 10 min; 40 cycles of 95 °C for 15 s and 60 °C for 1 min. 
Standard curves were generated and amplification plots were used to compare the 
results. Internal Positive Control (IPC) results were monitored for the presence of PCR 
inhibitors.  
From the results obtained, the samples with low DNA concentrations (< 0.01 ng) were 
re-quantified to confirm no error had happened during the sample preparation. The 
samples which still showed very low DNA amounts were re-extracted from the original 
FTA card using the Organic Solvent (phenol/chloroform/isoamyl alcohol) method and 
then quantified with Quantifler® kit. 
 
2.6. Reproducibility and Sensitivity study  
In order to evaluate the ability of the SNP genotyping method chosen for obtaining 
reliable and consistent results, a small internal validation study was performed based 
on the threshold level of 2 ng genomic DNA, which is now above the sensitivity level 
used in forensic casework.  
 
2.6.1. Serial dilutions  
A series of dilutions of Applied Biosystems TaqMan® Control Genomic DNA (Human; 10 
ng/ μl) were prepared as follows: (i) TaqMan® SNP Genotyping assays : (2.0, 1.0, 0.5, 
0.25, 0.125, 0.063, 0.032, 0.016, 0.008, 0.004 and 0.002) ng/ μl, and (ii) SNaPshot 
Reaction ( multiplex):  (2.5, 1.0, 0.5, 0.25, 0.13, 0.06, 0.03, 0.02 and 0.01) ng/ μl. 
 
CHAPTER 2  Materials & Methods  
 
47 
 
2.6.2. Testing population samples 
1 μl of each extracted DNA sample (Malaysian population samples), which ranged from 
0.01 ng/ μl to 569 ng/ μl was used to assessed the reproducibility of the four sets of 
SNaPshot multiplexes designed in this study.  
 
2.7. SNP Genotyping  
In this study, two SNP typing technologies were selected to genotype the autosomal 
SNP markers; (i) TaqMan® SNP Genotyping Assays and (ii) SNaPshot® Multiplex System 
(both, Applied Biosystems). The SNP typing was carried out using the AB® 7500 Real- 
Time PCR System and Genetic Analyzer 310 (both Applied Biosystems), respectively. 
 
2.7.1. TaqMan® SNP Genotyping Assays 
 
2.7.1.1.  Concept of the assay  
The assay of these SNP markers contains two locus-specific primers that flank the SNP 
of interest and two TaqMan® MGB probes. One probe labelled with VIC® dye detects 
the Allele 1 sequence and another probe labelled with FAM™ dye detects the Allele 2 
sequence. The assay determines the presence or absence of the two possible variant 
alleles at the SNP site in a DNA target sequence based on the change in fluorescence of 
the dyes associated with the probes.  
 
2.7.1.2.  Sample preparation  
Firstly, the TaqMan Genotyping Assay mix (consisting of primers and probe) were 
diluted from 40X to a 20X working stock with 1X TE buffer, vortexed and centrifuged. 
The assay was aliquotted and stored at -20 °C until it was used. Then, a 96-well 
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reaction plate for an Allelic Discrimination (AD) assay was set up with the samples and 
reaction mix. The optimization was carried out using TaqMan® Control Genomic DNA 
(Human; 10 ng/ μl) with different series of concentrations, and different PCR reaction 
mix volumes as follows: 
 
Table 2-3: Several PCR reaction mix volumes used for the study to observe the 
sensitivity of the assay. 
PCR Reaction Mix Volume (μl/well) 
Components 5µl 
reaction 
10µl 
reaction 
12.5µl 
reaction 
25µl  
reaction 
TaqMan Genotyping Master 
Mix  (2X) 
2.5 5 6.25 12.5 
TaqMan genotyping Assay Mix 
(2X) 
0.25 0.5 0.625 1.25 
DNase-free, RNase free Water 1.25 3.5 4.625 10.25 
Total 4.0 9.0 11.5 24.0 
 
 
The reaction mix was pipetted into each well of a reaction plate according to the 
calculated volumes as shown in Table 2.3. Then, 1 μl from each series of dilution was 
added into each well. The plate was covered with MicroAmp® Optical Adhesive Film 
and each well was inspected for volume uniformity or bubbles before putting it into 
the AB® 7500 Real- Time PCR instrument. 
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2.7.1.3.  Creating an Allelic discrimination (AD) Plate Document  
An AD plate document was created to store all information about the run, including 
sample names, markers, and detectors following the protocols provided by the 
manufacturers (Applied Biosystems 2005).  
 
2.7.1.4.  Creating an Absolute Quantification (AQ) Plate Document  
An AQ plate document was created to store real-time data for AD assays following the 
protocols provided by the manufacturers (Applied Biosystems 2005). This document 
was used only to amplify target sequences (not to quantify the PCR products), and 
therefore no standard curves were needed. 
 
2.7.1.5.  Performing Runs  
The AD assay involved three main steps (provided by the manufacturer in the User 
Manual (Applied Biosystems 2005)) as follows in order to generate data and results:  
 
2.7.1.5.1.  A pre-read run  
A run on an AD plate document to determine the baseline fluorescence associated 
with primers and probes before amplification.  
 
2.7.1.5.2.  An amplification run  
A run uses an Absolute Quantification (AQ) plate document to generate real-time PCR 
data, which can be used to analyze and troubleshoot the PCR data for the AD assay. 
The cycling program used; 50 °C for 2 min; 1 cycle of 95 °C for 10 min; and 40 cycles of 
95 °C for 15 s and 60°C for 1 min. 
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2.7.1.5.3.  A post-read run  
A run that uses the original AD plate document (pre-read plate document). The post-
read run automatically subtracts the baseline fluorescence determined during the pre-
read run, and then assigns allele calls (automatically or manually) using the amplified 
data.  
All above steps were carried out according to the manufacturer’s protocol. 
 
2.7.1.6.  Evaluating results  
After an AD post-read run, the 7500 SDS Software was used to analyze raw data. The 
raw data were converted and expressed in terms of fluorescence signal versus filters, 
to pure dye component. The software identified the dye components and determined 
the contribution of each dye in the raw data using the multicomponent algorithm. The 
results of AD were plotted on a scatter plot of Allele X versus Allele Y.  
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2.7.2. SNaPshot® Multiplex System  
52 pairs of SNPs primers (Sanchez et al. 2006a) were used in single and multiplex 
SNaPshot reactions following a flow diagram as shown in Figure 2-1.  
 
Figure 2-1: Overview of the procedure of PCR and SBE reactions for SNP genotyping 
whole process [Taken from Applied Biosystems 2009a]. 
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2.7.2.1.  Single SNP reaction 
Each of the 52 SNP markers was amplified individually in a single PCR reaction. Two 
control DNA samples (TaqMan® Control Genomic DNA and one Malay individual (M7-
7)) were used throughout the optimization study. Each was used at two different DNA 
concentrations: 0.5 ng and 1 ng to test the assays. Several concentrations of PCR and 
single base extension (SBE) primers were evaluated to determine the sensitivity of the 
assay (Table 2.4). 
 
Table 2-4: Combinations of primer concentrations in SNaPshot analysis. 
Stage Combination of the primer concentrations (µM) 
PCR 0.05 0.05 0.1 0.1 0.2 0.2 
SBE 0.05 0.1 0.05 0.1 0.05 0.1 
 
 
2.7.2.2.  Multiplex SNP assay set-up  
In this study, four sets of 13-plexes were developed, named as 13st, 13nd, 13rd and 13th. 
These multiplexed assays were used and tested for the optimal conditions. All 
sequences and sizes of all primers used are the same as described in the original study 
(Sanchez et al. 2006a). The combinations of the PCR and SBE primers were evaluated 
to increase the specificity of the assays. The final combinations of all primer pairs in 
each multiplex (PCR and SBE reactions) are presented in Table 2.5.  
 
2.7.2.3.  Amplification and optimization of SNP assays 
Optimization of each reaction was carried out to determine the optimal amplification 
conditions for different DNA targets. Two sets of reaction volumes, 12 μl and 15 μl 
were prepared as listed in Table 2.6. The final concentrations of each primer (forward 
and reverse) in single reaction was 0.2 μM, whilst for 13-plex reactions, it ranged 
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from     0.05 μM to 0.4 μM as shown in Table 2.7. All PCR were performed in a 
GeneAmp 9700 or VeritiTM 96 Well thermal cycler (both, Applied Biosystems), with the 
optimal cycling parameters (Table 2.8). 
 
2.7.2.4.  Agarose Gel Electrophoresis  
The amplified products (5 μl) of single SNP reactions were analyzed using a 2.5%  (w/v) 
agarose gel which was stained afterwards with ethidium bromide (0.5 μg/ml). The 20 
bp and 1 kb DNA Marker were used and loaded together with the samples onto the gel. 
The gel was photographed using a gel documentation system (Bio Doc-ItTM system at 
595 nm).  
Table 2-5: New combination and arrangement of the same 52 SNP code markers (from 
the original study) into four sets of 13-plex assays, 13st, 13nd, 13rd and 13th.  
Four sets of 13-plex PCR/SBE assays 
Markers Code 
13st 13nd 13rd 13th 
1 46 41 7 
2 13 27 33 
3 9 36 38 
22 10 21 51 
34 49 44 48 
23 11 8 52 
53 4 17 42 
20 25 32 37 
12 29 6 54 
14 24 19 45 
16 26 40 50 
5 18 30 35 
39 15 43 28 
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Table 2-6: PCR optimal conditions of single and multiplex reactions. 
Final concentrations (volume used in µl) 
Components Single reaction Multiplex 
Concentration of DNA used 
0.5 ng/ µl and 1 ng/ µl(1 
µl) 
0.01 ng/ µl to 32 ng/ µl 
(1 µl) 
Primers (Forward and 
reverse) 
0.2 µM each 
(0.96 µl) 
0.05 µM to 0.3 µM 
(1 µl) 
10X PCR Buffer II (100 mM 
Tris-HCL, 500 mM KCl, pH 8.3) 
1X 
(1.2 µl) 
1X 
(1.5 µl) 
 
25 mM MgCl2  Solution 
 
1.5 mM 
(0.72 µl) 
3.0 mM 
(1.8 µl) 
 
10 mM GeneAmp® dNTPs 
 
0.2 mM 
(0.24 µl) 
0.4 mM 
(0.6 µl) 
AmpliTaqGold Polymerase, 
5U/µl 
1.25U 
(0.25 µl) 
2U 
(0.4 µl) 
 
DNase-free, RNasefree 
Water 
*7.63 µl *8.7 µl 
 
Total Volume 
 
12 µl 15 µl 
*Any volume of water can be used as long as the total volume of the Master Mix, 
sample and primers equal to 12 μl or 15 μl. 
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Table 2-7: Optimized final primer concentrations (µM) for each multiplex set. 
Set of 
Multiplexes 
13st 13nd 13rd 13th 
M
u
lt
ip
le
xe
d
 L
o
ci
 w
it
h
 f
in
al
 p
ri
m
er
s 
co
n
ce
n
tr
at
io
n
s 
(µ
M
) 
 
1 0.15 46 0.1 41 0.1 7 0.1 
2 0.1 13 0.1 27 0.05 33 0.08 
3 0.15 9 0.1 36 0.1 38 0.15 
22 0.1 10 0.15 21 0.15 51 0.1 
34 0.15 49 0.1 44 0.1 48 0.15 
23 0.2 11 0.15 8 0.15 52 0.15 
53 0.1 4 0.3 17 0.1 42 0.1 
20 0.15 25 0.1 32 0.3 37 0.15 
12 0.15 29 0.1 6 0.25 54 0.15 
14 0.1 24 0.1 19 0.2 45 0.4 
16 0.1 26 0.15 40 0.1 50 0.2 
5 0.15 18 0.1 30 0.15 35 0.1 
39 0.1 15 0.15 43 0.15 28 0.07 
 
 
Table 2-8: The optimal thermal cycling parameters. 
PCR Cycling conditions Single reaction Multiplex reaction 
Initial denaturation 
 
95 °C for  1 min 
 
95 °C for  5 min 
 
Denaturation 
Annealing 
Extension 
 
95 °C for  30 sec 
60 °C for  30 sec 
65 °C for  30 sec 
 
95 °C for  30 sec 
60 °C for  30 sec 
65 °C for  30 sec 
 
Final extension 65 °C for  7 min 65°C for  7 min 
  
35X 35X 
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2.7.2.5.  PCR product Clean-up  
When amplification was complete, any non-incorporated dNTPs and primers remaining 
were removed using the ExoSAP-IT®, a single step enzymatic reaction (USB, Affymetrix). 
In each 3 μl PCR samples, 1.2 μl of ExoSAP-IT® reagent was added and then incubated 
at 37 °C for 15 min and 80 °C for another 15 min. The samples were kept in -20 °C until 
the single base reaction (SBE) amplification was carried out.  
 
2.7.2.6.  Single Base-reaction (SBE) Amplification  
To develop the four sets of 13 SBE multiplexes in this study a few of the SBE primers 
length were modified from the original SBE primers established (Sanchez et al. 2006a). 
Each modification involved the addition or reduction of poly thymidine (poly T) or poly 
cytosine (poly C) to the 5ʹ end of SBE primers, as suggested by the Applied Biosystems 
SNaPshot® User’s Manual. The new SBE length (bp) is shown in Table 2.9. 
The SBE reactions were carried out for both, single reaction and multiplex reaction 
using SNaPshot® Multiplex Kit (Applied Biosystems). The optimized reactions and 
optimized SBE primers (single and multiplex) are illustrated in Table 2.10 and Table 
2.11, respectively. Thermal cycling conditions were applied as suggested in the 
SNaPshotTM protocol: 25 cycles of 96 °C for 10 s, 50 °C for 5 s, and 60 °C for 30 s. 
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Table 2-9: Modified SBE length (bp). 
SNP Marker Code Original length (bp) Modified length 
(bp) 
SNP detected 
4 78 47 T/A 
5 74 70 A/G 
7 18 20 G/A 
8 42 40 C/T 
9 29 30 G/C 
11 46 44 C/T 
13 25 26 G/A 
16 70 68 T/C 
18 66 68 T/G 
19 58 60 C/T 
21 38 32 A/G 
22 34 36 A/G 
23 46 45 G/A 
51 32 31 A/G 
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Table 2-10: The optimal conditions used for the SBE reactions. 
Components Volumes (µl) 
Single 
reaction 
Multiplex 
reaction 
Positive 
Control 
NTC Control 
 
SNaPshot® Mix 
2 2 2 2 
 
Purified PCR 
product/ Control 
DNA 
1 1.5 1 1 
 
SBE primer (0.2 
µM) / SBE 
primers/ Control 
primers 
0.2 1 0.5 0.5 
 
DNase-free, 
RNasefree 
Water 
1.8 0.5 1.5 1.5 
 
Total 
 
5 
 
5 
 
5 
 
5 
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Table 2-11: The final concentrations (µM) of SBE primers used in the SNaPshot 
reactions. 
SNaPshot 
Reactions 
Single 
reaction 
Multiplex reaction 
13st 13nd 13rd 13th 
M
u
lt
ip
le
xe
d
 L
o
ci
 w
it
h
 f
in
al
 p
ri
m
er
s 
co
n
ce
n
tr
at
io
n
s 
(µ
M
) 
 
Each single 
SNP 
reaction 
used 0.2 µM 
SBE primer 
1 0.07 46 0.07 41 0.07 7 0.15 
2 0.1 13 0.06 27 0.05 33 0.1 
3 0.08 9 0.15 36 0.08 38 0.15 
22 0.1 10 0.15 21 0.15 51 0.1 
34 0.15 49 0.1 44 0.15 48 0.15 
23 0.2 11 0.1 8 0.2 52 0.1 
53 0.1 4 0.15 17 0.15 42 0.15 
20 0.2 25 0.15 32 0.3 37 0.15 
12 0.3 29 0.1 6 0.4 54 0.15 
14 0.15 24 0.15 19 0.2 45 0.2 
16 0.2 26 0.1 40 0.1 50 0.15 
5 0.3 18 0.2 30 0.15 35 0.15 
39 0.2 15 0.3 43 0.2 28 0.1 
 
 
2.7.2.7.  SBE products Clean-up by SAP (USB, Affymetrix)  
The excess of fluorescently labeled ddNTPs in the primer extension reaction were 
removed by the addition of 0.5 μl Shrimp Alkaline Phosphatase (SAP) into each 2.5 μl 
SBE product, the reactions were mixed briefly and incubated at 37 °C for 45 min and 
80 °C for 15 min.  
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2.7.2.8.  Capillary Electrophoresis  
 
2.7.2.8.1.   ABI PRISM® 310 Genetic Analyzer (Applied Biosystems) 
Electrophoresis running buffer was used at 1X concentration. The GSPOP 4 (1ml) 
E.md5 run module with dye set DS-02 (filter set E): dR110, dR6G, dTAMRA™, dROX™, 
and LIZ® dyes) was used with the following parameters: run temperature 60 °C, syringe 
pump time 150 s, pre-run voltage 15 kV, pre-run time    120 s, injection time 5 s, 
injection voltage 15 kV, run voltage 15 kV and run time 30 min.  
In a 0.2 ml PCR tube, 1 μl of SAP- treated SBE products was diluted in 11 μl of Hi-DiTM 
formamide and 0.4 μl GeneScan™ (GS) 120-LIZ® Internal Size Standards (both, Applied 
Biosysytems). Then, the samples were analyzed using ABI 310 PRISM® Genetic 
Analyzer (Applied Biosystems) with 36 cm capillary array and POP-4™ polymer. 
 
2.7.2.8.2.  3500 Genetic Analyzer (Applied Biosystems) 
For the concordance study and to increase the throughput of sample processing, DNA 
fragment analysis was also performed using a 3500 Genetic Analyzer. Following PCR 
amplification, electrophoretic separation of dye-labelled amplicons was performed on 
the 3500 using a 50 cm capillary array and 3500 POP-6™ polymer. The 
FragmentAnalysis50_POP6 run module was used in combination with the dye set DS-
02 (filter set E5): dR110, dR6G, dTAMRA™, dROX™, and LIZ® dyes) with the following 
parameters: run temperature 60 °C, pre-run voltage 15 KV, pre-run time 180 s, 
injection time 10 s, injection voltage 1.6 kV, run voltage 15 kV and run time 1800 s. 
Each sample for fragment analysis was prepared by adding 1 μl of PCR product to 10 μl 
of Hi-Di™ formamide (Applied Biosystems) containing 0.3 μl GS120 LIZ size standard 
(Applied Biosystems). The samples were heated at 95 °C for 5 min, and snap-cooled at 
least 3 min. Samples were subjected to capillary electrophoresis, detected by laser-
induced fluorescence. 
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2.7.2.8.3.  Analysis of DNA Profiles  
The data obtained from capillary electrophoresis (CE) were analysed using 
GeneMapper™ ID version 3.2 (ABI 310) and GeneMapper® ID-X Software version 1.2 
(3500 Genetic Analyzer). The parameters for the analysis of the multiplex amplicons 
were kept constant for each run and are described in Table 2.12. 
 
Table 2-12: Shown below are the parameters for the analysis of PCR fragments. 
Parameters Values 
Analysis Range Full Range 
Size Call Range All Sizes 
Size Calling Method Local Southern 
Peak Detection 50 RFU 
Baseline Window 51 pts 
Minimum Peak Half Width 2 pts 
Polynomial Degree 3 pts 
Peak Window Size 15 pts 
Slope Threshold for peak start/end  0-0 
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2.8. Data collection and evaluation.  
All SNaPshot results were collected and analyzed with peak thresholds set to a 
minimum of 120 RFUs (blue colour), 60 RFUs (green colour) and 30 RFUs (yellow, red 
and orange colours). The criteria for acceptable peak height ratio for heterozygous 
allele calls and homozygous allele calls for each locus were as described in the original 
study (Sanchez et al. 2006a).  
 
2.9. Statistical analysis  
The results were further analyzed using Arlequin Software version 3.5.1.3 (Excoffier, 
Lischer 2010) for allele frequencies, expected and observed heterozygosities (He and 
Ho, respectively), Hardy-Weinberg equilibrium (HWE) and pairwise FST values. The 
analyses Arlequin can perform on the data fall into two main categories: intra-
population and inter-population methods. In the first category statistical information is 
extracted independently from each population, whereas in the second category, 
samples are compared to each other. 
HWE is a test of non-random association of alleles within diploid individuals. It 
concerns the relationship between allele probabilities and genotype probabilities at 
one locus. In essence, the Hardy–Weinberg law is a statement of independence 
between alleles at one locus.  
Estimates of FST can identify regions of the genome that have been the target of 
election, and comparisons of FST from different parts of the genome can provide insight 
into the demographic history of those populations. In Wright’s notation, subscripts ST 
refer to “subpopulations within total”. FST plays a central role in population and 
evolutionary genetics, and FST has wide applications in fields from disease association 
mapping to forensic science. Thus, FST must be considered when allele frequencies are 
compared between “cases” and “controls” to ensure that differences between them 
are greater than expected by chance. Similarly, the match probability between a 
suspect and a crime scene sample is specific to the set of people who might reasonably 
be expected to be sources of the sample. But defining this set is difficult, so a “θ 
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correction” is applied to population frequencies to accommodate variation among 
subpopulations. The “θ correction” depends on the value of FST. θ, the co-ancestry 
coefficient, is the probability that two alleles in the population have descended from 
the same allele and are identical by descent. This is a measure of the coancestry of 
populations diverging due to genetic drift. The larger θ, the longer it has been since the 
populations diverged.  
The power of discrimination and match probability values were calculated for each 
locus using Powerstats software (Jones 1972, Botstein et al. 1980).  
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PART ONE: 
 
TAQMAN® SNP GENOTYPING ASSAYS 
 
3.1. INTRODUCTION 
The analysis of degraded DNA can be problematic. As DNA becomes degraded, the 
higher molecular weight STR loci fail to amplify (Golenberg et al. 1996) giving a partial 
DNA profile that has a lower discrimination power (Dixon et al. 2005). Recent advances 
in the identification and analysis of single nucleotide polymorphisms (SNPs) have 
demonstrated the advantage of these markers over short tandem repeats (STRs) is 
that they only require small amplicons (Goodwin et. al. 2011).  
There are various platforms for detecting SNP markers in single or multiplex reactions. 
TaqMan® SNP Genotyping Assays are the largest collection of single-tube and ready-to-
use SNP assays that are commercially available. The TaqMan SNP® Genotyping Assays 
library (snp.appliedbiosystems.com) consists of four human assay collections:the 
TaqMan® Validated SNP Genotyping Assays, TaqMan® Coding SNP Genotyping Assays, 
TaqMan® Pre-Designed SNP Genotyping Assays, and TaqMan® Drug Metabolism 
Genotyping Assays (Applied Biosystems 2006).  
The TaqMan® SNP Genotyping assays are a single-tube assay that exploit the 5 
exonuclease activity of AmpliTaq Gold® DNA Polymerase to discriminate the targeted 
alleles.  The assay comprises two locus-specific PCR primers that flank the SNP of 
interest, and two allele-specific oligonucleotide TaqMan® probes (Figure 3-1). These 
probes have a fluorescent reporter dye at the 5 end, and a non-fluorescent quencher 
(NFQ) with a minor groove binder (MGB) at the 3 end (Applied Biosystems 2010a).  
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Figure 3-1: Allelic discrimination is achieved by the selective annealing of TaqMan® 
MGB probes. [Taken from Applied Biosystems, 2010a]. 
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For each sample in an allele discrimination (AD) assay, a unique pair of fluorescent dye 
detectors is used. The AD assay measures the change in fluorescence of the dyes 
associated with the probes. One fluorescent dye is a perfect match to the wild type 
(allele 1) and the other fluorescent dye detector is a perfect match to the variant 
(allele 2) (Applied Biosystems 2010a). A large number of the validated TaqMan® SNP 
Genotyping assays are commercially available, which makes it possible to implement 
this type of SNP genotyping platform (De La Vega et al. 2005b).   
As for data analysis, TaqMan® Genotyper Software is commonly used as a SNP 
genotyping data analysis tool for TaqMan® SNP Genotyping Assays. This software is a 
standalone application that analyzes raw data from genotyping experiments 
performed on an Applied Biosystems® realtime PCR system. The software allows the 
user to choose between two methods to call genotypes: Auto-calling and Classification 
Scheme. In the Auto-calling method, the determining factor influencing the genotype 
call is a value that the algorithm assigns to each data point; that is the Quality value 
(Life Technologies 2013).  
The Quality value reflects the probability of the genotype call; the default threshold for 
the Quality value in the software is 0.95. This threshold is listed in the Analysis Settings 
on the QC Settings tab (Life Technologies 2013). Lowering the default threshold can 
increase the sample call rate (Figure 3-2 (B)), but usually a sample with a lower Quality 
value of 0.94, will receive an undetermined call (Figure 3-2 (A)).  
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Figure 3-2: The circled sample in the scatter plot (A) is assigned an undetermined call 
when the default threshold of 0.95 is applied for analysis, but it is assigned a 
heterozygous call (B) when the Quality value threshold is lowered to 0.80. [Taken from 
Life Technologies (2013)]. 
 
Referring to Figure 3-3, Angle (A) and amplitude (B) for each data point are calculated 
by the formulas below (Life Technologies 2013). 
 
 
The algorithm computes the models for the distribution of angles and amplitudes for 
each of the class labels. The score is an estimate of how closely a given data point 
belongs to those underlying models of angle and amplitude distributions for each 
genotype cluster. 
 
 
A B 
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Figure 3-3: Illustration of angle (A) and amplitude (B) calculated from the No Template 
control (NTC). Good cluster separation means good separation of data points from 
other clusters (angle) and leads to good angle scores. Good signal intensity means 
good separation of data points from the NTC and generates good amplitude scores. 
[Taken from Life Technologies (2013)]. 
The distribution of angles and amplitudes shown in Figure 3-4, shows that the data 
point would map between the distributions of NTC and genotype clusters.  
 
Figure 3-4: Distribution of angles (A) and amplitudes (B). The distribution of angles (A) 
shows three well-separated clusters. The distribution of amplitudes (B) shows three 
clusters with good signal intensity that is well separated from the NTC. [Taken from 
Life Technologies (2013)].  
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3.2. RATIONALE OF THE STUDY  
Currently, there is an increased availability of validated and ready-to-use SNPs assays. 
Therefore, it has been an important factor to review these TaqMan® SNP Genotyping 
assays as a SNP genotyping system in detecting SNP markers.  
In this study, two autosomal SNP markers (Sanchez et al. 2006a): rs1493232 (marker 
code 18) and rs1335873 (marker code 52) were selected to evaluate the TaqMan® SNP 
Genotyping assays (Applied Biosystems 2005). The TaqMan® Control Genomic DNA for 
rs1493232 is heterozygous with allele A and allele C, and homozygous for rs1335873 
with only allele T. In the SNaPshot assay the alleles detected for rs1493232 are G and 
allele T. This is because the primers or probe used in TaqMan® SNP Genotyping assays 
are in forward orientation, whilst in SNaPshot assay (SBE reaction) they were in the 
reverse orientation (Sanchez et al. 2006a).  
The analysis was carried out using the manufacturer’s protocol (Applied Biosystems 
2005, Applied Biosystems 2010a) and data were then analyzed using the TaqMan® 
Genotyper Software with a Quality value of 0.95 as a default (Life Technologies 2013).   
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3.3. RESULTS 
 
3.3.1. Sensitivity and reproducibility of the TaqMan® SNP Genotyping assays 
When employing any forensic tool, it is essential to carry out sensitivity and 
reproducibility studies.  This is to determine the minimum concentration at which 
samples can reliably be typed. In this study, a series of dilutions (1 μl each) of (2.0, 1.0, 
0.5, 0.25, 0.125, 0.063, 0.032, 0.016, 0.008, 0.004 and 0.002) ng/μl of Applied 
Biosystems TaqMan® Control Genomic DNA (Human; 10 ng/ μl) were used. 
 
3.3.2 Preparation of Allelic Discrimination (AD) study 
Several important steps and workflow were piloted before a number of assays were 
subjected into the analysis (Applied Biosystems 2005).  
 
3.3.2.1. Preparation of the documents 
Initially a few templates of AD documents were prepared in order to genotype the 
samples using the AB® 7500 Real-Time PCR System as shown in Appendix E. In creating 
a Pre-Read document, Allelic Discrimination assay was selected. New marker and 
detectors were appointed before the sample plate was set-up. Sample names and 
tasks (Unknown or No Template Control (NTC)) were labelled accordingly (Appendix E, 
Figure 11 to 14).  As for AD Amplification (AQ) reaction template, assay type of 
Standard Curve (Absolute Quantitation) was selected.  The same marker, detector, 
sample names with same positions (well number) and tasks were selected and labelled 
respectively, similar with the previous Pre-Read document (as shown in Appendix E, 
Figure 15 to 16). Finally, the AD Post-read document was also prepared, with an AD 
assay type, the similar marker, detector, sample names and tasks as above documents 
were selected (Figure 17 to 18).   
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3.3.2.2. Performing the run 
The samples were analyzed using a few different conditions in each AD type of assays 
(as shown in Appendix E, Figure 19 to 21).  In a Pre-Read analysis, the background of 
fluorescence used of each well of the of the subjected AD Pre-Read document was 
recorded. A Standard Amplification (AQ) run was performed only to amplify the 
samples using the selected PCR conditions, not use to quantify the PCR data.  As for a 
post-read run, during the analysis, the Pre-Read fluorescence was subtracted from the 
post-Read fluorescence to interpret for pre-amplification background fluorescence in 
order to ensure the results were accurate.  
 
3.3.2.3. Generating the results 
A few types of data were collected in the following analysis: 
 
3.3.2.3.1. A Pre-Read data 
As shown in Appendix E, Figure 22 and Figure 23, no alleles were observed and no 
report was generated. This is because in this type of analysis, the software only 
determines the fluorescence used in the assay.    
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3.3.2.3.2. Amplification (AQ) data 
As for the AQ analysis, the amplification plot and real-time data (Figure 3-5 (a) and (b)) 
were observed and stored. The report produced in this stage also showed the targeted 
SNP marker. This analysis can be used to study the questionable allele-calls at the end 
of the whole AD process. However, no allele was observed in the Allelic Discrimination 
tab.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-5: (a) An amplification plot of the AQ analysis, and (b) Report of the AQ 
analysis; that showed the targeted SNP marker and cycle threshold (CT) of the samples.  
(a) 
(b) 
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3.3.2.3.3. Post-Read data 
Data were analyzed using the 7500 SDS Software version 1.4, where the raw data were 
converted and expressed in terms of fluorescence signal versus filters.  The SDS 
software plotted the results as shown in Figure 3-6, on a scatter plot of Allele X versus 
Allele Y. Initially, each well represented by X (Undetermined) on the plot. However, 
after analysis with Automatic/Manual Allele Calling settings, the clustering points were 
varied either along the horizontal axis (Allele X), vertical axis (Allele Y) or diagonal 
(Allele X and Allele Y). At this stage the genotype of the allele sample was determined 
(Applied Biosystems 2005). As shown below, after analysis three clusters were 
separated into 4 different positions, including the undetermined alleles. In addition, 
the report of the SNPs detected was also produced together with allele’s position 
information (Figure 3-7). 
 
 
 
 
 
 
 
 
Figure 3-6: Detected alleles (homozygote A, homozygote G, heterozygote alleles AG 
and undetermined alleles) were plotted in Allelic Discrimination tab.  
 
 
Homozygous G 
Heterozygous AG 
Homozygous A 
Undetermined/NTC 
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Figure 3-7: Report generated from the Post-Read analysis. 
 
3.3.3. TaqMan® SNP Genotyping assays optimization 
There are two main variables that are very important to assess in achieving the optimal 
conditions for TaqMan® SNP Genotyping assays: total PCR volume and template DNA 
concentration.  For example, as shown in Figure 3-8, with higher amounts of template 
DNA, that ranged from 0.013 ng to 2 ng, the CT (cycle threshold) was around 29 to 34.  
But, at lower DNA concentrations either the CT was higher or DNA was not amplifiable 
at all. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-8: Effects of DNA concentrations on Rn versus cycles. 
2 ng 
0.25 ng 
0.06 ng 
0.015 ng 
0.5 ng 
0.13 ng 
1 ng 
0.008 ng 
0.03 ng 
0.001 ng 
0.002 ng 
0.004 ng 
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To test the effect of the PCR volume, variations in PCR reaction components were 
evaluated as described in Chapter 2, section 2.7.1.2., Table 2-3.  Data presented in 
Figure 3-9 were generated by running the samples at low to high DNA concentrations 
and with various PCR volumes. The data plot and circles show samples with relatively 
high DNA concentration from 0.0625 ng to 2 ng, that are more consistent in developing 
the clusters for the relevant alleles compared to the samples with low DNA 
concentrations. The square boxes represent the unambiguous alleles and NTC. 
With a total PCR volume of 25 µl results were reproducible for all series of DNA 
concentrations. All reactions with template DNA of 0.063 ng or more also gave reliable 
and reproducible results in all reaction volumes. In this study the final composition of 
the reaction mix and DNA concentrations chosen to be used were 5 µl of PCR volume 
and 0.125 ng of DNA concentration, due to its robustness as well as the reduced 
amount of reaction mix used in this system. 
As part of the optimization, further study was carried out to observe clearly how 
robust this assay was especially in clustering the genotypes based on the optimal PCR 
but with two different DNA concentrations, that were 0.0078 ng and 0.125 ng.   
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Notes: *a, b, c, d, e, f, g, h and i represent (2, 1, 0.5, 0.25, 0.125, 0.063, 0.032, 0.016 and 0.008) 
ng, respectively. *x represent undetermined allele. 
 
Figure 3-9: Genotype clusters and allele calls generated from the optimization of 
various PCR volumes and series of control DNA concentrations, (i) total PCR of   5 µl, (ii) 
10 µl, (iii) 12.5 µl and (iv) 25 µl.  
 
As shown in Figure 3-10, the data plot of population samples with (a) 0.125 ng DNA 
concentrations yields measurable results with good clustering of alleles. But, as for the 
samples with lower DNA the clusters became diffuse and it was difficult to identify the 
genotypes correctly and some were not detectable at all. 
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Note: *x represent undetermined allele. 
Figure 3-10: Clusters of data generated from testing 19 population samples. All PCR 
reactions were in 5 µl, but with two different DNA concentrations; (a) 0.125 ng and (b) 
0.0078 ng.   
(b) 
 
 
 
Allele G 
Allele AG 
NTC 
(a) 
Allele A 
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3.3.4. TaqMan® SNP Genotyping analysis on testing population samples 
Thirty DNA samples from each ethnic group were genotyped under the optimal 
conditions: (i) a total of 5 µl PCR reaction volume, and (ii) 1 µl of DNA sample (0.125 
ng). The analysis was carried out using specific TaqMan® MGB probes and primers of 
two chosen SNP markers: rs1493232 and rs1335873 (Sanchez et al. 2006a).  Results 
showed the same alleles were clustered together and different types were clustered 
separately, for both SNP markers as shown in Figure 3-11(a) and (b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-11: Clustered plots of 90 Malaysian DNA samples and 3 NTCs using the 
optimal conditions for 2 SNP markers: (a) rs1493232 (A/C), and (b) rs1335873 (A/T).   
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3.4. DISCUSSION 
Real-time (RT) PCR methods for genotyping SNPs are becoming increasingly important 
in various fields of biological sciences (Gibson 2006). The advantage of this method is 
that only one simple reaction set up is required without any processing after that and 
it is suitable for both 96 or 384 sample reactions (Ragoussis 2006).  
As for forensic casework, it is common to be faced with samples containing minute 
amounts of DNA and/or samples where the DNA is likely to be highly degraded. In 
some circumstances standard STRs are prone to fail in amplifying the DNA samples. To 
successfully resolve such cases an alternative marker, such as autosomal SNP typing 
can be used (Phillips et al. 2008a). 
 
3.4.1. Allelic discrimination using TaqMan® SNP Genotyping assays and AB® 7500 
Real- Time PCR System   
In this study, TaqMan® SNP Genotyping assays were chose to be used because they 
provided the simplest workflow and a large number of validated SNP markers. Applied 
Biosystems Company, which is currently known as Life Technologies, offers the largest 
collection of ready-to-use human and mouse single nucleotide polymorphisms (SNP) 
assays available with TaqMan MGB probes. Human TaqMan® SNP Genotyping Assays 
collection consists of approximately 30,000 assays for SNPs in gene-coding regions, 
160,000 gene centric assays and also more than 3 million genome-wide assays that 
include known disease mutations and SNPs in protein domains associated with drug 
binding regions (Applied Biosystems, 2006).  
Secondly, the use of the TaqMan probes provides the specificity of PCR amplification. 
There are two types of TaqMan probes available: TaqMan probes with TAMRA™ dye as 
quencher and FAM™, TET™ or VIC® as 5ʹ label dye; TaqMan MGB (minor groove-
binding) probes with nonfluorescent quencher (NFQ) and FAM™, TET™, NED™ or VIC® 
as 5ʹ label dye are recommended when the probes exceed 30 nucleotides. The non-
fluorescent quencher allows the instrument to measure the reporter dye contributions 
more precisely. The MGB probes have greater differences in melting temperature 
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values between matched and mismatched probes, which allow more accurate allelic 
discrimination ((Applied Biosystems 2006, Pakstis et al. 2007). 
As stated in the product protocol, the reaction needs only three components: genomic 
DNA template, SNP Genotyping Assay and PCR Master Mix (TaqMan® Universal PCR 
Master Mix). The standard protocol of PCR amplification is valid for each assay: 1 cycle 
for 10 min at 95 °C to activate the AmpliTaq Gold enzyme and 40 cycles of 15 sec at 
92 °C, 1 min at 60 °C. These simple steps reduce the chance of contamination, sample 
mix-up and sample loss, and the need to optimize each reaction separately (Applied 
Biosystems 2006). 
Besides that, the interpretation of data is easy because results/alleles will be displayed 
in cluster forms, and report will be presented as a table format. This TaqMan SNP 
Genotyping Assay is read at the PCR endpoint rather than in real time incontrasted to 
TaqMan assays designed for either absolute or relative quantitation (as in gene 
expression studies). Genotype calls for individual samples are made by plotting the 
normalized intensity of the reporter dyes in each sample well on a Cartesian plot (also 
known as a scatter or cluster plot). A clustering algorithm in the data analysis software 
assigns individual sample data to a particular genotype cluster.  SNP Genotyping Assays 
produce three clusters biallelic SNPs (De La Vega et al. 2005a).  
The instrument, such as AB® 7500 can meet all throughput needs and budgets. The 
7500 offers variable excitation and 5-colour detection via FAM/SYBR Green, VIC/JOE, 
NED/TAMRA/Cy3, ROX/Texas Red, and Cy5. Detection is superior in the red of the 
spectrum compared to the 7300 system. The format is Peltier-based thermal cycling 
systems allowing the use of both 96-well plates and 0.2 ml tubes (Gibson 2006). In 
addition, following PCR amplification, an assay endpoint can be read on any Applied 
Biosystems Real-Time PCR System.   
 
3.4.2. Detection level of the TaqMan® SNP Genotyping assays on few parameters  
To develop an efficient multiplex PCR, careful planning, several tests in primer 
designing and balancing reactions are required (Butler 2011). In this study, variations in 
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PCR volumes reaction and DNA concentration for each reaction were assessed to 
achieve the optimal conditions for the TaqMan® SNP assays. According to the 
manufacturer’s protocol, a total of 25 µl PCR volumes per well in a 96-well plate was 
recommended, in which 13.75 µl PCR mix is added with 11.25 µl of DNA (1-20 ng with 
DNase-free water).  
However, from the study’s evaluation, the reduced volume of PCR-TaqMan reactions 
with 0.125 ng genomic DNA and 5 µl total PCR reaction mix gave reproducible signals 
that were assigned to clear genotypes called. Signals obtained on reactions with less 
than 0.125 ng were not clearly plotted or clustered, and thus no accurate genotyping 
was possible with these low concentrations using this assay (as shown in Figure 3-10 
(b)).   
The samples with relatively high DNA concentrations were easily scored, but with 
samples with lower DNA concentrations, such as 0.01 ng and 0.1 ng, clusters became 
diffuse making the alleles scoring difficult. 
Zubakov et al. (2010), stated that the high sensitivity of TaqMan® MicroRNA Assays 
makes them potentially valuable tools for future forensic applications. He and his co-
workers analyzed 20 ng to 2 pg of RNA with TaqMan® MicroRNA Assays using real-time 
PCR. They found that all four markers were detected in the target body fluid using the 
lowest amount of total RNA (2 pg) for cDNA synthesis (Zubakov et al. 2010).  
 
3.4.3. Limitation of TaqMan® SNP assays 
From this study’s observations, which are based on the sensitivity and reproducibility 
data, TaqMan® SNP genotyping assays can be used as a SNP genotyping platform. A 
large number of SNP assays have been validated and pre-designed. However, these 
assays will just involve one reaction and one marker per run.   
Vega et.al. (2005)(De La Vega et al. 2005a) agreed that the TaqMan® SNP assay offers 
sensitive, robust and fast genotyping using real-time methods and would be useful in 
detecting single reaction or one targeted SNP marker at one time. It is also only 
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involves a single reaction which might be useful and suitable for the selection of 
markers for genetic studies and simple forensic casework (De La Vega et al. 2005a, 
Kidd et al. 2006, Pakstis et al. 2007). 
As for forensic purposes, a medium throughput is required for paternity testing or 
criminal casework, but a high throughput would be needed to implement criminal DNA 
databases. An important factor that is a limiting step for forensic genetics in all these 
technologies is the amount of DNA required per genotype. The main drawback of this 
TaqMan technology is the limited multiplexing capability (Sobrino et al. 2005b). 
Kidd and co-workers (Kidd et al. 2006) stated that they used TaqMan for the screening 
procedures because they were screening markers individually and did not have to 
develop or optimize the assays. Multiplex assays will be essential in any actual forensic 
application but TaqMan is not capable of being multiplexed. Therefore, a SNP panel 
will require a different typing method. 
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PART TWO: 
 
SNAPSHOT ASSAYS 
 
3.1. INTRODUCTION 
Multiplex PCR is an extension of the standard PCR protocol in which multiple loci are 
amplified simultaneously in order to save time, improve throughput, and reduce the total 
cost of reagents and amount of DNA (Rachlin et al. 2005a). 
As for this study, 52 SNP markers (Sanchez et al. 2006a) were chosen to be evaluated on 
the Malaysian population and casework samples. This selection was made based on the 
features of these markers, including the number of SNP markers involved, the amplicon 
size of each SNP marker and its potential in human identification. In addition, these 
markers have also been reported to be polymorphic in European, Asian and African 
populations (Sanchez et al. 2006a, Musgrave-Brown et al. 2007).  
Gill calculated that when using binary polymorphisms between 50 and 80 loci are required 
to match the discrimination levels of 16 STRs (Gill 2001). Dixon has suggested that to 
develop new SNP multiplexes for forensic identification purposes, there are a number of 
factors that have to be considered. One of them is to have low molecular weight genomic 
targets, specifically lower than current conventional STR systems with the amplicon size 
preferably less than 150 bp (Dixon et al. 2005). 
According to the original paper (Sanchez et al. 2006a), these 52 SNP markers were 
amplified in one PCR reaction followed by detection of SNPs with two single-base 
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extension (SBE) reactions by Capillary Electrophoresis (CE) as shown in Figure 3-12. The 
two SBE multiplexes comprised the first 23 primers (marker codes 1 to 23) and another 29 
primers (marker codes 24 to 54). The PCR product sizes ranged from 59 bp to 115 bp, 
whilst the SBE products size ranged from 16 bp to 92 bp. The original system was tested 
using the SNaPshot® Multiplex System to detect the SNP genotypes on three genetic 
analyzers: ABI 310 PRISM®, ABI 3100 PRISM® or ABI 3100 PRISM® Avant, all with 36 cm 
capillary arrays and performance optimized  polymer, POP-4™. 
 
Figure 3-12: A 52 SNP marker assay with two sets of SBE reactions; A) 23 markers, and B) 
29 markers. [Taken from the original study (Sanchez et al. 2006a)] 
In addition, Sanchez et al. (2006a) also stated that the sensitivity of the ABI 310 PRISM® 
was only 20% of the sensitivity of the ABI 3100 PRISM®, and therefore most of their 
studies were carried out using higher version systems, i.e., the ABI 3100 and ABI 3100-
Avant PRISM® Genetic Analyzers.  
There are many other studies have been carried out using these markers for several 
purposes, such as population study, routine casework and paternity testing.  Schwark et al.  
(2012b) presented the use of 50-plex SNP assay of SNPforID 52plex on several routine 
cases from their laboratory. Samples were subjected to two different multiplex reactions, 
21-plex and 29-plex assays (which they termed Auto 1 and Auto 2). They reported that 29-
plex (Auto 2) was more sensitive than the 21-plex (Auto 1) when using ABI 310 genetic 
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analyzers. With input DNA less than 500 pg, fewer successfully amplified SNPs were found 
in the 21-plex, with only 5 SNPs successfully analyzed, but half of the 29 SNPs were still 
detectable with DNA input as low as 25 pg. They further suggested to use the 29-plex PCR 
first and then, depending on the outcome, subject the sample material to the less-
sensitive 21-plex in routine work (Schwark et al. 2012b).  
 
Bulbul et al. (2009) have performed an internal validation of 29-plex (Auto 2) using ABI 
310 and demonstrated all 29 samples were typed successfully with between 0.5 ng and 20 
ng DNA input. They also found that even 0.2 ng gave results although allele drop out was 
observed (Bulbul et al. 2009). 
 
3.2. RATIONALE OF THE STUDY 
Although SNPs will not replace STRs in the near future as the primary source of 
information used in criminal investigations, it is advantageous to assess and validate DNA 
typing platforms for reliable, accurate and high throughput multiplex SNP typing to be 
used along with PCR-STRs.  Therefore, the objectives of this study are as the following: 
 
3.2.1. Sensitivity and reproducibility evaluation of the SNaPshot assay(s) 
The sensitivity and reproducibility of the SNaPshot assay were carried out as mentioned in 
Chapter 2, section 2.6.1., for multiplex reactions, and for single reactions, 0.5 ng and 1 ng 
of TaqMan Control DNA and M7-7 (Malay individual sample) were used as the controls 
throughout the study. To ensure the appropriate SBE size, correct SNP markers and alleles 
exhibited, single SNaPshot reactions were performed (as shown in Figure 3-13) for all 52 
markers using both controls, TaqMan DNA and M7-7 (as described in Chapter 2, sections 
2.7.2.3 to 2.7.2.8.1)  
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Figure 3-13: Single nucleotide primer extension [Taken from Applied Biosystems, 2010b]. 
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3.2.2. Developing a series of multiplex assays to be used in the study 
A few series of multiplex assays was developed to observe the effect of primer-primer 
interactions, dyes and peak height exhibited and also to test the PCR/SBE systems used in 
the study. 
 
3.2.3. Optimization and validation of the selected SNaPshot multiplex assays 
Based on experimental work, a series of multiplex assays were chosen to be used. These 
multiplexes comprised four sets of PCR/SBE 13-plex assays, which designated as 13st, 13nd, 
13rd and 13th. Optimization and validation studies had been carried out for these assays to 
observe their stability and reproducibility level.    
 
3.2.4. SNP genotyping and characterization of 30 unrelated testing individuals 
Genotyping analysis of 30 samples from each Malaysian ethnic group (Malays, Chinese 
and Indians) was carried out using these 13-plex assays. These samples had already been 
analyzed using the TaqMan® genotyping method for comparison in the detection of SNP 
alleles.  
SNP analysis had also been carried out on 9947A (Positive control from Applied 
Biosystems) using protocol developed in this study and the result was sent to Dr. 
Christopher Phillips from SNPforID Consortium. We had passed the assessment that shows 
concordance result with the Consortium. This also confirmed the dyes labelled and SNPs 
detected were all correct with the peak-ratio criteria as suggested by Sanchez et. al. 2006a.  
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3.3. RESULTS 
3.3.1. Single SNaPshot reaction 
Initially, several primer concentrations and combinations were tested for PCR-SBE 
reactions as described in Chapter 2, section 2.7.2.1.  Each of the PCR-SBE reactions used 1 
µl of control DNA (0.5 ng). The allele peak generated from PCR/SBE primers combination 
(Table 3-1) was shown as in Figure 3-14. 
Table 3-1: Table shows the combination of primers concentration used in the study.  
Stage Combination of the primer concentrations (µM) 
PCR 0.05 0.05 0.1 0.1 0.2 0.2 
SBE 0.05 0.1 0.05 0.1 0.05 0.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-14: Amplicons generated from the single reaction assay with the effects of primer 
concentrations.  
      (a) (b) (c) (d) (e) (f) 
(a) 
3000 RFU 
(b) 
7500 RFU 
(c) 
6000 RFU 
(d) 
7500 RFU 
(e) 
5500 RFU 
(f) 
7000 RFU 
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The data demonstrated the effects of primer concentrations. For example, as shown in 
Table 3-1, although the primer concentrations are as low as 0.05 (for both, PCR and SBE 
reactions), the allele peak generated was 3000 RFU, which is considered adequate for SNP 
detection.  
The size, dye and allele type for each 52 SNP markers of both controls were recorded and 
used in evaluating each SNP marker in the multiplex assays.     
 
3.3.2. Series of multiplexes developed throughout the study 
In order to multiplex the markers several trials that involved several combinations of 
markers were carried out as listed below: 
 
3.3.2.1. First trial of developing 3-plex, 5-plex and 10-plex assays 
Initially multiplexes with 3-, 5- and 10-plexes of markers were conducted as shown in 
Table 3-2. Single reaction amplification was also performed for each individual marker, in 
order to confirm the correct target was detected.    
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Table 3-2: The SNP markers with primer concentrations (µM) used in the multiplex assays 
(first trial). 
Multiplexes with SNP code markers, primers concentrations (µM) and SBE size (nt) 
3-plex 5-plex 10-plex 
Marker PCR SBE SBE 
size 
Marker PCR SBE SBE 
size  
Marker PCR SBE SBE 
size  
3 0.3 0.2 29 1 0.3 0.2 18 2 0.1 0.2 24 
*10 0.4 0.3 60(34) 3 0.3 0.2 29 3 0.15 0.2 29 
*18 0.3 0.3 53(66) *4 0.3 0.3 36(78) *4 0.15 0.2 36(78) 
    *18 0.3 0.3 53(66) *6 0.15 0.3 44(54) 
    *10 0.3 0.3 60(34) *7 0.2 0.2 48(18) 
        *10 0.2 0.2 60(34) 
        *12 0.2 0.3 29(58) 
        *17 0.15 0.3 49(42) 
        *18 0.1 0.2 53(66) 
        *20 0.25 0.2 60(50) 
Note: * indicates modified SBE primers length. Number in brackets indicates the original SBE 
amplicon size (Sanchez et al. 2006a).  
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Figure 3-15: Three multiplex assays; 3-plex, 5-plex and 10-plex of TaqMan control DNA 
(0.5 ng).  Arrows show the drop-out allele C (for code marker 10). 
As shown above in Figure 3-15, there is a drop-out allele for SNP marker 10, which should 
be heterozygous CT, but only allele T was detected in all multiplexes. This phenomenon 
could be due to lower primer concentrations for marker 10 and also preferential 
amplification of the markers. The difference in SBE product size for code marker 10 (CT) 
and 18 (CT) is 7 nucleotides (nt) length. 
With the 10-plex assay a few markers were chosen that had similar SBE product size to 
observe if there are any significant primer-primer reactions that will lead to ‘drop-in’ or 
‘drop-out’. From Table 3-2, marker 3 and 12 (29 nt), and marker 10 and 18 (60 nt) have 
the same product size. After the analysis, as can be seen from Figure 3-15, homozygous 
alleles 3 and 12 are clear, but as for heterozygous alleles 10 and 20, only allele GT (marker 
20) can be clearly observed, whilst the heterozygous alleles CT dropped-out.       
3-PLEX 
5-PLEX 
10-PLEX 
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3.3.2.2. Second attempt at developing 3-plex, 5-plex and 10-plex assays with new 
SBE sizes. 
Table 3-3: Multiplex assays consisting of SNP markers with different SBE size and primer 
concentrations. 
Multiplexes with SNP code markers, primers concentrations (µM) and SBE size (nt) 
3-plex2 5-plex2 10-plex2 
Marker PCR SBE SBE 
size 
Marker PCR SBE SBE 
size  
Marker PCR SBE SBE 
size  
3 0.3 0.2 29 1 0.3 0.2 18 1 0.1 0.07 18 
10 0.3 0.3 34 3 0.3 0.2 29 2 0.1 0.05 24 
*18 0.4 0.3 45(66) 4 0.3 0.3 47 3 0.1 0.06 29 
    *18 0.3 0.3 45(66) *4 0.15 0.15 47(78) 
    10 0.3 0.3 34 *5 0.15 0.3 70(74) 
        6 0.1 0.2 54 
        *7 0.1 0.05 20(18) 
        *8 0.1 0.15 40(42) 
        *9 0.1 0.05 30(29) 
        10 0.2 0.15 34 
Note: * indicates modified SBE primer length. Number in brackets indicates the original SBE 
amplicon size (Sanchez et al. 2006a). 
 
The results obtained from the analysis of the multiplex assays (Table 3-3 and Figure 3-16), 
shows that the smaller the size of SBE product, the clearer the alleles (as shown in 3-plex2 
and 5-plex2). Whilst, for the 10-plex2, if the bigger SBE product size was incorporated, 
larger differences in SBE length (nt) were needed to produce good and clear genotypes. 
However, in this experiment, the SNP marker 2 was not detected, in both, single and 10-
plex2 reactions. New primers (with same sequences) for PCR and SBE of marker 2 were re-
ordered.   
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Figure 3-16: Three different multiplex assays for the second trial in multiplexing the 
markers; 3-plex2, 5-plex2 and 10-plex2 of TaqMan control DNA (0.5 ng).   
3-PLEX2 
5-PLEX2 
10-PLEX2 
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3.3.2.3. First trial in developing four sets of 13-plex assays 
Based on the results obtained from the trials (section 3.3.1 to 3.3.2.2), the original SNP 
markers (Sanchez et al. 2006a) were divided into four sets of 13-plex assays, 1st-plex, 2nd-
plex, 3rd-plex and 4th-plex (Table 3-4).  The markers were re-arranged in accordance with 
the SBE product size, to ensure clear separation of alleles in all multiplex assays. The first 
two 13-plex assays, 1st-plex and 2nd-plex, comprised SNP markers of code number 1 to 26 
(Sanchez et al. 2006a), whilst the other two 13-plex assays comprised SNP markers of code 
number 27 to 54. Both controls, TaqMan Control DNA and M7-7 (each, 0.5 ng and 1 ng) 
were analyzed with all 13-plex assays. For better visualization and interpretation of the 
sample, all 13-plex assays were presented as a whole profile (52 autosomal SNP markers) 
with 4 panels per individual. 
Table 3-4: The first construction of four sets 13-plex PCR/SBE assays.  
Four 13-plex assays with SNP code markers and primers concentrations (µM) 
1st 2nd 3rd 4th 
Marker PCR SBE Marker PCR SBE Marker PCR SBE Marker PCR SBE 
1 0.1 0.07 7 0.15 0.05 41 0.15 0.05 46 0.1 0.1 
2 0.15 0.05 13 0.1 0.06 33 0.1 0.06 27 0.1 0.07 
3 0.1 0.06 9 0.1 0.05 36 0.15 0.07 38 0.15 0.08 
21 0.1 0.05 10 0.15 0.15 44 0.1 0.08 51 0.1 0.1 
22 0.15 0.1 8 0.2 0.15 48 0.15 0.07 49 0.15 0.1 
17 0.15 0.15 11 0.15 0.1 34 0.15 0.09 52 0.15 0.1 
23 0.1 0.15 4 0.1 0.15 32 0.1 0.1 42 0.1 0.1 
20 0.15 0.1 25 0.1 0.15 37 0.15 0.15 53 0.15 0.1 
6 0.15 0.2 24 0.1 0.15 29 0.1 0.15 54 0.2 0.1 
12 0.1 0.2 19 0.2 0.1 40 0.1 0.1 45 0.15 0.1 
14 0.1 0.15 26 0.1 0.1 30 0.15 0.1 50 0.1 0.15 
16 0.15 0.2 18 0.1 0.2 39 0.1 0.15 35 0.1 0.15 
5 0.15 0.3 15 0.1 0.3 43 0.15 0.15 28 0.15 0.1 
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Figure 3-17: An example of the first 13-plex assays (1st-plex, 2nd-plex, 3rd-plex and 4th-plex) 
of M7-7 DNA sample (0.5 ng) developed in this study.   
In Figure 3-17, these multiplex assays (as combinations in Table 3-4) showed the alleles 
were separated well from each other except for the heterozygote alleles of SNP marker 21 
(shown with an arrow). Also, the alleles in 1st and 2nd assays were quite close to each other 
compared to the other two 13-plex assays, 3rd and 4th. This is because the SBE size for 
marker 1 to 26 for these assays ranged from 16 nt to 80 nt. As for the other two 13-plex 
assays, the SBE size in these developed assays ranged from 16 nt to 92 nt.  
In addition, the dyes exhibited in the 2nd-plex and 3rd-plex had more red dyes, compared 
to the other two 13-plex assays, whilst the 4th-plex had more green dyes exhibited. This 
presentation of SNP profile could potentially lead to misinterpretation of data.  
Therefore, another experiment was carried out using a different arrangement of the SNP 
markers, in order to balance the size and dyes produced in the analysis.  The organization 
of the new four sets of 13-plex assays was presented as in Table 3-5.   
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3.3.2.4. Second trial in developing four sets of 13-plex assays 
Table 3-5: Second trial of 13-plex assays developed in the study. 
Four 13-plex assays with SNP code markers and primers concentrations (µM) 
1st2 2nd2 3rd2 4th2 
Marker PCR SBE Marker PCR SBE Marker PCR SBE Marker PCR SBE 
1 0.1 0.07 7 0.15 0.08 41 0.15 0.1 46 0.1 0.1 
2 0.15 0.1 13 0.1 0.06 27 0.1 0.1 33 0.1 0.1 
3 0.1 0.08 9 0.1 0.15 36 0.15 0.08 38 0.15 0.15 
22 0.15 0.1 10 0.15 0.15 21 0.1 0.15 51 0.1 0.1 
34 0.15 0.1 8 0.2 0.15 44 0.1 0.15 48 0.15 0.1 
11 0.15 0.1 17 0.15 0.15 49 0.15 0.1 52 0.15 0.1 
23 0.1 0.15 4 0.1 0.15 32 0.15 0.15 42 0.1 0.1 
20 0.15 0.2 25 0.1 0.15 53 0.15 0.1 37 0.15 0.15 
6 0.15 0.25 24 0.1 0.15 29 0.1 0.1 54 0.2 0.15 
12 0.1 0.2 19 0.2 0.15 40 0.1 0.1 45 0.15 0.2 
14 0.1 0.15 26 0.1 0.1 30 0.15 0.15 50 0.15 0.15 
16 0.15 0.2 18 0.1 0.2 39 0.1 0.15 35 0.1 0.15 
5 0.15 0.3 15 0.1 0.3 43 0.15 0.15 28 0.15 0.1 
 
In this second arrangement a few markers; 11, 17, 21, 27, 33, 34, 37, 48, 49 and 53, were 
swapped into different multiplex assays (Table 3-5). As illustrated in Figure 3-18, the 13-
plex assays profile of M7-7 individual showed clearer separation of alleles. However, it is 
noticeable there are alleles which overlapped with other alleles, such as marker 7, and 
also some of the markers have preferential amplification over other markers, for example 
marker 20 and marker 6 (shown with the arrows).  Therefore, another change in markers 
positions was carried out to reduce the preferential amplification among the targeted loci.  
The final designated four sets of 13-plex assays: 13st, 13nd, 13rd and 13th were introduced 
as in Table 3-6.   
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Figure 3-18: An example of the second 13-plex assays (1st2-plex, 2nd2-plex, 3rd2-plex and 
4th2-plex) of M7-7 DNA sample (0.5 ng) developed in this study.   
 
3.3.3.  Development, optimization and validation of the 13-plex PCR/SNaPshot 
reactions; 13st, 13nd, 13rd and 13th.   
Finally, after all criteria were evaluated, such as primer-primer interactions, correct allele 
dyes obtained and peak height threshold, four sets of 13-plex PCR and SNaPshot reactions 
were developed in this study to carry out the SNP analysis on the Malaysian population. 
Table 3-6 showed the modification of the new 13-plex assays from the original multiplex 
assays. The original SBE size (Sanchez et al. 2006a) was indicated in the brackets for the 
SNP marker that labelled with * symbol.  
The sensitivity study of these 13-plex assays was carried out using a series of control DNA 
dilutions. All analysis was performed as described earlier in Chapter 2, sections 2.7.2.3 to 
2.7.2.8.1.  Results obtained from the analysis (as shown in Figures 3-19 to 3-22) 
demonstrate 13-plex assays (13st, 13nd, 13rd and 13th) of TaqMan® Control Genomic DNA 
serial dilutions of (1.0, 0.5, 0.125 and 0.03) ng.  Figure 3-23, shows an example of a marker 
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bin (13nd assays) that can be created using the GeneMapper version 3.2 and used to 
characterize the SNP alleles. 
The peak thresholds were set to a minimum of 120 RFUs (blue colour), 60 RFUs (green 
colour) and 30 RFUs (yellow, red and orange colours). A maximum peak height ratio of 3:1 
was accepted as a heterozygote, and a minimum peak of 5:1 was accepted as a 
homozygote (Sanchez et al. 2006a). 
In all series of DNA concentrations, complete 52 autosomal SNP profiles were successfully 
generated under all tested conditions with more than 30 ng of template. In Figure 3-19, 
the profile is nearly complete, but allele C for marker 32 dropped-out. This shows that the 
thermal conditions, PCR components, SNaPshot reactions, the combination of PCR and 
SBE primers concentrations were established for an optimal performance of these 
multiplex assays for DNA input higher than 30 pg. 
 
 
 
 
 
 
 
 
 
 
Figure 3-19: Human control DNA with 1 µl of serial dilution (0.03 ng).  The arrow shows an 
allele C that dropped-out.  
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Table 3-6: Four sets of 13-plex assay reactions developed in this study. 
  
Sanchez et al., 2006  
(Original  SBE Multiplexes) 
New Developed Assays in this study PCR Single base extension (SBE) 
SBE 
Multiplex 
Marker 
Code 
SNP 
(rs#) 
Designated 
multiplex 
assays 
Marker 
Code 
SNP 
(rs#) 
Final primer 
concentration 
(µM) 
Amplicon 
size (bp) 
Final primer 
concentration 
(µM) 
Amplicon 
size (bp) 
 
 
 
 
 
 
 
 
 
 
 
Auto-1 
(23 SBE) 
1 rs1490413 13st 1 rs1490413 0.15 68 0.07 18 
2 rs876724 2 rs876724 0.1 83 0.1 24 
3 rs1357617 3 rs1357617 0.15 90 0.08 29 
4 rs2046361 22 rs733164* 0.1 68 0.1 36 (34) 
5 rs717302 34 rs1979255 0.15 86 0.15 40 
6 rs1029047 23 rs826472* 0.2 85 0.2 45 (46) 
7 rs917118 53 rs1028528 0.1 113 0.1 48 
8 rs763869 20 rs1031825 0.15 98 0.2 50 
9 rs1015250 12 rs2107612 0.15 93 0.3 58 
10 rs735155 14 rs1454361 0.1 73 0.15 62 
11 rs901398 16 rs729172* 0.1 60 0.2 68 (70) 
12 rs2107612 5 rs717302* 0.15 86 0.3 70 (74) 
13 rs1886510 39 rs354439 0.1 93 0.2 80 
14 rs1454361 13nd 46 rs1360288 0.1 103 0.07 16 
15 rs2016276 13 rs1886510* 0.1 86 0.06 26 (25) 
16 rs729172 9 rs1015250* 0.1 95 0.15 30 (29) 
17 rs740910 10 rs735155 0.15 100 0.15 34 
18 rs1493232 49 rs1005533 0.1 107 0.1 36 
19 rs719366 11 rs901398* 0.15 70 0.1 44 (46) 
20 rs1031825 4 rs2046361* 0.3 79 0.15 47 (78) 
21 rs722098 25 rs873196 0.1 63 0.15 52 
22 rs733164 29 rs1024116 0.1 76 0.1 56 
23 rs826472 24 rs2831700 0.1 62 0.15 56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Auto-2 
(23 SBE) 
24 rs2831700 26 rs1382387 0.13 69 0.1 64 
25 rs873196 18 rs1493232* 0.1 59 0.2 68 (66) 
26 rs1382387 15 rs2016276 0.15 90 0.3 80 
27 rs2111980 13rd 41 rs737681 0.1 96 0.07 16 
28 rs2056277 27 rs2111980 0.05 72 0.05 23 
29 rs1024116 36 rs2076848 0.1 89 0.08 27 
30 rs727811 21 rs722098* 0.15 81 0.15 32 (38) 
32 rs1413212 44 rs914165 0.1 100 0.15 32 
33 rs938283 8 rs763869* 0.15 100 0.2 40 (42) 
34 rs1979255 17 rs740910 0.1 87 0.15 42 
35 rs1463729 32 rs1413212 0.3 84 0.3 44 
36 rs2076848 6 rs1029047 0.25 100 0.4 54 
37 rs1355366 19 rs719366* 0.2 105 0.2 60 (58) 
38 rs907100 40 rs2040411 0.1 94 0.1 68 
39 rs354439 30 rs727811 0.15 78 0.15 72 
40 rs2040411 43 rs251934 0.15 98 0.2 88 
41 rs737681 13th 7 rs917118* 0.1 87 0.15 20 (18) 
42 rs2830795 33 rs938283 0.08 85 0.1 22 
43 rs251934 38 rs907100 0.15 91 0.15 27 
44 rs914165 51 rs891700* 0.1 109 0.1 31 (32) 
45 rs10495407 48 rs964681 0.15 106 0.15 36 
46 rs1360288 52 rs1335873 0.15 110 0.1 40 
48 rs964681 42 rs2830795 0.1 97 0.15 44 
49 rs1005533 37 rs1355366 0.15 90 0.15 48 
50 rs8037429 54 rs1528460 0.15 115 0.15 60 
51 rs891700 45 rs10495407 0.4 102 0.2 68 
52 rs1335873 50 rs8037429 0.2 108 0.15 76 
53 rs1028528 35 rs1463729 0.1 87 0.15 84 
54 rs1528460 28 rs2056277 0.07 73 0.1 92 
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Figure 3-20: Full SNP profile of human control DNA with 1 µl of serial dilution (0.125 ng).  
 
 
 
 
 
 
 
 
 
 
Figure 3-21: Full SNP profile of human control DNA with 1 µl of serial dilution (0.5 ng).  
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Figure 3-22: Full SNP profile of human control DNA with 1 µl of serial dilution (1.0 ng). 
 
Figure 3-23: Three population samples (1 ng each) analyzed using the 13nd bin created 
using the GeneMapper v 3.2. 
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3.3.4. Evaluation of 13-plex SNaPshot assays with testing population samples 
Using these assays a further study was carried out on the population. A wide range of DNA 
concentrations of the testing population samples (0.04 ng to 569 ng) was used to assess 
the reproducibility of the 13-plex SNaPshot assays. The samples tested included 10 
samples that were classed as undetermined by the Quantifler™ Human DNA Quantification 
kit (Applied Biosystems, USA). These samples when subjected to SNaPshot analysis 
typically resulted in partial profiles and only 3 samples produced full SNP profiles. 
Representatives of full and partial profiles are shown as in Figure 3-24 and 3-25, 
respectively. These samples were re-extracted using Organic Solvent 
(phenol/chloroform/isoamyl alcohol) method, quantified with Quantifler™ Human DNA 
Quantification kit (Applied Biosystems, USA) and then, re-genotyped to collect the SNP 
data.  
Overall, full complete SNP profiles were successfully generated from all 90 population 
samples, at input DNA as low as 0.04 ng and as high as 70 ng, and no drop-out or unusual 
peaks were observed. However, peak imbalances and allele drop-out were observed in 
samples at lower DNA amounts that less than 0.04 ng or higher than 70 ng (Figure 3-16).  
In addition, the background noise was quite prominent in samples with higher template 
levels. Two examples of SNP profiles produced from the samples with input DNA 
approximately 70 ng and 569 ng are shown in Figures 3-26 and 3-27, respectively.   
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Figure 3-24: Full SNP profile of an individual with 0.04 ng DNA input. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-25: Partial SNP profile generated from undetermined DNA template.  
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Figure 3-26:  SNP profile from an individual with 1 µl (70 ng) of DNA template.  
In Figure 3-27, arrows showed the marker locus where both alleles dropped-out. The 
samples with high DNA concentrations that gave poor SNP profiles, were diluted to 5 
ng/µl before subjected to re-amplification and CE using AB 310 genetic analyzer.  
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Figure 3-27: SNP profile of an individual with 1 µl (569 ng) of DNA template. 
As for comparison to the TaqMan Genotyping Assays data, all tested samples that 
obtained from the SNP analysis showed identical allele genotypes as presented in         
Table 3-7. 
Table 3-7: A summary of alleles genotyped in 90 Malaysian individuals using TaqMan® SNP 
Genotyping assays which similar to the SNaPshot assay data. 
SNP Marker rs1493232 (A/C) rs1335873 (A/T) 
Ethnic Malay Chinese Indian Malay Chinese Indian 
Type of 
Genotypes 
 
21 AC  
  9 CC 
  6 AA 
13 AC 
11 CC 
14 AA 
11 AC 
  5 CC 
16 AA 
13 AT 
  1 TT 
12 AA 
13 AT 
  5 TT 
19 AA 
  8 AT 
  3 TT 
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3.4. DISCUSSION 
 
3.4.1. Selection of SNP markers and platform 
To obtain a parallel power of discrimination as STR analysis in forensic casework more 
than 50 SNP markers are needed. However, currently the greatest problem in developing 
useful SNP arrays for forensic use is not related to statistical issues; rather, the problems 
are biochemical. Making a large balanced multiplex of 50 loci for less than 1 ng of genomic 
template is challenging (Gill 2001).  
As stated by Sobrino, there are a large number of SNP genotyping methods available 
(Sobrino et al. 2005b), and usually the choice of the appropriate method depends on the 
number of SNPs and the number of individuals that need to be typed.  Brion and 
colleagues have explained that the main reason favouring multiplexing PCR with the single 
base extension (SBE) reaction method using the SNaPshot multiplex kit for laboratories 
involved in forensic DNA analysis, was the possibility of genotyping SNPs without 
investment in new technologies, simply using a capillary electrophoresis (CE) instrument, 
which is available in most of these laboratories for multiplex STR typing by fragment 
analysis (Brión et al. 2005). 
Therefore, in this study, 52 SNP markers identified from The SNP Consortium (TSC) and 
Sanchez et al. were selected to carry out SNP genotyping on Malaysian population and 
forensic casework samples. Sanchez and colleagues have established one PCR multiplex of 
52 SNP markers with the two sets of multiplex system comprised of 23 SBE and 29 SBE 
reactions for human SNPs genotyping (Sanchez et al. 2006a).  
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3.4.2. Development of the multiplex assays 
Multiplex PCR is a key technology for detecting infectious microorganisms, whole genome 
sequencing, forensic analysis, and for enabling flexible yet low-cost genotyping. However, 
the design of a multiplex PCR assay requires the consideration of multiple competing 
objectives (Rachlin et al. 2005b).  As suggested by Butler, to develop an efficient multiplex 
PCR, careful planning, several tests in primer designing and balancing reactions are 
required (Butler 2011). In addition, Dixon et al. (2005) has stated that ppreparing new 
multi-mix batches was one of the main challenges as each batch will be slightly different 
and at the same time these new batches must be balanced. Many rounds of altering 
primer concentrations was also required to optimize inter or intra locus balance (Dixon et 
al. 2005).  So, as for this study, several trials, such as developing 3-plexes, 5-plexes, 10-
plexes and 13-plexes assays had been carried out along with SNaPshot single reaction of 
each marker individually, to observe and understand the primer-primer interactions and 
the capability of the SNP markers to be multiplexed.  
The trial results showed that the combination and the concentrations of the PCR-SBE 
primers and the SBE product’s size were very important in order to get clear and balanced 
alleles in a SNP profile. Nicodeme and Steyaert (1997) suggested electrophoresis distance 
constraints that require two amplicons to have some minimum length difference so that 
they can be distinguished after being processed through an electrophoresis gel (Nicodeme 
1997). 
The study from the original paper (Sanchez et al. 2006a) indicated that the sensitivity of 
ABI 310 PRISM® was poorer than the sensitivity of ABI 3100 PRISM®, and most of their 
studies were carried out using ABI 3100 or ABI 3100-Avant PRISM® Genetic Analyzers. 
Therefore, in this study, four reliable 13-plex assays (designated as 13st, 13nd, 13rd and 13th) 
were developed from these 52 SNP markers to be analyzed with the ABI 310. This has 
improved the capabilities of the assays using ABI 310 genetic analyzer.  
This final multiplex assays then were chosen to be used throughout the study. Each 
multiplex assay has 13 loci in the form of the lowest to the highest SBE amplicon size. 
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Fourteen SBE primer lengths were adjusted to balance the designated assays. The 
experimental results in this study have showed that the reduction of the primers (marker 
loci) used in one multiplex assay, as expected, improved the resolution of SNP profiles that 
were obtained. The optimal final combination and concentrations of the PCR-SBE primers 
were presented as in Table 3-6; together with the original established multiplex (Sanchez 
et al. 2006a). 
Rachlin and colleagues have studied primer-primer interaction for screening individual 
primers as well as forward-reverse primer pairs, and for determining compatibility of two 
SNPs within a single multiplex PCR assay. They found that primer selection stringency is 
obviously a critical factor impacting the performance of any multiplex PCR design process. 
They have suggested that if fewer SNP markers more carefully chosen, it would be more 
likely to produce a working assay but could undermine one's ability to identify high 
multiplex designs (Rachlin et al. 2005a). 
 
Another important factor that was taken into consideration was the optimal conditions of 
both, PCR and SBE reactions, such as the concentrations of PCR buffer, DNA Taq 
Polymerase, Mg2+ ions, deoxynucleotides or dideoxynucleotides and the PCR/SBE cycling 
conditions. Several adjustments of PCR/SBE components’ concentrations were tested 
using the same thermal conditions as described by Sanchez et al. (2006a). The final 
optimal compositions of the PCR/SBE reactions which produce balanced and good SNP 
profiles in all 13-plex assays were described in Chapter 2, sections 2.7.2.3. to 2.7.2.8.1. 
Also, it is very important to ensure that the correct targeted SNP allele(s) were obtained 
and the appropriate dyes exhibited by 13 SNPs homozygotes or heterozygotes alleles in 
each multiplex assays.  Results from the experiment have showed that the targeted SNP 
allele(s) of each SNP marker were correctly labelled with the correct dyes, and they 
exhibited stably for all four 13-plex assays.  This shows that the reduction of alleles loci in 
one multiplex assay, has decreased the dyes and primer-primer preferential amplification 
and makes the interpretation of the profile became easier. Borsting et. al. (2009) stated 
that the strengths of the fluorophore emissions from the four dyes used in the SNaPshot 
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kit are unbalanced and that the peak height of one allele may be up to 6 times higher than 
the peak height of the other allele in the same locus. This scenario increases the risk of 
false interpretation of the results by the analyst, especially when many SNPs need to be 
analyzed in the same electropherogram (Borsting et al. 2009). 
The analysis and interpretation of the SNP profiles have generally relied on the 
observation of the number and dye colour(s) of the peaks at each locus and the relative 
allele peak heights. Therefore, the multiplex assays developed in this study proposed a 
simpler and easier alternative to prepare and genotype the samples. It is also suitable for 
the laboratories that only have ABI 310 genetic analyzer to carry out genotyping analysis.  
Furthermore, clear resolution and full profile of 52 SNPs were observed from all series of 
control DNA dilutions.  As described by Borsting et al.(2009) that when some discrepancies 
were observed between the laboratories, it was often caused by simple misinterpretations 
of the electropherograms such as the SBE primers being labelled with two different dyes, 
for the heterozygous individuals, and are detected at different wavelengths and appear in 
different dye windows of the electropherogram.  
 
3.4.3. The stability of the multiplex assays 
Along with the control DNA, TaqMan DNA and M7-7, 90 test population samples were 
used to study the reproducibility and stability of these four 13-plex assays, where 1 µl of 
each sample, where template DNA ranged from 0.04 ng up to 569 ng were used. The 
results obtained show the sensitivity and reproducibility of the 13-plex assays developed, 
which they were able to amplify DNA as low as 0.03 ng and higher than 70 ng. As for 
forensic casework, these 13-plex assays could be useful tools in detecting low template 
DNA that less than 0.2 ng. In addition, the concordance TaqMan genotyping data 
confirmed that the targeted alleles were correctly genotyped using the 13-plex assays.   
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Sanchez et al. (2006b) has reported that the multiplex PCR (with 23 and 29 SBE reactions) 
has allowed full complete allele-called from DNA input as low as 0.5 ng. However, the 
optimal amount of DNA in the PCR was 1–10 ng for successful amplification, and 
acceptable results were obtained with up to 70 ng DNA.  With DNA input lower than 0.2 
ng, the alleles started to drop-out and gave unbalanced peak heights.    
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ANALYSIS OF 13-PLEX ASSAYS (13st, 13nd, 13rd and 13th) 
USING 3500 GENETIC ANALYZER 
 
4.1. INTRODUCTION 
Over the last years there has been a vast number of developments and applications of 
capillary electrophoresis (CE) and microchip-CE. This growth has influenced the recent 
developments in instrumentation associated with CE. CE offers high separation 
efficiency, low cost, fast analysis, and minimal waste generation (Felhofer et al. 2010). 
Today, CE and microchip-CE devices have become well accepted, multi-dimensional 
analytical platforms in the biomedical, pharmaceutical, environmental, and forensic 
sciences.     
CE is the primary methodology used for separating and detecting short tandem repeats 
(STR) alleles in forensic DNA laboratories worldwide. The first CE introduced was the 
single-capillary ABI PRISM® 310. But currently, a number of capillary array 
electrophoresis (CAE) systems are commercially available (Butler et al. 2004). These 
CAE systems offer from 8 to 384 capillaries run in parallel for the high throughput 
analysis as shown in Table 4-1. 
The latest generation of CE instruments are 3500 and 3500xl Genetic Analyzers, which 
became commercially available in 2010, supplied by Applied Biosystems (Life 
Technologies, Foster City, USA). These instruments are available in 8 capillary (3500) 
and 24 capillary (3500xl), and were designed with simplified setup reaction, operation 
and maintenance. These series are also incorporated with the RFID (Radio Frequency 
Identification) labels on all capillary arrays, polymer pouches, buffer containers and 
conditioning pouches.  The RFID labels are for tracking and reporting the consumable 
usage (lot, part numbers and expiration dates). The consumables data can be retrieved 
or tracked from Data Collection Software even after the consumables have been 
removed from the instrument. These 3500 series designed for use with the 96 or 384-
well microtiter plates’ format and also for 96-well Fast and 8-tube standard or fast 
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strips (Applied Biosystems 2009b). Other additional features includes an improved 
mechanical pump for polymer filling of the capillaries with less waste, new laser 
technology, reduced power requirements and 6-dye detection capabilities (Butler 
2011).    
Table 4-1: The number of arrays in commercial CAE systems [Adapted from (Butler et 
al. 2004, Butler 2011)]. 
Type of Arrays No. of capillaries 
Applied Biosystems 
(Foster City, CA, USA) 
 
ABI 3100 Avant 4 
ABI 3100 16 
ABI 3130 series 4 & 16 
ABI 3700 96 
ABI 3730 series 48 & 96 
ABI 3500 series 8 & 24 
  
Amersham Biosciences 
(Piscataway, NJ, USA) 
 
MegaBACE 500 48 
MegaBACE 1000 96 
MegaBACE 4000 384 
  
SpectruMedix Corporation 
(State College, PA, USA) 
 
SCE 2410  24 
SCE 9610 96 96 
SCE 19210 192 
  
Beckman Coulter 
(Fullerton, CA, USA) 
 
CEQ 8800 8 
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4.2. RATIONALE OF THE STUDY 
As demonstrated in the previous chapter, four sets of 13-plex PCR/SBE assays (13st, 13nd, 
13rd and 13th) have been developed and internal validation study includes the sensitivity 
and reproducibility assessment had been carried out using the ABI PRISM® 310 genetic 
analyzer. In addition, 90 population samples have been evaluated. 
 
4.2.1. Concordance analysis using the 3500 Genetic Analyzer    
The main aim of this study was to assess the sensitivity and reproducibility of the 13st, 
13nd, 13rd and 13th assays using the 3500 Genetic Analyzer before applied these assays 
to a larger number of population samples and forensic casework samples.  
To begin with, all 13-plex assays generated from each series of Control DNA from the 
previous study (Chapter 3, Part Two), were re-electrophoresed using a 3500 Genetic 
Analyzer with polymer POP-7™ as recommended by the manufacturer’s protocol 
(Applied Biosystems 2009b).  
 
4.2.2. Assessment of the 13-plex assays using different polymers and parameters    
Following the primary results obtained, a few experiments were carried out to test the 
three commercially available polymers for SNP analysis on the 3500 genetic analyzer. 
Applied Biosystems supplied two primary polymers, that for use with the ABI PRISM 
310 and other CAE systems: POP-4TM and POP-6TM, where “POP” is stands for 
Performance Optimized Polymer. POP-4TM is commonly used for DNA fragment 
analysis while POP-6TM is capable of higher resolution, which is suitable for DNA 
sequencing. Recently, POP-7TM has been also introduced for both applications (Butler 
2011).  
POPTM polymers dynamically coat the capillary wall to control electro-osmotic flow as 
illustrated in Figure 4-1. This figure illustrates a cross-section through a CE capillary. 
Electrophoretic flow is the movement of DNA fragments from the negative electrode 
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(cathode) towards the positive electrode (anode). There are strands of entangled 
polymer that sieve these DNA fragments progress based on their size, meaning that 
the smaller fragments will get through the obstructions easier than the longer 
fragments.  
There is also another opposite force that also produced inside the capillary, which 
known as an electro-osmotic flow or EOF. The capillaries are made of glass or fused 
silica (silicon dioxide, SiO2) which has a negatively charged hydroxyl group (silanol, 
SiOH) along the inner walls. Under the electric field strength, the positive ions from the 
electrophoresis buffer will move towards the negative electrode producing a plug like 
flow having a flat velocity distribution across the capillary diameter. Velocity of the 
electro-osmotic flow depends on the composition, pH and ionic strength of the 
electrolyte solution (Butler 2011, Corradini, Sprecacenere 2003).  
 
Figure 4-1: Illustration of internal capillary environment and forces with moving DNA 
molecules through a sieving polymer buffer. [Taken from (Butler 2011)]. 
Madabhushi and colleagues (1997, 1998) studied Poly (N,N-dimethylacrylamide)/ 
pDMA as a DNA-sequencing matrix, focusing on this self-coating feature. However, ABI 
holds a basic patent on any water soluble polymers with self-coating features. These 
polymer comprising 4% and 6% concentrations of dimethyl polyacrylamide and high 
concentration urea (Wenz 1994, Rosenblum et al. 1997, Madabhushi et al. 1997, Wenz 
et al. 1998, Lazaruk et al. 1998, Madabhushi 1998, Maruyama 2005, Butler 2011).   
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Since ABI declared that POP, the polymer matrices for its sequencing instruments, has 
self-coating features, it has been widely believed that POP consists of pDMA. ABI has 
never released any part of POP's ingredients, except from the related published 
articles that stated the 3700TM instrument uses a separation matrix that is based on 
relatively low molar mass, linear poly-dimethylacrylamide, which is commercially 
known as POP 7 (Maruyama 2005).  Apart from the above information, the only 
characteristic of the polymers known is as listed Table 4-2.  
Table 4-2: Polymer characteristics [Adapted from (Applied Biosystems 2012). 
Polymer type Characteristics 
POP-4™ Less viscous, fast runs 
POP-6™ More viscous, slow runs 
POP-7™ Less viscous, fast runs 
In order to carry out the polymer evaluation for genotyping the 13-plex assays, 
approximately 20 control and population samples were re-analyzed using a 3500 
Genetic Analyzer but with different parameters as shown in Table 4-3.  
Table 4-3: Run parameters for the SNP analysis on the 3500 Genetic Analyzer. 
3500 Genetic Analyzer Run Parameters 
Parameters Polymer types 
 POP-4™ POP-6™ POP-7™ 
Capillary array 36 cm 50 cm 50 cm 
Application type HID Fragment Fragment 
Dye set E5 E5 E5 
Run module HID36_POP4 FragmentAnalysis50_POP6 FragmentAnalysis50_POP7 
Run 
temperature 
60°C 60°C 60°C 
Injection voltage 1.2 kV 1.6 kV 1.6 kV 
Injection time 10 s 10 s 10 s 
Run time 2800 s 2800 s 2800 s 
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4.2.3. Analysis of tested samples with optimal parameters and conditions    
Based on the preliminary results obtained, which displayed over-amplification, the 
volume for each SBE multiplex assay was reduced to 1.7 µl of SNaPshot mix, 1 µl of 
purified PCR product and 1 µl of mixed SBE primers, and made to a final volume of 5 µl 
with nuclease-free water. 
As for final optimization, all control DNA samples (single and multiplex reactions), with 
template amounts ranging from 0.01 ng to 2.5 ng (in triplicates) and tested population 
samples were analyzed with polymer POP-6™ on a 3500 Genetic Analyzer as described 
in Chapter 2, section 2.7.2.8.2. 
 
4.3. RESULTS  
 
4.3.1. Separation and detection of 13-plex assays on the 3500   
Initially, the analysis of the same SBE products (from the previous internal validation 
study-Chapter 3, Part two) was carried out using POP-7™ with 50 cm capillary array on 
the 3500, following the recommended manufacturer’s protocol (Applied Biosystems 
2009b). However, the resolution and mobility aptitude of the alleles was very poor, 
especially for the SBE products below 60 nt. As shown in Figure 4-2(A), 13th assay 
profiles of Control DNA samples that with (0.03, 0.125, 0.25 and 0.5) ng demonstrates 
poor resolution. The first eight alleles in those profiles are close to each other.  
 
A similar observation was noted in few other tested samples that had been re-analyzed 
on the 3500 genetic analyzer. As shown in Figure 4-1(B), a worse scenario was 
observed when compared to Figure 4-2(A), because these samples have more 
heterozygous SNP alleles. The 13rd-plex assay comprises alleles’ ranging in size from 16 
nt to 88 nt but on polymer POP-7™, the alleles’ size have been shifted to 
approximately from 32 nt to 95 nt.  
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Figure 4-2: Electropherograms displaying the separation of: (A) SNaPshot profiles of 
13th multiplex assay of Control DNA, and (B) SNaPshot profiles of 13rd multiplex assay 
of 3 different individual samples using POP-7™ on 3500 Genetic Analyzer.   
B 
Individual 1 
Individual 2 
Individual 3 
A 
0.03 ng 
0.13 ng 
0.25 ng 
0.50 ng 
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4.3.2. Effect of different polymers and parameters on the 13-plex assays analyzed 
using the 3500 Genetic Analyzer 
Re-analysis of the same SBE products but with different parameters and polymers, 
POP-4™ and POP-6™ was carried out as described in Table 4-3.  
The results obtained were compared as shown in Figure 4-3, where the 13th-plex assay 
profiles of the same SBE products (0.5 ng Control DNA) has been analyzed with 36 cm 
capillary and POP-4™ on ABI 310 (A), 36 cm capillary and POP-4™ on ABI 3500 (B), 50 
cm capillary and POP-6™ on ABI 3500 (C) and 50 cm capillary and POP-7™ on ABI 3500 
(D). It was clearly noted that this sample has more homozygous alleles that differ in 
size by at least more than 2 nucleotides (nt) from each other. But, each of the profiles 
(Figure 4-3 B, C and D) showed different allelic migration patterns, especially for SNP 
alleles below 60 nt. However, the peak heights exhibited were quite similar (5000 to 
7000 RFU) for all profiles.  
The boxes show the most affected area of the allele migrations. But, the separation of 
the SNP alleles obtained from sample runs on the 310 (A) and 3500 (B) analyzers have 
no significant differences. Sample on the POP-7™ has very poor resolution. However, 
the sample analyzed with POP-6™ (C) on the 3500 gave the best allele resolution.  
The close-up of these selected areas is shown as in Figure 4-4 (A, B and C).  The arrows 
show the allele migration from the SNP code marker’s locus that was created based on 
the allele’s size of Control DNA (triplicates) generated using POP-6™ polymer. The 
difference in allele size obtained for SNP markers 7, 33, 38 and 48 of these profiles 
were calculated from the actual allele size for each particular marker.  
As can be seen from Table 4-4, there are huge differences between allele migrations in 
POP-7™ compared to POP-4™ and POP-6™ polymers.  This data (Control DNA) was 
obtained from one same sample that has been electrophoresed using all polymers.    
 
CHAPTER 4                                                      Verification of the Four 13-Plex Assays using ABI PRISM® 3500 
 
121 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-3: Comparison of SNaPshot profiles of 13th multiplex assay using polymers;                  
A) POP-4™ on ABI 310 PRISM® Genetic Analyzer, B) POP-4™, C) POP-6™ and D) POP-7™ 
on the 3500 Genetic Analyzer. Boxes show the most affected SNPs alleles.  
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Figure 4-4: Allele migration of Control DNA in different polymer types; A) POP-4™, B) 
POP-6™ and C) POP-7™ on 3500 Genetic Analyzer. Code markers’ positions were 
highlighted in red. The arrows show the first allele’s movement in each dye.  
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Table 4-4: Data of allele’s migration (bp) on different type of polymers. 
Allele’s migration measurement(nt) 
Markers Actual Size (nt) POP-6™ POP-4™ POP-7™ 
38 27.0 28.91 31.45 38.75 
Size deviation  1.91 4.45 11.75 
7 18.0 23.79 27.19 35.74 
Size deviation 5.79 9.19 17.74 
48 36.0 37.99 39.90 45.13 
Size deviation 1.99 3.9 9.13 
33 22.0 25.82 29.81 39.26 
Size deviation 3.82 7.81 17.26 
The polymer performance evaluation has also been carried out on the Positive Control 
provided along with the ABI PRISM® Multiplex Kit and other tested population samples. 
The results are shown as in Figure 4-5. As observed, the green peaks and a blue peak of 
the Positive Control have merged into one huge peak on the POP-7™ polymer. Whilst 
the separation on POP-4™ and POP-6™ can still differentiate all the alleles although 
there is a noticeable mobility differences between these two polymers.         
The alleles were not separated well even for the population sample analyzed on the 
POP-7™.  As can be seen from Figure 4-5 B, the first five alleles have merged as a 
complicated complex and it was hard to identify them correctly. This 13rd-plex assay 
has actual allele size ranging from 16 to 88 nt, but for these five alleles alone, the size 
ranging from 16 to 38 nt.  However, from the results obtained on POP-7™, the allele’s 
size for markers 41, 27, 36, 21 and 44 was cramped from 34.28 to 43.47 nt.  On POP-
6™, these five alleles have better separation with allele sizes ranging from 19.47 to 
35.36 nt.   
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Figure 4-5: (A) SNP profiles of Positive Control of ABI PRISM® SNaPshot Multiplex kit 
and (B) 13rd-plex
 profiles of an individual sample electrophoresed in different polymer 
types; POP-4™, POP-6™ and POP-7™ on 3500 Genetic Analyzer. Arrows show poor 
separation of the allele’s occurrence.  
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POP 4 
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4.3.3. Sensitivity and reproducibility assessment using polymer POP-6™ and optimal 
parameters on the 3500 Genetic Analyzer 
 
4.3.3.1. Detection level of sample loaded on the 3500 
To observe SNP allele’s detection level on the 3500 genetic analyzer, 0.4 μl and 1 μl of 
each type of 13-plex assays were loaded into 96 microtitre-plates, together with the 
internal size standard and formamide. Figure 4-6 demonstrates that no significant 
difference was observed between the profiles’ peak height and profiles’ quality for 
Figure 4-6 (A) and (B), but as for (C) and (D), a slight difference in the peak height was 
observed. This scenario was witnessed only in longer assays: 13rd-plex and 13th-plex 
profiles, which the alleles’ size approximately around 16 to 92 nt, compared to the 
other two shorter 13-plex assays, the alleles’ size were from 16 to 80 nt.     
 
 
 
 
 
 
 
 
 
 
Figure 4-6: A) and B) are the profiles of 13nd–plex assay, but with 0.4 μl and 1 μl of 
samples loaded, respectively. C) and D) are the profiles of 13th-plex assay, with 0.4 μl 
and 1 μl of samples loaded, respectively using polymer POP-6™ on the 3500 Genetic 
Analyzer.  
A 
B 
C 
D 
13nd-plex – 0.4 μl 
13nd-plex – 1 μl 
13th-plex – 0.4 μl 
13th-plex – 1 μl 
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4.3.3.2. Peak height observation 
Results obtained from the concordance study showed that the peak height in relative 
fluorescence units (RFU) of the same product was 3 times higher when it was 
electrophoresed using the 3500 (Figure 4-7(B)) than the ABI 310 (Figure 4-7(A)), which 
were 14,000 RFU and 4200 RFU, respectively. Because of these observations, the SBE 
reagents consumed for multiplex assays have been reduced as mentioned in section 
4.2. Figure 4-7(C) shows the same PCR product generated using the new optimal SBE 
conditions (reduced reaction mix) that has exhibited average peak height (5000 RFU) 
on the 3500. This determines that the sensitivity and detection limit of 3500 is higher 
than ABI 310.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-7: Peak height (RFU) comparison of three SNP electropherograms of the same 
Control DNA sample (0.5 ng/µl) using; (i) an optimal conditions and parameters with 
ABI 310 PRISM® Genetic Analyzer, (ii) Same product as (A) but electrophoresed and 
analyzed with 3500 Genetic Analyzer, and iii) new optimal conditions with 3500 
Genetic Analyzer.   
A 
4200 RFU 
B 
14000 RFU 
5000 RFU 
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Above results have indicated that the new optimal criteria of the capillary 
electrophoresis using 3500 Genetic Analyzer were the PCR and SBE reactions and 
conditions as mentioned in section 2.3 and 2.7. Whilst the suitable polymer was POP-
6™, with 50 cm capillary array, 10s (injection time), 1.6 kV (injection voltage), 2800s 
(run time), E5 dye set and with run module: fragmentAnalysis50_POP6. 
 
4.3.3.3. Stability of the assays on the 3500 Genetic Analyzer  
With these new optimal conditions and parameters, several samples including the 
controls (TaqMan Control DNA and 9947A) have been re-analyzed using the 3500.  All 
Control DNA samples which ranged from 0.01 to 2.5 ng were analyzed in triplicate for 
comparison purpose. Figure 4-8 shows triplicates of two different DNA concentrations 
(2.5 and 0.1 ng) of two different assays (13th and 13nd assays). Results determined the 
stability of the assays. 
 
4.3.3.4. Sensitivity level of DNA input 
As for the sensitivity of the assays on the 3500, a full SNP profile (52 markers) was 
obtained from all Control DNA and samples with input higher than 30 pg. In some 
samples with 30 pg template DNA one or two allele(s) dropped out. In addition, peak 
imbalances and additional peaks were observed for DNA input lower than 30 pg. 
Overall, from the results obtained, these 13-plex assays found to work best and 
consistently with template DNA of 60 pg and higher.  
Figure 4-9 shows the comparison of 13nd-plex profiles from different DNA 
concentrations: (0.01, 0.02, 0.03, 0.06, 0.125, 0.25 and 0.5) ng. Full 13 alleles are 
clearly observed from DNA amount of 30 pg to 0.5 ng. Well-balanced profiles were 
witnessed from samples with DNA input of 60 pg to 0.5 ng.   
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Figure 4-8: Electropherograms of; A) triplicates of 13th–plex assay with 2.5 ng of 
Control DNA and B) triplicates of 13nd-plex assay with 0.1 ng of Control DNA, using 
polymer POP-6™ and 3500 Genetic Analyzer, each at constant 9000 RFU and 6000 RFU, 
respectively.  
A
B
13th-plex of 2.5 ng 
13nd-plex of 0.1 ng  
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Figure 4-9: 13nd -plex profiles of a series of DNA template input: all are shown with a scale of 4000 RFU.   
0.01 ng 
0.02 ng 
0.03 ng 
0.06 ng 
0.13 ng 
0.25 ng 
0.50 ng 
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The potential of these assays in detecting SNP alleles using the 3500 genetic analyzer 
under controlled laboratory conditions has been tested with focusing on the DNA 
sensitivity level that is from 10 pg to 60 pg of DNA input. As shown in Figure 4-10, at 
very low levels of DNA template stochastic variations such as allele drop-in, allele drop-
out and peak imbalances are seen. The triplicates of these DNA template amounts 
were consistent. 
 
 
 
 
 
 
 
 
 
 
Figure 4-10: SNP electropherograms of 13st–plex assay generated from DNA serial 
dilutions: A) 0.01 ng, B) 0.02 ng, C) 0.03 ng and D) 0.06 ng. The arrows show the 
targeted allele(s) that dropped out.  
A 
B 
C 
D 
0.01 ng 
0.02 ng 
0.03 ng 
0.06 ng 
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Lower template levels were also seen to improve results, overcoming some bias 
problems of the preferential amplifications and electrokinetic injection that were seen 
with higher template levels. As shown in Figure 4-11, the same sample with two 
different DNA amounts: 3.3 ng and 0.3 ng, were analyzed using the same optimal 
conditions have demonstrated different quality of SNP profiles. The sample with lower 
input DNA has better resolution with a cleaner baseline. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-11: SNP profiles generated from the same sample but with different DNA 
concentrations; A) 3.3 ng/µl, and B) 0.3 ng/µl, electrophoresed with polymer POP-6™ 
using ABI 3500 PRISM® Genetic Analyzer.  
A 
B 
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All four 13-plex assays were arranged as 4 panels per individual (52 autosomal SNP 
markers) for better visualization and interpretation of the SNPs profile. Figure 4-12 
demonstrates a full SNP profile (13st, 13nd, 13rd and 13th) obtained from 1 ng of 9947A 
on the POP-6™ and 3500 Genetic Analyzer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-12: SNPs electropherogram of 52 markers generated from 1 ng 9947A.    
13st 
13nd 
13rd 
13th 
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Another example of full SNP markers in one electropherogram that generated from 
tested population sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-13: SNPs electropherogram of 52 markers generated from 1 ng tested 
individual sample.  
13st 
13nd 
13rd 
13th 
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4.4. DISCUSSION 
In the previous chapter, four reliable 13-plex assays (designated as 13st, 13nd, 13rd and 
13th) from the 52 SNP markers (Sanchez et al. 2006a) have been developed and 
validated using the polymer POP-4™ and the ABI PRISM® 310. As mentioned in the 
original paper (Sanchez et al. 2006a), the ABI PRISM®310 has lower sensitivity than the 
ABI PRISM® 3100. Most of their studies were carried out using ABI PRISM® 3100 or ABI 
3100-Avant Genetic Analyzers. As for this study, the capability of a 3500 in detecting 
designated SNP assays was assessed as this instrument will be used to analyze a 
number of Malaysian population samples and forensic real-casework samples.  
 
4.4.1. Corroboration analysis with the 3500  
Any instrumentation used for forensic applications must be accurate and allow correct 
allelic designation of samples processed (Koumi et al. 2004). Therefore, for comparison 
with the ABI PRISM® 310, the same multiplex assays and positive controls generated 
from the previous study (Chapter 3, Part two), were analyzed using POP-7™ and a 3500 
genetic analyzer. However, an unexpected scenario had occurred where the results 
demonstrated in this study show the resolution of the alleles on POP-7™ was very poor.  
 
4.4.2. DNA separation and resolution analysis with different polymer types 
To more closely examine the problem encountered, further analysis was performed 
using different parameters and polymer types as mentioned in section 4.2.2.  This 
experiment has been repeated again with different batches of capillary arrays, buffers 
and polymers, and using recommended run voltage and temperature. Similar results 
were obtained. Results show consistently that there are significant mobility differences 
between alleles analyzed on POP-7™ with the actual SNP allele sizes for all Control 
DNA and tested samples. Besides that, polymer POP-6™ was also found to be the most 
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suitable polymer to be used for 13-plex assays detection on the 3500. It gave better 
resolution than other type of polymers, even for sizes as small as 20 nt.  
Bekeart and co-workers have experienced the unresolved alleles at size ranging from 
30 to 40 nt of 34-SNPplex assay when using POP-7™ on ABI 3130xl genetic analyzer, 
which was suggested to be due to the higher viscosity of the polymer (Bekaert et al. 
2011).  
According to Wenz, a sample with a consistent conformation between fragments could 
be an indicator of a resolution for a CE system. He also added that for single-nucleotide 
genotyping, it requires the separation of length variant alleles from common alleles 
that can differ in size by one nucleotide. In addition, Wenz et al. has suggested to use a 
higher concentrated polymer formulation (POP-6™) for DNA sequencing, because it 
provides 1-nucleotide separation up to at least 400 nucleotides, although POP-4 is 
sufficient for most genotyping experiments, but it provides 1-nucleotide separation 
beyond 250 nucleotides in some instances (Wenz et al. 1998).   
Apart from the resolution problem, which occurred within the range of 20 to 60 nt, all 
peaks height, size and shape were good and no other artifacts were encountered; such 
as shoulder peaks or blobs, in any profiles analyzed with the different types of 
polymers on both genetic analyzers. Therefore, no further analysis was carried out.  
 
4.4.3. Overview of polymer solutions, includes POP-4™, POP-6™ and POP-7™ 
There are several factors affecting the resolution in a CE system, which include 
capillary length, polymer concentrations, the buffer’s ionic strength and separation 
voltage (Butler 2011). But polymer solution is one of the most important parameters in 
CE since it determines the migration behavior, including the resolution of charged 
molecule.  
Many studies had been carried out in finding, developing and improving the suitable 
polymer to be used in separating DNA efficiently (Wenz 1994, Rosenblum et al. 1997, 
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Madabhushi et al. 1997, Mandabhushi 1998, Lazaruk et al. 1998, Wenz et al. 1998, 
Behr et al. 1999, Madabhushi 2001, Albarghouthi et al. 2002, Fredlake et al. 2008, 
Maruyama 2005). Most of them have been working on the development of low 
viscosity matrices to allow the refilling of the capillary after each analysis. A 
‘replaceable’ or ‘replenishable’ polymer system extends the life time of a capillary, 
prevents polymer contamination, and avoids sample carry-over. 
Based on theoretical considerations and proved by experiments, Madabhushi and 
collegues at Applied Biosystems stated that pDMA is close to an ideal matrix for DNA 
separation; it can also be pumped through the capillaries in less than a minute and 
provides a very high resolution for the separation of dsDNA as well as ssDNA 
(Madabhushi 1998). The most important property of pDMA is its self-coating ability: 
the hydrophilic pDMA chains adhere to the capillary wall, therefore effectively 
suppressing electroosmotic flow (Behr et al. 1999). The polymer solution needs to be 
simply flushed through the capillaries to coat them. Alternatively, addition of small 
amounts of these coating polymers to other sieving polymers allows the use of 
uncoated capillaries (Madabhushi 1998). Using the 3500 over 1000 runs has been 
possible without any decline in capillary performance. 
Poly (dimethyl acrylamide)/ (PDMA) and polyvinylpyrrolidone (PVP) are non-covalent 
coating polymers and were used for DNA sequencing. These polymers suppress EOF 
and DNA-wall interactions better than PEO due to their strong adsorption 
characteristics. At least 100 sequencing runs were performed in a PDMA coated 
capillary before surface regeneration was required (Madabhushi 1998, Madabhushi 
2001). 
The composition of the POP-4™ and POP-6™ were already known (Wenz 1994, 
Madabhushi et al. 1997, Madabhushi 1998) , but for POP-7™, only information about 
its characteristic and analysis features are acknowledged, such as POP-7™ was 
designed for a wide range of short-read to long-read sequencing applications. However, 
there was one chemical analysis of POP7 that had been conducted by Maruyama to 
study the main ingredient of POP-7, and from the results obtained, he has suggested 
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that POP-7™ consists mainly of Linear polyacrylamide (LPA) and trace amount of pDMA, 
urea and N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid (TAPS) 
(Maruyama 2005). 
In the forensic field, POP-7™ was the newest polymer developed specifically to be used 
with ABI 3700 series genetic analyzer.  Kazim et al. reported that with POP-7™, the 
occurrence of the artifacts such as, spikes and stutters were greatly reduced (Detwiler 
et al. 2004). POP-7™ also was introduced to be used with the flexible 3130 Series 
Systems, to perform sequencing and fragment analysis (Applied Biosystems 2004). 
Sizing differences resulting from mobility changes between various types of polymer 
are more apparent for sequences smaller than 50 nt. Due to the nature of the polymer, 
smaller fragments (< 50 nt) run on POP-7™ polymer on the 3130/xl Genetic Analyzers 
and on the 3730/xl DNA Analyzers may have slightly different mobility. Applied 
Biosystems has recommended that genotyping projects should be started and 
completed on the same instrument, using consistent run conditions. Besides that, the 
single-base extension primers should be designed not shorter than 25 nt to prevent 
sizing inconsistency. In addition, the spacing between the alleles should be at least 6-8 
nt for primers that are less than 30 nt and 4-6 nt for primers that are greater than 30 
nt (Applied Biosystems 2010b). 
 
4.4.4. Verification studies under optimal conditions and parameters on the 3500 
Genetic Analyzer   
Koumi and colleagues described the need to evaluate and validate the platforms for 
forensic use, where a number of key acceptance criteria were examined, including 
correct designation of known sample profiles, precision, resolution, and sensitivity 
(Koumi et al. 2004). 
In this study, all criteria were assessed to ensure the reliability of the assays and the 
genetic analyzer systems. Although no allelic ladder was used, the whole process was 
evaluated using the TaqMan DNA Controls and control DNA 9947A.   
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Koumi and colleagues also stated that the instrument’s precision study, consisting of a 
number of allelic ladder runs or demonstrated an internal size standard migrating at a 
linear rate in achieving precise sizing (Koumi et al. 2004). Sizing precision is an indicator 
that the instrument is performing consistently rather than sizing accuracy, which is a 
measure of how closely fragments are sized to their true length. Differences are 
observed in assigned allele sizes when using different instruments, separation 
matrices, and size standards (Lazaruk et al. 1998, Vainer et al. 1997).  
In this study, some additional tests were conducted on the polymers to ensure how 
accurate 3500 in resolving alleles, where the difference in length (nt) were measured 
between the alleles electrophoresed on the polymer POP-4™, POP-6™ and POP-7™. 
There were significant deviations between the alleles electrophoresed on POP-7™ 
compared to the other two polymers. 
Therefore, POP-6™ was chosen to be used for SNP genotyping of population and 
casework samples. A few other parameters such as the sensitivity of DNA level 
detection for 13-plex assays and others also had been evaluated before performing the 
13-plex assays on the samples.  
From the evaluation, it shows that although the samples loaded on the 3500 was as 
low as 0.4 µl (of sample following SBE reaction and clean-up) full SNP profile were 
generated with a threshold of approximately 3000 RFU.  Early in the development of 
DNA testing with CE, it was demonstrated that a simple dilution of the sample in water 
or deionized formamide can be an effective method for sample preparation because 
the sample ionic strength is reduced relative to the buffer ionic strength (Behr et al. 
1999). 
In addition, the SBE reaction mix has been also reduced from the original quantity, 
because the 3500 was found to be more sensitive in detecting the 13-plex assays 
compared to the ABI 310 genetic analyzer.  
The results also showed consistency in triplicates that the 13-plex assays can be 
detected for DNA input as low as 30 pg, although in some instances, a few of the 
 
CHAPTER 4                                                      Verification of the Four 13-Plex Assays using ABI PRISM® 3500 
 
139 
 
population samples have one or two allele(s) drop-out. A drop out observed at 30 pg 
template DNA probably due to variations introduced during the PCR set-up procedure 
rather than instrument effects. The best SNP profile obtained was at input DNA 60 pg 
and above.  Koumi and colleagues suggested that sensitivity was examined using 
dilutions of PCR products and measured by the ability to generate a full profile by the 
instruments (Koumi et al. 2004). 
Finally, the 13-plex assays were arranged as a full SNP profile (52 markers) as four 
different panels (eg. Figure 4-12 and 4-13). In this way it is a lot easier to interpret the 
SNP data.  
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SNP ANALYSIS OF MALAYSIAN POPULATION SAMPLES  
WITH 13-PLEX PCR/SBE ASSAYS (13st, 13nd, 13rd and 13th) 
 
5.1. INTRODUCTION 
SNPs could be polymorphic in one population but completely monomorphic in another 
population (Pfaff et al. 2004, Sanchez et al. 2006a), while others are known to be 
polymorphic in all major population groups. For human identification purposes, loci 
with low FST values and a heterozygosity of 40% are generally considered adequate 
However, a major problem with SNPs is that the frequency of an allele can range from 
zero to one among divergent populations; causing a very large dependence of the 
match probability on the population allele frequencies used for the calculation, 
potentially to a level many fold greater than for CODIS markers (Kidd et al. 2006).  
Before any new forensic markers are used, it is very important to generate appropriate 
allele frequency databases that can be referred to. This is especially important in 
markers such as SNPs, where allele frequencies can vary considerably between 
populations. Information on allele frequency measurements from a group or 
representative sample set (usually 100 individuals), is used. These individuals are 
completely anonymous and only classified with their ethnicity (Butler 2011). With 
modern cosmopolitan populations, allele frequencies for all forensically relevant 
populations should be known to avoid courtroom challenges (Kidd et al. 2006, Pakstis 
et al. 2007, John M. Butler, Michael D. Coble, Peter M. Vallone 2007). 
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In Malaysia, there is no accessible intelligence DNA databank system yet such as 
NDNAD (UK) or CODIS (USA). However there are published allele frequency data for 9 
STRs (Lim et al. 2001), 15 STRs (Izuan et al. 2005, Seah et al. 2003) and 16 or 17 YSTRs 
(Chang et al. 2007) from three major ethnic population groups of Malaysia (Malay, 
Chinese and Indians) and three major native populations in Sarawak: Iban, Bidayuh and 
Melanau (Suadi et al. 2007, Chang et al. 2009). All forensic DNA cases are evaluated 
using these DNA population databases. 
 
5.1.1. 52-SNPforID plex   
Sanchez and colleagues have studied these populations (Table 5-1) in order to study 
the chosen SNP markers to be used in forensic applications. They have reported quite 
huge SNP population data and also carried out studies on the forensic samples, which 
includes kinship study.  
Table 5-1: The populations included in the Sanchez study (Sanchez et al. 2006a). 
Population Total number of populations analyzed with 52-
plex SNPforID  
European: 
Danish  
German  
Turkish 
 
156 
49 
96 
Asians: 
Chinese 
Taiwanese 
Japanese 
Thais 
Greenlander 
 
63 
43 
7 
33 
149 
African: 
Somali 
 
104 
Total 700 
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5.1.2.  SNPforID Browser   
Several members of the European Forensic community launched a project in 2003 
known as SNPforID. This group has developed large multiplexed SNP assays for human 
identification that comprised 52 SNP markers (Sanchez et al. 2006a, Butler 2011). This 
group has also established a web-based tool, termed as “SNPforID Browser” (shown in 
Figure 5-1) for the visualization or query of SNP allele frequency data and other 
population parameters generated by the consortium (Amigo et al. 2008a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-1: (A) The SNPforID Browser homepage, and (B) several population databases 
that can be used for data comparison. [Taken from (SNPforID Consortium , Amigo et al. 
2008a).  
A) 
B) 
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5.2. RATIONALE OF THE STUDY 
In this study, 52 SNP markers have been chosen to be applied to Malaysian forensic 
casework samples. Hence, before applying these SNP markers to the samples, various 
forensic genetic and population genetic parameters needed to be collected.  
 
5.2.1. Malaysian population samples 
The population samples (Lim et al. 2001, Seah et al. 2003, Izuan et al. 2005, Chang et al. 
2007) were genotyped with the four 13-plex assays (13st, 13nd, 13rd and 13th) designed 
in this study (Chapter 3, Part two) using  optimal analysis parameters (as mentioned in 
Chapter 2, section 2.3 and 2.7). 
 
5.2.2. Data Collection and statistical evaluation 
The population samples from three ethnic groups were analyzed with          
GeneMapper ID-X® (Applied Biosystems). Forensic parameters such as allele 
frequencies, power of discrimination (PD), random match probability (MP), paternity 
index (PI), probability of exclusion (PE) and polymorphism information content (PIC) 
were determined using Powerstats software (Jones 1972, Botstein et al. 1980). 
Observed and expected heterozygosity estimates, exact tests for Hardy-Weinberg 
equilibrium (HWE) and linkage equilibrium (LE),  and pairwise FST  values were 
calculated using Arlequin version 3.5.1.3 software (Excoffier, Lischer 2010).   
 
5.2.3. The Snipper app suite online software   
Phillips and colleagues (2007) have established a straightforward Bayesian system for 
predicting ancestral origin and to estimate misclassification rates by testing the CEPH 
human genome diversity cell line panel (CEPH-HGDP) comprising samples of confirmed 
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geographic origin. This classification algorithm has been incorporated into an open 
access web portal to allow simple analysis of SNP profiles, including those with partial 
data (Phillips et al. 2007b). This portal was enhanced to allow analysis of a user’s 
custom population(s) and SNP markers (Pereira et al. 2012, Fondevila et al. 2013b) 
with the same Bayesian classification algorithm and error estimation systems. Training 
sets for the classification algorithm were created for each population-group by 
combining two population samples comprising: sub-Saharan Africans (60 Mozambican 
and 60 Somali), Europeans (60 Galician from Spain and 60 Danish) and East Asians (60 
Mainland Chinese and 60 Taiwanese). The CEPH-HGDP panel comprising 1064 samples 
from 51 geographically diverse populations was also used to test classification 
performance with new profiles.  
This software was used in this study to demonstrate the performance of the 52 SNP 
markers in inferring the ancestral origin of a DNA sample. The classification success 
was estimated using the “verbose cross validation” option by choosing the ‘Thorough 
analysis of population data with a custom Excel file’ method.  All profiles were also 
predicted and classified by choosing the ‘Classification and predicted admixture 
components of multiple profiles with a custom Excel file of populations’ method 
(Snipper SNP-Indel application portal).  
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5.2.4. Data comparison between Malaysia and neighbouring countries 
SNPforID Browser has genotypes and statistical information of several sets of 
population groups (Figure 5-2) that have been analyzed with the SNPforID 52-plex 
(Sanchez et al. 2006a); and includes Africa, America, Europe, Middle East, Central 
South-Asia, East Asia and Oceania (SNPforID Consortium ).   
 
Figure 5-2: Several groups of populations that involved in SNPforID project [Taken from 
(SNPforID Consortium)].  
 
Data generated from other neighbouring countries as well as from nearby regions such 
as East Asia, Central-South Asia and Oceania by the SNPforID Consortium (Table 5-2) 
were used for comparison with data collected from Malaysian population samples. 
Data from Europe were also used as a reference in this study, as these 52 SNP markers 
were originally designed and selected based on the maximum heterozygosity found in 
European populations.   
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Table 5-2: Groups of populations used for comparison in this study from the (SNPforID 
Consortium ). 
SNPforID 52-plex 
Malaysia 
(4 x 13-plex 
assays) 
(N=325) 
N East Asia 
(N=378) 
N Central-South Asia 
(N=234) 
N Oceania 
(N=28) 
N Europe 
(N=1140) 
N 
      
Malays 109 
Cambodia-
Cambodian 
10 China Uygur 10 
Bougainville
-Melanesian 
11 Britain 18 
Chinese 107 China-Dai 10 Indian (in UK) 32 
New Guinea 
Papuan 
17 Denmark 156 
Indians 109 China-Daur 10 Pakistan-Balochi 24   France-French 28 
  China-Han 44 Pakistan-Brahui 25   
France-French 
Basque 
24 
  China-Hezhen 9 Pakistan-Burusho 25   Germany 49 
  China-Lahu 8 Pakistan-Hazara 22   Ireland 24 
  China-Miaou 10 Pakistan-Kalash 23   
Italy (Reggio 
Calabria) 
33 
  China-Naxi 9 Pakistan-Makrani 25   Italy (Veneto) 30 
  China-Oroqen 9 Pakistan-Pathan 24   Italy -Sardinian 28 
  China-She 10 Pakistan-Sindhi 24   Italy-Tuscan 8 
  China-Tu 10     Italy-Bergamo 13 
  China-Tujia 10     N.W. Spain 151 
  China-Xibo 9     
Orkney Islands-
Orcadian 
15 
  China-Yizu 10     Portugal 193 
  
Chinese ( in 
Germany) 
63     Russia-Russian 25 
  Japan-Japanese 29     
Russia Caucasus-
Adygei 
17 
  
Japanese (in 
Germany) 
7     Slovenia 154 
  Mongola 10     Sweden 78 
  Siberia-Yakut 25     Turkey 96 
  Taiwan 43       
  Thailand 33       
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5.3. RESULTS 
5.3.1. Allele Frequencies 
In this study, a total of 325 individuals comprising 109 Malays, 107 Chinese and 109 
Indians were genotyped using 52 SNP markers. Table 5-3, shows data comparison of 
allele frequencies obtained in these three ethnic groups with the reference data from 
other countries for comparison (SNPforID Consortium ). 
The minimum allele frequency observed in Malaysian population samples is 0.079 in 
the Chinese and 0.096 in the Malays (both at SNP code marker 29), and 0.142 in the 
Indians (at SNP code marker 16). The values were italicized and emboldened. No 
values below 0.023 (the calculated minimum allele frequency of 5/2 N) were observed.  
It is notable that allele frequencies of most SNP markers in Malays and Chinese are 
very similar to each other and also to the East Asian populations. Whilst for the Indians, 
the allele frequencies observed for most SNP markers are very similar to the Central 
South Asia and European populations.  
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Table 5-3: Allele frequencies data of Malaysian and neighbouring countries populations 
Individual Identification SNPs (IISNPs) Allele frequencies 
Marker 
Code 
SNP Allele Malaysia East Asia  
(N = 378) 
Central - 
South Asia 
(N = 234) 
Oceania  
(N = 28) 
Europe 
 (N = 1140) Malay 
(N=109) 
Chinese 
(N=107) 
Indian 
(N=109) 
1 rs1490413 
C 0.427 0.444 0.486 0.423 0.482 0.333 0.564 
T 0.573 0.556 0.514 0.577 0.518 0.667 0.436 
2 rs876724 
C 0.647 0.682 0.674 0.564 0.724 0.981 0.685 
T 0.353 0.318 0.326 0.436 0.276 0.019 0.315 
3 rs1357617 
A 0.161 0.178 0.275 0.188 0.293 0.054 0.293 
T 0.839 0.822 0.725 0.812 0.707 0.946 0.707 
4 rs2046361 
A 0.454 0.449 0.385 0.417 0.432 0.593 0.350 
T 0.346 0.551 0.615 0.583 0.568 0.407 0.650 
5 rs717302 
A 0.734 0.855 0.601 0.848 0.625 0.696 0.503 
G 0.266 0.145 0.399 0.152 0.375 0.304 0.497 
6 rs1029047 
A 0.339 0.290 0.495 0.357 0.370 0.240 0.396 
T 0.661 0.710 0.505 0.643 0.630 0.760 0.604 
7 rs917118 
A 0.225 0.285 0.413 0.267 0.448 0.232 0.283 
G 0.775 0.715 0.587 0.733 0.552 0.768 0.717 
8 rs763869 
C 0.431 0.421 0.216 0.346 0.287 0.429 0.486 
T 0.569 0.579 0.784 0.654 0.713 0.571 0.514 
9 rs1015250 
C 0.573 0.491 0.596 0.535 0.716 0.179 0.786 
G 0.427 0.509 0.404 0.465 0.284 0.821 0.214 
10 rs735155 
C 0.179 0.126 0.339 0.190 0.393 0.643 0.536 
T 0.821 0.874 0.661 0.810 0.607 0.357 0.464 
11 rs901398 
C 0.257 0.294 0.335 0.265 0.274 0.214 0.326 
T 0.743 0.706 0.665 0.735 0.726 0.786 0.674 
12 rs2107612 
A 0.706 0.738 0.500 0.871 0.728 0.411 0.673 
G 0.294 0.262 0.500 0.129 0.272 0.589 0.327 
13 rs1886510 
A 0.142 0.159 0.271 0.117 0.209 0.161 0.436 
G 0.858 0.841 0.729 0.869 0.700 0.804 0.505 
14 rs1454361 
A 0.564 0.570 0.615 0.492 0.476 0.143 0.531 
T 0.436 0.430 0.385 0.508 0.524 0.857 0.469 
15 rs2016276 
C 0.349 0.350 0.261 0.377 0.214 0.054 0.231 
T 0.651 0.650 0.739 0.623 0.786 0.946 0.769 
16 rs729172 
G 0.844 0.860 0.858 0.836 0.726 0.946 0.598 
T 0.156 0.140 0.142 0.164 0.274 0.054 0.402 
17 rs740910 
A 0.867 0.916 0.839 0.922 0.738 0.815 0.702 
G 0.133 0.084 0.161 0.078 0.262 0.185 0.298 
18 rs1493232 
G 0.601 0.631 0.390 0.511 0.242 0.714 0.336 
T 0.399 0.369 0.610 0.489 0.758 0.286 0.664 
19 rs719366 
C 0.335 0.215 0.312 0.231 0.377 0.778 0.373 
T 0.665 0.785 0.688 0.769 0.623 0.222 0.627 
20 rs1031825 
G 0.463 0.486 0.546 0.568 0.577 0.714 0.731 
T 0.537 0.514 0.454 0.432 0.423 0.286 0.269 
21 rs722098 
A 0.583 0.486 0.555 0.446 0.680 0.500 0.782 
G 0.417 0.514 0.445 0.554 0.320 0.500 0.218 
22 rs733164 
A 0.280 0.164 0.183 0.145 0.252 0.463 0.296 
G 0.720 0.836 0.817 0.855 0.748 0.537 0.704 
23 rs826472 
A 0.202 0.121 0.390 0.174 0.312 0.648 0.376 
G 0.798 0.879 0.610 0.826 0.688 0.352 0.624 
24 rs2831700 
C 0.427 0.542 0.225 0.493 0.335 0.519 0.408 
T 0.573 0.458 0.775 0.507 0.665 0.481 0.592 
25 rs873196 
A 0.839 0.911 0.812 0.864 0.703 0.679 0.599 
G 0.161 0.089 0.188 0.136 0.297 0.321 0.401 
26 rs1382387 
G 0.413 0.393 0.408 0.304 0.293 0.185 0.319 
T 0.587 0.607 0.592 0.696 0.707 0.815 0.681 
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Table 5-3: Allele frequencies data of Malaysian and neighbouring countries populations 
(continued). 
Individual Identification SNPs (IISNPs) Allele frequencies 
Marker 
Code 
SNP Allele Malaysia East Asia  
(N = 378) 
Central - 
South Asia 
(N = 234) 
Oceania  
(N = 28) 
Europe  
(N = 1140) Malay 
(N=109) 
Chinese 
(N=107) 
Indian 
(N=109) 
27 rs2111980 
A 0.610 0.603 0.509 0.619 0.491 0.648 0.456 
G 0.390 0.397 0.491 0.381 0.509 0.352 0.544 
28 rs2056277 
A 0.170 0.121 0.206 0.133 0.167 0.056 0.259 
G 0.830 0.879 0.794 0.867 0.833 0.944 0.741 
29 rs1024116 
A 0.096 0.079 0.284 0.121 0.412 0.500 0.573 
G 0.904 0.921 0.716 0.879 0.588 0.500 0.427 
30 rs727811 
A 0.541 0.640 0.674 0.688 0.513 0.661 0.552 
C 0.459 0.360 0.326 0.312 0.487 0.339 0.448 
32 rs1413212 
C 0.422 0.341 0.390 0.545 0.656 0.574 0.697 
T 0.578 0.659 0.610 0.455 0.344 0.426 0.303 
33 rs938283 
C 0.284 0.150 0.161 0.150 0.103 0.019 0.169 
T 0.716 0.850 0.839 0.850 0.897 0.981 0.831 
34 rs1979255 
C 0.459 0.444 0.372 0.436 0.435 0.268 0.339 
G 0.541 0.556 0.628 0.564 0.565 0.732 0.661 
35 rs1463729 
A 0.495 0.533 0.454 0.449 0.507 0.058 0.556 
G 0.505 0.467 0.546 0.551 0.493 0.942 0.444 
36 rs2076848 
A 0.252 0.322 0.436 0.340 0.446 0.286 0.441 
T 0.748 0.678 0.564 0.660 0.554 0.714 0.559 
37 rs1355366 
C 0.330 0.164 0.518 0.157 0.473 0.096 0.421 
T 0.670 0.836 0.482 0.843 0.527 0.904 0.579 
38 rs907100 
C 0.468 0.533 0.463 0.550 0.550 0.786 0.606 
G 0.532 0.467 0.537 0.450 0.450 0.214 0.394 
39 rs354439 
A 0.408 0.421 0.569 0.431 0.638 0.875 0.418 
T 0.592 0.579 0.431 0.569 0.362 0.125 0.582 
40 rs2040411 
A 0.326 0.332 0.472 0.271 0.461 0.750 0.629 
G 0.674 0.668 0.528 0.729 0.539 0.250 0.371 
41 rs737681 
C 0.835 0.864 0.606 0.827 0.651 0.982 0.594 
T 0.165 0.136 0.394 0.173 0.349 0.018 0.406 
42 rs2830795 
A 0.399 0.537 0.706 0.516 0.770 0.821 0.709 
G 0.601 0.463 0.294 0.484 0.230 0.179 0.291 
43 rs251934 
A 0.867 0.888 0.688 0.875 0.758 0.696 0.614 
G 0.133 0.112 0.312 0.125 0.242 0.304 0.386 
44 rs914165 
C 0.706 0.640 0.578 0.689 0.571 0.286 0.604 
T 0.294 0.360 0.422 0.311 0.429 0.714 0.396 
45 rs10495407 
C 0.720 0.696 0.844 0.671 0.740 0.978 0.643 
T 0.280 0.304 0.156 0.329 0.260 0.022 0.357 
46 rs1360288 
A 0.220 0.350 0.486 0.347 0.373 0.074 0.335 
G 0.780 0.650 0.514 0.653 0.627 0.926 0.665 
48 rs964681 
C 0.335 0.360 0.436 0.298 0.423 0.375 0.417 
T 0.665 0.640 0.564 0.702 0.577 0.625 0.583 
49 rs1005533 
A 0.197 0.290 0.335 0.332 0.399 0.519 0.536 
G 0.803 0.710 0.665 0.668 0.601 0.481 0.464 
50 rs8037429 
A 0.422 0.374 0.390 0.456 0.543 0.583 0.516 
G 0.578 0.626 0.610 0.544 0.457 0.417 0.484 
51 rs891700 
A 0.472 0.458 0.422 0.504 0.417 0.357 0.475 
G 0.528 0.542 0.578 0.496 0.583 0.643 0.525 
52 rs1335873 
A 0.716 0.617 0.702 0.658 0.728 0.923 0.691 
T 0.284 0.383 0.298 0.342 0.272 0.077 0.309 
53 rs1028528 
A 0.555 0.589 0.550 0.688 0.709 0.232 0.742 
G 0.445 0.411 0.450 0.312 0.291 0.768 0.258 
54 rs1528460 
A 0.528 0.477 0.523 0.616 0.603 0.250 0.690 
G 0.472 0.523 0.477 0.384 0.397 0.750 0.310 
*Bold and italic number(s) represent minor allele frequency in three ethnic groups: the Malays, Chinese and 
Indians. 
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5.3.2. Tests for Hardy-Weinberg Equilibrium (HWE) 
The observed and expected heterozygosity values among the Malaysian ethnic groups 
are summarized in Table 5-4. The highlighted cells in the P-value column show 
significant deviation from HWE at p<0.05 using an exact test, and in Ho column, shows 
minimum observed heterozygosity in each ethnic group.  
As shown, the minimum observed heterozygosities (highlighted in yellow) for Malays, 
Chinese and Indians are 0.16, 0.15 and 0.17, respectively and the minimum expected 
heterozygosities (highlighted in blue) are 0.17, 0.15 and 0.23, respectively. The average 
observed heterozygosities for Malays, Chinese and Indians are 0.42, 0.41 and 0.46, 
respectively and the average expected heterozygosities are 0.41, 0.40 and 0.44. 
Significant departures from HWE, at p values <0.05 were observed at 3 SNP markers in 
Malays, 4 SNP markers in Chinese and 9 SNP markers in Indian samples as shown in 
Table 5-4. The rs2107612 marker (code 12), rs722098 marker (code 21), rs2076848 
marker (code 36) and rs907100 marker (code 38) in the Indians, and rs1528460 marker 
(code 54) in the Chinese and also in the Indians, showed the lowest p value, that is 
p=0.0. 
As for SNP markers that show p values <0.05, the Bonferroni correction at p <0.00096 
(0.05 divided by 52 i.e. the number of loci tested) was applied and data were re-
analyzed.  After the Bonferroni correction, significant deviation(s) from HWE was 
observed at 1 SNP marker (code marker 26) in the Malays, 2 SNP markers (code marker 
46 and 54) in the Chinese and 5 SNP markers (code marker 12, 21, 36, 38 and 54) in the 
Indians. 
Observed and expected heterozygosity values of Malaysian population were then 
compared with data collated from the SNPforID Browser as demonstrated in Table 5-5. 
The values that represented HWE departures in Malaysian population are highlighted 
in red, and the corresponding values from this locus are emboldened and italicized for 
the other populations but found to be in HWE in these populations.  
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Table 5-4: Observed (Ho) and expected [He] heterozygosities and P values from an 
exact test for HWE across 52 SNPs typed in 325 individuals from three ethnic groups. 
Yellow represents minimum Ho; blue represents minimum He; and red represents p 
value <0.05. 
Marker 
Code 
SNP 
(rs#) 
Malay Chinese Indian 
Obs.H Exp.H 
 
P-value Obs.H Exp.H 
 
P-value Obs.H Exp.H 
 
P-value 
1 rs1490413 0.50 0.50 1.00 0.41 0.49 0.12 0.51 0.50 0.85 
2 rs876724 0.50 0.46 0.40 0.40 0.43 0.51 0.41 0.44 0.52 
3 rs1357617 0.28 0.27 0.73 0.29 0.29 1.00 0.50 0.40 0.0166 
4 rs2046361 0.50 0.50 1.00 0.54 0.50 0.43 0.44 0.48 0.54 
5 rs717302 0.33 0.39 0.14 0.21 0.25 0.23 0.55 0.48 0.17 
6 rs1029047 0.40 0.44 0.39 0.42 0.42 1.00 0.46 0.50 0.44 
7 rs917118 0.32 0.35 0.41 0.48 0.41 0.10 0.55 0.49 0.23 
8 rs763869 0.42 0.49 0.17 0.47 0.49 0.70 0.39 0.34 0.15 
9 rs1015250 0.47 0.49 0.70 0.48 0.50 0.70 0.44 0.48 0.43 
10 rs735155 0.28 0.30 0.35 0.23 0.22 1.00 0.42 0.45 0.53 
11 rs901398 0.38 0.38 1.00 0.35 0.42 0.10 0.43 0.45 0.83 
12 rs2107612 0.38 0.44 0.13 0.44 0.38 0.20 0.72 0.50 *0.00000 
13 rs1886510 0.28 0.25 0.12 0.32 0.27 0.07 0.43 0.40 0.47 
14 rs1454361 0.47 0.49 0.70 0.54 0.49 0.33 0.46 0.48 0.84 
15 rs2016276 0.42 0.46 0.53 0.44 0.46 0.68 0.31 0.38 0.08 
16 rs729172 0.25 0.26 0.72 0.22 0.24 0.43 0.17 0.23 0.0171 
17 rs740910 0.27 0.23 0.21 0.17 0.16 1.00 0.25 0.27 0.47 
18 rs1493232 0.52 0.48 0.43 0.51 0.47 0.40 0.44 0.48 0.43 
19 rs719366 0.49 0.45 0.40 0.34 0.34 1.00 0.42 0.43 0.83 
20 rs1031825 0.52 0.50 0.70 0.54 0.50 0.44 0.56 0.50 0.25 
21 rs722098 0.49 0.49 1.00 0.54 0.50 0.44 0.76 0.50 *0.00000 
22 rs733164 0.39 0.40 0.81 0.23 0.27 0.15 0.31 0.30 1.00 
23 rs826472 0.35 0.32 0.56 0.22 0.21 1.00 0.45 0.48 0.55 
24 rs2831700 0.49 0.49 1.00 0.54 0.50 0.44 0.35 0.35 1.00 
25 rs873196  0.23 0.27 0.15 0.15 0.16 0.59 0.32 0.31 0.76 
26 rs1382387  0.68 0.49 *0.00000 0.58 0.48 0.05 0.58 0.49 0.05 
27 rs2111980  0.52 0.48 0.42 0.46 0.48 0.69 0.54 0.50 0.45 
28 rs2056277 0.32 0.28 0.30 0.19 0.21 0.18 0.34 0.33 1.00 
29 rs1024116  0.16 0.17 0.25 0.15 0.15 1.00 0.33 0.41 0.05 
30 rs727811 0.51 0.50 0.85 0.48 0.46 0.83 0.54 0.44 0.0194 
32 rs1413212 0.61 0.49 0.0194 0.47 0.45 0.83 0.61 0.48 0.0025 
33 rs938283  0.40 0.42 0.82 0.22 0.26 0.25 0.25 0.27 0.47 
34 rs1979255 0.44 0.50 0.25 0.48 0.50 0.70 0.43 0.47 0.42 
35 rs1463729 0.51 0.50 0.85 0.49 0.50 0.85 0.56 0.50 0.25 
36 rs2076848 0.43 0.39 0.32 0.46 0.44 0.82 0.71 0.49 *0.00000 
37 rs1355366 0.51 0.44 0.13 0.33 0.27 0.07 0.52 0.50 0.70 
38 rs907100 0.35 0.50 0.0016 0.43 0.50 0.17 0.27 0.50 *0.00000 
39 rs354439 0.43 0.49 0.32 0.52 0.49 0.55 0.46 0.49 0.56 
40 rs2040411 0.45 0.45 1.00 0.42 0.45 0.66 0.56 0.50 0.25 
41 rs737681 0.29 0.28 0.73 0.25 0.23 0.69 0.42 0.48 0.23 
42 rs2830795 0.50 0.48 0.70 0.59 0.50 0.08 0.44 0.42 0.65 
43 rs251934 0.21 0.23 0.40 0.19 0.20 0.62 0.46 0.43 0.66 
44 rs914165 0.35 0.42 0.11 0.42 0.46 0.40 0.46 0.49 0.56 
45 rs10495407 0.39 0.41 0.64 0.42 0.42 1.00 0.31 0.26 0.07 
46 rs1360288 0.33 0.35 0.78 0.65 0.46 *0.00000 0.57 0.50 0.18 
48 rs964681 0.45 0.45 1.00 0.51 0.47 0.40 0.49 0.49 1.00 
49 rs1005533 0.32 0.32 1.00 0.45 0.41 0.48 0.50 0.45 0.20 
50 rs8037429 0.51 0.49 0.70 0.55 0.47 0.10 0.43 0.48 0.32 
51 rs891700 0.50 0.50 1.00 0.43 0.50 0.17 0.54 0.49 0.32 
52 rs1335873 0.44 0.41 0.49 0.50 0.47 0.55 0.38 0.42 0.36 
53 rs1028528  0.58 0.50 0.12 0.39 0.49 0.0443 0.46 0.50 0.44 
54 rs1528460 0.52 0.50 0.70 0.80 0.50 *0.00000 0.70 0.50 *0.00000 
Mean 0.42 0.41  0.41 0.40  0.46 0.44  
s.d. 0.11 0.09  0.14 0.12  0.12 0.08  
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Table 5-5: Comparison of Observed (Ho) and Expected (He) heterozygosities obtained in this 
study with the reference data (SNPforID Consortium ). Red represents p value 0.05. 
Individual Identification SNPs 
(IISNPs) 
Malaysia 
(N = 325) 
East Asia 
(N = 378) 
Central-
South Asia 
(N = 234) 
Oceania 
(N = 28) 
Europe 
(N = 1140) 
Malay 
(N = 109) 
Chinese 
(N = 107) 
Indian 
(N = 109) 
Marker 
Code 
SNP (rs#) Alleles 
detected 
Ho He Ho He Ho He Ho He Ho He Ho He Ho He 
1 rs1490413 A/G 0.50 0.50 0.41 0.49 0.51 0.50 0.47 0.49 0.46 0.50 0.44 0.44 0.48 0.49 
2 rs876724 C/T 0.50 0.46 0.40 0.43 0.41 0.44 0.44 0.49 0.38 0.40 0.04 0.04 0.44 0.43 
3 rs1357617 A/T 0.28 0.27 0.29 0.29 0.50 0.40 0.31 0.31 0.46 0.41 0.11 0.10 0.39 0.41 
4 rs2046361 A/T 0.50 0.50 0.54 0.50 0.44 0.48 0.46 0.49 0.52 0.49 0.22 0.48 0.47 0.46 
5 rs717302 A/G 0.33 0.39 0.21 0.25 0.55 0.48 0.23 0.26 0.47 0.47 0.46 0.42 0.46 0.50 
6 rs1029047 A/T 0.40 0.44 0.42 0.42 0.46 0.50 0.47 0.50 0.50 0.47 0.40 0.37 0.48 0.48 
7 rs917118 C/T 0.32 0.35 0.48 0.41 0.55 0.49 0.40 0.39 0.53 0.50 0.32 0.36 0.41 0.41 
8 rs763869 C/T 0.42 0.49 0.47 0.49 0.39 0.34 0.42 0.45 0.35 0.41 0.50 0.49 0.47 0.50 
9 rs1015250 C/G 0.47 0.49 0.48 0.50 0.44 0.48 0.51 0.50 0.37 0.41 0.29 0.29 0.34 0.34 
10 rs735155 A/G 0.28 0.30 0.23 0.22 0.42 0.45 0.29 0.31 0.47 0.48 0.36 0.46 0.50 0.50 
11 rs901398 C/T 0.38 0.38 0.35 0.42 0.43 0.45 0.45 0.39 0.39 0.40 0.29 0.34 0.45 0.44 
12 rs2107612 A/G 0.38 0.44 0.44 0.38 0.72 0.50 0.20 0.23 0.38 0.40 0.32 0.48 0.44 0.44 
13 rs1886510 C/T 0.28 0.25 0.32 0.27 0.44 0.40 0.22 0.23 0.41 0.46 0.32 0.33 0.46 0.55 
14 rs1454361 A/T 0.47 0.49 0.54 0.49 0.46 0.48 0.50 0.50 0.41 0.50 0.21 0.25 0.49 0.49 
15 rs2016276 A/G 0.42 0.46 0.44 0.46 0.31 0.38 0.42 0.47 0.33 0.34 0.11 0.10 0.34 0.36 
16 rs729172 A/C 0.25 0.26 0.22 0.24 0.17 0.23 0.27 0.27 0.38 0.40 0.11 0.10 0.46 0.48 
17 rs740910 A/G 0.27 0.23 0.17 0.16 0.25 0.27 0.14 0.14 0.34 0.39 0.22 0.30 0.39 0.42 
18 rs1493232 C/A 0.52 0.48 0.51 0.47 0.44 0.48 0.27 0.50 0.18 0.37 0.14 0.41 0.43 0.45 
19 rs719366 C/T 0.49 0.45 0.34 0.34 0.42 0.43 0.35 0.36 0.46 0.47 0.30 0.35 0.44 0.47 
20 rs1031825 A/C 0.52 0.50 0.54 0.50 0.56 0.50 0.50 0.49 0.46 0.49 0.29 0.41 0.39 0.39 
21 rs722098 A/G 0.49 0.49 0.54 0.50 0.76 0.50 0.47 0.49 0.36 0.44 0.31 0.50 0.33 0.34 
22 rs733164 A/G 0.39 0.40 0.23 0.27 0.31 0.30 0.25 0.25 0.36 0.38 0.48 0.50 0.43 0.42 
23 rs826472 C/T 0.35 0.32 0.22 0.21 0.45 0.48 0.28 0.29 0.39 0.43 0.41 0.46 0.48 0.47 
24 rs2831700 G/A 0.49 0.49 0.54 0.50 0.35 0.35 0.49 0.50 0.42 0.45 0.58 0.50 0.50 0.48 
25 rs873196 C/T 0.23 0.27 0.15 0.16 0.32 0.31 0.24 0.24 0.37 0.42 0.36 0.44 0.50 0.48 
26 rs1382387 G/T 0.68 0.49 0.58 0.48 0.58 0.49 0.42 0.42 0.37 0.42 0.30 0.30 0.43 0.43 
27 rs2111980 A/G 0.52 0.48 0.46 0.48 0.54 0.50 0.45 0.47 0.51 0.50 0.48 0.46 0.50 0.50 
28 rs2056277 C/T 0.32 0.28 0.19 0.21 0.34 0.33 0.23 0.23 0.27 0.28 0.04 0.11 0.40 0.38 
29 rs1024116 A/G 0.16 0.17 0.15 0.15 0.33 0.41 0.19 0.21 0.43 0.48 0.33 0.50 0.48 0.49 
30 rs727811 A/C 0.51 0.50 0.48 0.46 0.54 0.44 0.44 0.43 0.55 0.50 0.54 0.45 0.50 0.50 
32 rs1413212 A/G 0.61 0.49 0.47 0.45 0.61 0.48 0.48 0.50 0.41 0.45 0.48 0.49 0.41 0.42 
33 rs938283 C/T 0.40 0.42 0.22 0.26 0.25 0.27 0.23 0.26 0.17 0.19 0.04 0.04 0.29 0.28 
34 rs1979255 C/G 0.44 0.50 0.48 0.50 0.43 0.47 0.51 0.49 0.48 0.49 0.32 0.39 0.47 0.45 
35 rs1463729 A/G 0.51 0.50 0.49 0.50 0.56 0.50 0.43 0.50 0.50 0.50 0.12 0.11 0.48 0.49 
36 rs2076848 A/T 0.43 0.39 0.46 0.44 0.71 0.49 0.44 0.45 0.48 0.49 0.43 0.41 0.48 0.49 
37 rs1355366 A/G 0.51 0.44 0.33 0.27 0.52 0.50 0.28 0.27 0.50 0.50 0.19 0.17 0.48 0.49 
38 rs907100 C/G 0.35 0.50 0.43 0.50 0.27 0.50 0.39 0.50 0.28 0.50 0.07 0.34 0.38 0.46 
39 rs354439 A/T 0.43 0.49 0.52 0.49 0.46 0.49 0.48 0.49 0.44 0.46 0.18 0.22 0.50 0.49 
40 rs2040411 A/G 0.45 0.45 0.42 0.45 0.56 0.50 0.36 0.40 0.50 0.50 0.50 0.38 0.45 0.47 
41 rs737681 C/T 0.29 0.28 0.25 0.23 0.42 0.48 0.28 0.29 0.40 0.45 0.04 0.04 0.46 0.48 
42 rs2830795 A/G 0.50 0.48 0.59 0.50 0.44 0.42 0.51 0.50 0.33 0.35 0.29 0.29 0.44 0.41 
43 rs251934 C/T 0.21 0.23 0.19 0.20 0.46 0.43 0.21 0.22 0.38 0.37 0.32 0.42 0.49 0.47 
44 rs914165 A/G 0.35 0.42 0.42 0.46 0.46 0.49 0.42 0.43 0.49 0.49 0.36 0.41 0.51 0.48 
45 rs10495407 G/A 0.39 0.41 0.42 0.42 0.31 0.26 0.40 0.44 0.41 0.39 0.04 0.04 0.45 0.46 
46 rs1360288 C/T 0.33 0.35 0.65 0.46 0.57 0.50 0.42 0.45 0.43 0.47 0.07 0.14 0.43 0.45 
48 rs964681 C/T 0.45 0.45 0.51 0.47 0.49 0.49 0.41 0.42 0.45 0.49 0.54 0.47 0.46 0.49 
49 rs1005533 A/G 0.32 0.32 0.45 0.41 0.50 0.45 0.42 0.44 0.52 0.48 0.50 0.50 0.53 0.50 
50 rs8037429 C/T 0.51 0.49 0.55 0.47 0.43 0.48 0.46 0.50 0.44 0.50 0.42 0.49 0.50 0.50 
51 rs891700 A/G 0.50 0.50 0.43 0.50 0.54 0.49 0.47 0.50 0.48 0.49 0.43 0.46 0.48 0.50 
52 rs1335873 A/T 0.44 0.41 0.50 0.47 0.38 0.42 0.44 0.45 0.36 0.40 0.15 0.14 0.44 0.43 
53 rs1028528 A/G 0.58 0.50 0.39 0.49 0.46 0.50 0.42 0.43 0.42 0.41 0.40 0.36 0.39 0.38 
54 rs1528460 C/T 0.52 0.50 0.80 0.50 0.70 0.50 0.47 0.47 0.42 0.48 0.36 0.38 0.39 0.43 
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Heterozygosity values were found to be similar across all populations at several loci 
but there were marked differences seen in some populations especially the Oceanians 
where several loci showed very low heterozygosity values (e.g. SNP marker code 2, 3 
and few others), most likely due to small sample numbers. 
Overall, heterozygosity values for the Malays and Chinese were similar to the East 
Asians, except at few highlighted values (in red), whereas heterozygosity values for the 
Indians were quite similar to the Central-South Asians. But, there are big differences 
between both at the highlighted locus.  
Table 5-6, demonstrates average observed heterozygosities obtained from Malaysian 
ethnic groups which were compared with data obtained from (Sanchez et al. 2006a). 
The results show that the Malaysian Indian ethnic group has similar He to the 
Europeans, and somewhat higher than the Asians and Somali, whilst, the Malays and 
Chinese show higher He values than the Asians but very close to the Somalis.   
 
Table 5-6: Average Expected heterozygosity (He) values of all 52 SNPs markers in 
different populations, p= 0.05.   
 
Average He 
Malaysiana Asiansb Somalib European
b 
Mal Ch Ind 
0.38 0.41 0.44 
0.41 0.40 0.44 
a: represents average He calculated from this study. Mal= Malays, Ch= Chinese, Ind= Indian 
b:represents average He from reference data (Sanchez et al. 2006a).   
CHAPTER 5  SNPs Genotyping of Malaysian Population 
 
155 
 
5.3.3. Exact test for Linkage Equilibrium (LE) 
Exact tests for LE using pairwise comparisons in each ethnic group for all 52 loci have 
also been conducted as shown in Table 5-7.  Significant LD was observed at p<0.05: 73 
pairs of loci in the Malays, 55 pairs in the Chinese and 80 pairs in the Indians.   
The significant LD of all pairs of loci was plotted as shown in Figure 5-3 for the Malays, 
Figure 5-4 for the Chinese and Figure 5-5 for the Indians. All significant LD at p<0.05 
are highlighted with the pink boxes.  
However, after Bonferroni correction was applied at p<0.0000377 (0.05 divided by 
2601 (51x51 loci number of loci involved)) only 1 pair of loci (highlighted with a red box) 
in the Malays was found to be remain significant (at p<0.00001922). The association is 
between locus 3 (at Chromosome 3) and locus 53 (at Chromosome 22). 
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Table 5-7: Significant linkage disequilibrium at p<0.05 in Malays, Chinese and Indians. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Marker Code SNP 
(rs#) 
Linked loci per locus  
Malay Chinese Indian 
1 rs1490413 6 0 0 
2 rs876724 7 3 2 
3 rs1357617 4 1 2 
4 rs2046361 4 2 6 
5 rs717302 3 3 2 
6 rs1029047 2 0 2 
7 rs917118 5 1 4 
8 rs763869 3 2 3 
9 rs1015250 2 5 5 
10 rs735155 3 2 3 
11 rs901398 2 0 2 
12 rs2107612 1 1 1 
13 rs1886510 2 1 4 
14 rs1454361 1 4 2 
15 rs2016276 3 4 4 
16 rs729172 2 3 2 
17 rs740910 3 4 4 
18 rs1493232 3 2 3 
19 rs719366 2 0 6 
20 rs1031825 2 1 0 
21 rs722098 1 1 2 
22 rs733164 5 2 6 
23 rs826472 1 5 1 
24 rs2831700 3 2 2 
25 rs873196 1 1 2 
26 rs1382387 5 2 3 
27 rs2111980 0 4 4 
28 rs2056277 6 1 2 
29 rs1024116 3 1 3 
30 rs727811 3 3 2 
32 rs1413212 5 0 2 
33 rs938283 1 1 4 
34 rs1979255 2 1 4 
35 rs1463729 3 1 3 
36 rs2076848 3 2 8 
37 rs1355366 2 2 6 
38 rs907100 5 3 2 
39 rs354439 1 2 0 
40 rs2040411 5 4 0 
41 rs737681 3 4 7 
42 rs2830795 0 1 0 
43 rs251934 2 4 2 
44 rs914165 5 2 3 
45 rs10495407 4 2 7 
46 rs1360288 4 4 3 
48 rs964681 1 1 2 
49 rs1005533 0 1 7 
50 rs8037429 2 3 3 
51 rs891700 4 2 3 
52 rs1335873 3 3 2 
53 rs1028528 2 3 2 
54 rs1528460 1 3 6 
Total linked loci 146 (73 pairs) 110 (55 pairs) 160 (80 pairs) 
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Note:          represent significant LD with p<0.05, but not significant after Bonferroni correction at p<0.00001922.  
                                                       represent significant LD d after Bonferroni correction at p<0.00001922. 
Figure 5-3:  Significant LD detected in the Malays.  
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Note:          represent significant LD with p<0.05, but not significant after Bonferroni correction at p<0.00001922.  
         
Figure 5-4:  Significant LD detected in the Chinese.  
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 Note:          represent significant LD with p<0.05, but not significant after Bonferroni correction at p<0.00001922.  
         
Figure 5-5:  Significant LD detected in the Indians. 
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5.3.4. Population Genetic Structure 
To examine population differentiation among the Malaysian ethnic groups, pairwise FST 
values were determined using Arlequin version 3.5.1.3, with a total of 1023 
permutations for associated p values as shown in Table 5-8.  The FST value between 
Malay and Chinese at 0.00711 is significantly lower than that between Malay and Indian 
or between Chinese and Indian (0.0346 and 0.04133 respectively) indicating a closer 
relationship between Malay and Chinese ethnic groups. 
 
Table 5-8: Pairwise F-statistic (FST) values of 52 SNPs.   
 Malays Chinese Indians 
Malays 0.00000   
Chinese 0.00711 0.00000  
Indians 0.03460 0.04133 0.00000 
 
F-statistic (FST) p values.   
 Malays Chinese Indians 
Malays *   
Chinese 0.00000 +- 0.0000 *  
Indians 0.00000 +- 0.0000 0.00000 +- 0.0000 * 
 
 
5.3.5. Population assignment of individual genotypes 
The likelihood of individual multi-locus genotypes belonging to each of the three 
groups was analyzed using both Snipper and Arlequin ver 3.5 software. The results are 
presented in Table 5-9. Results from both software (A and B) gave very similar 
proportions of distribution of the individuals within each ethnic group. Within Malays, > 
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70% of the genotypes was correctly classified whereas >81 % and >88 % were correctly 
classified within Chinese and Indian ethnic groups. A larger proportion of Malay 
genotypes were misclassified as Chinese (17 – 21%) than Indian (8%). Similarly, a larger 
proportion of Chinese were misclassified as Malay (18 – 19%) than Indian (1- 3%). The 
proportion of misclassified genotypes was minimal in the Indian group (11%) but 
interestingly, a greater proportion was misclassified as Malay (8%) than Chinese (2-3%). 
Table 5-9: Percentages of population assignment using Snipper (A) and Arlequin 
version 3.5 (B). 
Likelihood 
Malays Chinese Indians 
A B A B A B 
Population of Malay origin 72.48% 70.64% 19.27% 17.76% 8.26% 8.26% 
Population of Chinese origin 16.82% 21.10% 81.31% 81.31% 1.87% 2.75% 
Population of Indian origin 8.26% 8.26% 2.75% 0.93% 88.99% 88.99% 
 
The classification probabilities obtained are also represented as a triangular plot and 
density plots in Figure 5-6, which (A) clearly shows many Malay and Chinese individuals 
positioned closely together. In contrast, fewer Chinese and Malay were misclassified as 
Indians, and Indians as Chinese and Malay. Once again, this indicates a close 
relationship between the Malays and the Chinese, than either has to the Indians. 
Whilst, Figure 5-6 (C), (D) and (E) show each group density plot and (B) is when the 
group plots were overlaid on top of each other.  
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Figure 5-6: (A) Triangular plot classifying the individuals, (B) to (E) are density plot of 
the likelihood of all ethnic groups of data analyzed with the Snipper software.   
B 
Likelihood Malay, Chinese & Indians 
D 
C 
E 
A 
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Table 5-10: Use of ‘cross verbose-validation’ to compute the success ratio using the 52 
SNPs with The Snipper software.  
 
Success ratio computation 
 Malays Chinese Indians 
Population of Malay origin 22.94% 60.55% 16.51% 
Population of Chinese origin 0.00% 53.27% 46.73% 
Population of Indian origin 5.50% 0.00% 94.50% 
 
Table 5-10 shows the performance of the 52 SNPs that were used in this study in 
differentiating the co-ancestry contributors. The results show that the success ratio 
(values in bold) for the Indians is far higher at 94.5% than in the Chinese (53.27%) and 
the Malays (22.94%). Indirectly, this also indicates these 52 SNP markers have high 
probabilities in discriminating Indians from the Malays and the Chinese with only a low 
probability of differentiating between the Chinese and Malays.   
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5.3.6. Forensic statistical analysis 
The match probability (MP) was calculated for the 52 locus profile using allele 
frequency data obtained from each ethnic group as shown in Table 5-11.  
The combined mean MP for the 52 SNPs markers of Malays, Chinese, and Indians are 1 
in 3.9654e-19, 1 in 5.3964e-18 and 1 in 1.7459e-19 respectively corresponding to a 
combined power of discrimination of  >99.9999% in each case..  
Most of the SNP markers showed PIC values (Botstein et al. 1980) greater than 0.25, 
which shows that these SNP markers are reasonably informative for Malaysian 
population samples. 
In Malays, 9 markers were found to be less informative: code marker 3, 13, 16, 17, 25, 
28, 29, 41 and 43, in the Chinese, 12 markers were less informative: code marker 5, 10, 
16, 17, 22, 23, 25, 28, 29, 33, 41 and 43, whilst in the Indians, only four markers were 
appeared less informative: code marker 16, 17, 33 and 45. These are highlighted in red, 
emboldened and italicized. 
It is also notable that the least informative marker is SNP marker 29 in Malay and 
Chinese groups.  All three ethnic groups show low informativeness at 2 SNP markers: 
code marker 16 and 17.   
Table 5-12 demonstrates typical paternity index (PI) and power of exclusion (PE) for 
each of the 52 loci within each ethnic group. The combined PI (CPI) and average 
exclusion probability were also estimated. Results showed that the CPI for Malay, 
Chinese and Indians are 9.7072e-4, 1.9363e-2 and 8.7491e-2, respectively. The exclusion 
probabilities for all ethnic groups are similar at 99.99%.   
CHAPTER 5  SNPs of Malaysian Population 
 
165 
 
Table 5-11: Forensic parameters calculated for 52 SNPs from each Malaysian ethnic 
group. MP represents match probability, PD represents power of discrimination, and 
PIC represents polymorphism information content. 
Marker 
Code 
SNP 
(rs#) 
Allele 
(1/2) 
Malay Chinese Indian 
MP PD PIC MP PD PIC MP PD PIC 
1 rs1490413 T/C 0.379 0.621 0.37 0.351 0.649 0.37 0.383 0.617 0.37 
2 rs876724 C/T 0.420 0.580 0.35 0.409 0.591 0.34 0.404 0.596 0.34 
3 rs1357617 T/A 0.567 0.433 0.23 0.543 0.457 0.25 0.474 0.526 0.32 
4 rs2046361 T/A 0.373 0.627 0.37 0.404 0.596 0.37 0.377 0.623 0.36 
5 rs717302 A/G 0.433 0.557 0.31 0.607 0.393 0.22 0.419 0.581 0.36 
6 rs1029047 A/T 0.397 0.603 0.35 0.431 0.569 0.33 0.357 0.643 0.37 
7 rs917118 G/A 0.485 0.515 0.29 0.457 0.543 0.32 0.419 0.581 0.37 
8 rs763869 C/T 0.355 0.645 0.37 0.373 0.627 0.37 0.501 0.499 0.28 
9 rs1015250 G/C 0.371 0.629 0.37 0.364 0.636 0.37 0.369 0.631 0.37 
10 rs735155 T/C 0.546 0.454 0.25 0.628 0.372 0.20 0.397 0.603 0.35 
11 rs901398 C/T 0.456 0.544 0.31 0.418 0.582 0.33 0.402 0.598 0.35 
12 rs2107612 A/G 0.442 0.558 0.33 0.467 0.533 0.31 0.563 0.437 0.38 
13 rs1886510 G/A 0.593 0.407 0.21 0.566 0.434 0.23 0.453 0.547 0.32 
14 rs1454361 A/T 0.369 0.631 0.37 0.409 0.591 0.37 0.383 0.617 0.36 
15 rs2016276 T/C 0.391 0.609 0.35 0.395 0.605 0.35 0.447 0.553 0.31 
16 rs729172 T/G 0.579 0.421 0.23 0.610 0.390 0.21 0.627 0.373 0.21 
17 rs740910 A/G 0.609 0.391 0.20 0.720 0.280 0.14 0.575 0.425 0.23 
18 rs1493232 T/G 0.408 0.592 0.36 0.417 0.583 0.36 0.378 0.622 0.36 
19 rs719366 C/T 0.423 0.577 0.35 0.496 0.504 0.28 0.416 0.584 0.34 
20 rs1031825 T/G 0.390 0.610 0.37 0.399 0.601 0.37 0.414 0.586 0.37 
21 rs722098 A/G 0.391 0.609 0.37 0.399 0.601 0.37 0.614 0.386 0.37 
22 rs733164 A/G 0.436 0.564 0.32 0.575 0.425 0.24 0.534 0.466 0.25 
23 rs826472 G/A 0.511 0.489 0.27 0.638 0.362 0.19 0.378 0.622 0.36 
24 rs2831700 C/T 0.379 0.621 0.37 0.402 0.598 0.37 0.486 0.514 0.29 
25 rs873196 A/G 0.580 0.420 0.23 0.717 0.283 0.15 0.528 0.472 0.26 
26 rs1382387 G/T 0.528 0.472 0.37 0.447 0.553 0.36 0.440 0.560 0.37 
27 rs2111980 A/G 0.411 0.589 0.36 0.378 0.622 0.36 0.398 0.602 0.37 
28 rs2056277 A/G 0.522 0.448 0.24 0.652 0.348 0.19 0.506 0.494 0.27 
29 rs1024116 A/G 0.706 0.294 0.16 0.733 0.267 0.14 0.426 0.574 0.32 
30 rs727811 A/C 0.386 0.614 0.37 0.403 0.597 0.35 0.459 0.541 0.34 
32 rs1413212 C/T 0.457 0.543 0.37 0.415 0.585 0.35 0.476 0.524 0.36 
33 rs938283 C/T 0.434 0.566 0.32 0.597 0.403 0.22 0.575 0.425 0.23 
34 rs1979255 G/C 0.354 0.646 0.37 0.370 0.630 0.37 0.381 0.619 0.36 
35 rs1463729 A/G 0.382 0.618 0.37 0.370 0.630 0.37 0.414 0.586 0.37 
36 rs2076848 A/T 0.470 0.530 0.31 0.420 0.580 0.34 0.550 0.450 0.37 
37 rs1355366 C/T 0.440 0.560 0.34 0.560 0.440 0.24 0.388 0.612 0.37 
38 rs907100 G/C 0.336 0.664 0.37 0.349 0.651 0.37 0.343 0.647 0.37 
39 rs354439 A/T 0.365 0.635 0.37 0.400 0.600 0.37 0.366 0.634 0.37 
40 rs2040411 A/G 0.414 0.586 0.34 0.401 0.599 0.35 0.412 0.588 0.37 
41 rs737681 C/T 0.560 0.440 0.24 0.609 0.391 0.21 0.367 0.633 0.36 
42 rs2830795 A/G 0.398 0.602 0.36 0.434 0.566 0.37 0.436 0.564 0.33 
43 rs251934 A/G 0.625 0.375 0.20 0.666 0.334 0.18 0.428 0.572 0.34 
44 rs914165 C/T 0.419 0.581 0.33 0.384 0.616 0.35 0.369 0.631 0.37 
45 rs10495407 C/T 0.433 0.567 0.32 0.422 0.578 0.33 0.571 0.429 0.23 
46 rs1360288 A/G 0.490 0.510 0.28 0.524 0.476 0.35 0.417 0.583 0.37 
48 rs964681 C/T 0.408 0.592 0.35 0.432 0.568 0.35 0.377 0.623 0.37 
49 rs1005533 A/G 0.517 0.483 0.27 0.442 0.558 0.33 0.432 0.568 0.35 
50 rs8037429 A/G 0.394 0.606 0.37 0.443 0.557 0.36 0.372 0.628 0.36 
51 rs891700 A/G 0.379 0.621 0.37 0.351 0.649 0.37 0.416 0.584 0.37 
52 rs1335873 T/A 0.443 0.557 0.32 0.405 0.595 0.36 0.418 0.582 0.33 
53 rs1028528 A/G 0.429 0.571 0.37 0.354 0.646 0.37 0.362 0.638 0.37 
54 rs1528460 A/G 0.389 0.611 0.37 0.666 0.334 0.37 0.553 0.467 0.37 
Combined calculations 
MP = 1 in 3.9654e
-19 
PD >99.9999% 
MP = 1 in 5.3964e
-18 
PD >99.9999% 
MP = 1 in 1.7459e
-19 
PD >99.9999% 
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Table 5-12: Combined Paternity index and exclusion probability of 52 markers in 
Malays, Chinese and Indian groups.   
Marker 
Code 
SNP 
(rs#) 
Allele 
(1/2) 
Malay Chinese Indian 
PI PE PI PE PI PE 
1 rs1490413 T/C 0.97 0.176 0.86 0.127 1.03 0.200 
2 rs876724 C/T 1.01 0.192 0.85 0.121 0.85 0.122 
3 rs1357617 T/A 0.70 0.057 0.71 0.063 0.99 0.184 
4 rs2046361 T/A 0.96 0.176 1.09 0.227 0.89 0.140 
5 rs717302 A/G 0.75 0.077 0.64 0.034 1.09 0.226 
6 rs1029047 A/T 0.87 0.128 0.85 0.121 0.92 0.154 
7 rs917118 G/A 0.74 0.073 0.96 0.168 1.11 0.236 
8 rs763869 C/T 0.87 0.128 0.94 0.160 0.83 0.111 
9 rs1015250 G/C 0.94 0.161 0.96 0.168 0.89 0.140 
10 rs735155 T/C 0.68 0.050 0.65 0.040 0.87 0.128 
11 rs901398 C/T 0.81 0.105 0.76 0.084 0.88 0.134 
12 rs2107612 A/G 0.92 0.154 0.91 0.146 1.82 0.468 
13 rs1886510 G/A 0.70 0.057 0.73 0.071 0.88 0.134 
14 rs1454361 A/T 0.94 0.161 1.09 0.227 0.92 0.154 
15 rs2016276 T/C 0.87 0.128 0.89 0.140 0.74 0.073 
16 rs729172 T/G 0.67 0.047 0.64 0.037 0.61 0.023 
17 rs740910 A/G 0.68 0.050 0.60 0.022 0.66 0.044 
18 rs1493232 T/G 1.05 0.208 1.03 0.200 0.91 0.147 
19 rs719366 C/T 0.97 0.176 0.75 0.080 0.87 0.128 
20 rs1031825 T/G 1.05 0.208 1.09 0.227 1.14 0.245 
21 rs722098 A/G 1.01 0.192 1.09 0.227 2.10 0.530 
22 rs733164 A/G 0.83 0.111 0.65 0.040 0.73 0.069 
23 rs826472 G/A 0.77 0.086 0.64 0.037 0.91 0.147 
24 rs2831700 C/T 0.97 0.176 1.09 0.227 0.78 0.090 
25 rs873196 A/G 0.65 0.038 0.59 0.020 0.74 0.073 
26 rs1382387 G/T 1.56 0.396 1.19 0.267 1.18 0.265 
27 rs2111980 A/G 1.05 0.208 0.92 0.153 1.09 0.266 
28 rs2056277 A/G 0.74 0.073 0.61 0.026 0.76 0.081 
29 rs1024116 A/G 0.59 0.019 0.59 0.020 0.75 0.077 
30 rs727811 A/C 1.03 0.200 0.96 0.168 1.09 0.226 
32 rs1413212 C/T 1.27 0.298 0.96 0.168 1.30 0.309 
33 rs938283 C/T 0.84 0.116 0.64 0.037 0.66 0.044 
34 rs1979255 G/C 0.89 0.140 0.96 0.168 0.88 0.134 
35 rs1463729 A/G 1.03 0.200 0.97 0.176 1.14 0.245 
36 rs2076848 A/T 0.88 0.134 0.92 0.153 1.70 0.438 
37 rs1355366 C/T 1.03 0.200 0.74 0.075 1.05 0.208 
38 rs907100 G/C 0.77 0.086 0.88 0.133 0.68 0.050 
39 rs354439 A/T 0.88 0.134 1.05 0.209 0.92 0.154 
40 rs2040411 A/G 0.91 0.147 0.86 0.127 1.14 0.245 
41 rs737681 C/T 0.71 0.061 0.67 0.046 0.87 0.128 
42 rs2830795 A/G 1.01 0.192 1.22 0.278 0.89 0.140 
43 rs251934 A/G 0.63 0.033 0.61 0.026 0.92 0.154 
44 rs914165 C/T 0.77 0.086 0.86 0.127 0.92 0.154 
45 rs10495407 C/T 0.80 0.100 0.86 0.127 0.73 0.069 
46 rs1360288 A/G 0.75 0.077 1.41 0.348 1.16 0.255 
48 rs964681 C/T 0.91 0.147 1.07 0.218 0.97 0.176 
49 rs1005533 A/G 0.74 0.073 0.91 0.146 1.01 0.192 
50 rs8037429 A/G 1.03 0.200 1.14 0.246 0.88 0.134 
51 rs891700 A/G 1.01 0.192 0.88 0.133 1.11 0.236 
52 rs1335873 T/A 0.89 0.140 1.01 0.192 0.80 0.100 
53 rs1028528 A/G 1.18 0.265 0.82 0.109 0.92 0.154 
54 rs1528460 A/G 1.05 0.208 2.55 0.606 1.65 0.424 
Cumulative probability 
CPI= 9.7072e
-4 
Ave. PE= 99.99% 
CPI= 1.9363e
-2 
Ave. PE=99.99% 
CPI= 8.7491e
-2 
Ave. PE=99.99% 
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All forensic data obtained from the Malays, Chinese and Indians were also compared 
to other reference population data (SNPforID Consortium ) as shown in Table 5-13.   
The Europeans had the lowest cumulative MP values across 52 loci compared to the 
others.  The Malaysians (Malays, Chinese and Indians) had similar RMP with the East 
Asians, East Timorese and the Africans. The Oceanians showed slightly high matching 
probability value from the others.  
However, all populations show identical combined power of discrimination, which was 
99.9999 % for all loci, and the Malaysian ethnic groups demonstrate the highest 
percentage of cumulative exclusion probability.  
 
 Table 5-13: Forensic data comparison among the populations. 
Parameters 
Populations 
Malaysia 
East Asia
1
 
East 
Timor
1
 
Oceania
1
 Africa
1
 Europe
1
 
Malay Chinese  Indian  
Cumulative 
random 
match 
probability 
4.0 x 10
-19
 5.4 x 10
-18
 1.7 x 10
-19
 5.0 x 10
-19
 2.0 x 10
-18
 5.2 x 10
-16
 1.1 x 10
-19
 5.0 x 10
-21
 
Combined 
power of 
discrimination 
99.9999% 99.9999% 99.9999% 99.9999% 99.9999% 99.9999% 99.9999% 99.9999% 
Cumulative 
exclusion 
probability 
99.99% 99.99% 99.99% 99.91% 99.87% 99.58% 99.95% 99.98% 
1: data obtained from (Santos et al. 2011, SNPforID Consortium )   
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5.3.7. Comparison of forensic parameters between Malaysian SNP data with 
Malaysian STR data 
SNP data obtained in this study were compared to the existing Malaysia STR allele 
frequency database at Department of Chemistry Malaysia. The results show that the 
52 SNPs data gave a lower matching probability compared to the STRs. However, the 
rest of the parameters remain similar (shown in Table 5-14).   
Table 5-14: Forensic data collected and estimated for Malaysian populations. 
Population 
Cumulative 
random match 
probability 
Combined 
power of 
discrimination 
Cumulative 
exclusion 
probability 
52-SNPs: 
Malay 
Chinese 
Indians 
 
4.10 x 10-19  
5.4 x 10-18  
1.7 x 10-19 
 
99.9999% 
99.9999% 
99.9999% 
 
99.99% 
99.99% 
99.99% 
STR-Peninsular Malaysiaa 
Malay 
Chinese 
Indians 
 
2.6 x 10-17 
7.0 x 10-16 
3.6 x 10-16 
 
99.9999% 
99.9999% 
99.9999% 
 
99.99% 
99.99% 
99.99% 
STR-East Malaysia (Sarawak)b 
Iban  
Bidayuh  
Melanau 
 
3.29 x 10-17 
6.52 x 10-17 
1.52 x 10-16 
 
99.9999% 
99.9999% 
99.9999% 
 
99.99% 
99.99% 
99.99% 
a: data obtained from (Seah et al. 2003) , and 
b: data obtained from (Suadi et al. 2007).  
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5.5. DISCUSSION 
The increasing interest in using SNPs as forensic markers has led to more population 
studies. However, allele frequencies can vary greatly among populations; therefore it is 
essential to determine the allele distributions of relevant SNPs within populations 
before forensic analysis.  These SNPs can also provide valuable information for 
population admixture detection and in the estimation of bio-geographical ancestry 
(Sanchez et al. 2006a).  
 
5.5.1. Allele distribution among the populations 
Although the 52 SNP markers used in this study were chosen by Sanchez et al (2006) 
because they had allele frequencies close to 0.5/0.5 in Europeans, frequencies 
observed in Malay, Chinese and Indian ethnic groups varied, ranging from a minimum 
of  0.079  and a maximum of 0.921. 
The Malays and the Chinese showed very similar allele frequencies for most SNP loci 
used in this study, and both showed similar frequencies to the East Asians (SNPforID 
Consortium ). However, the Malaysian Indians appeared to be more similar with the 
Central-South Asians.  
 
5.5.2. Hardy-Weinberg Equilibrium (HWE) and LE departures 
Among the Malaysian groups, the Chinese demonstrated the lowest average 
heterozygosity across the 52 loci (0.40). Sanchez also has reported that among the 
population groups studied, the lowest heterozygosity was found in the Greenlander 
and Taiwanese groups, which both with 0.37.  In contrast, the Malaysian Indians had 
the highest heterozygosity (0.46) among the populations even higher than the 
Europeans (0.44). In the original paper, Sanchez and colleagues have stated that they 
expected to obtained the highest heterozygosity value for the Europeans because one 
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of the primary SNP selection criteria was for maximum heterozygosity in European 
population  with less emphasis on other populations.  
As for pairwise LE analysis, after the Bonferroni correction (p<0.00001922), there was 
only one significant association between loci was found between the SNP marker 3 and 
SNP marker 53 in the Malays. However, two other groups have no significant deviation. 
In the original study (Sanchez et al. 2006a), no significant association of the alleles 
across 52 loci was reported after sequential Bonferroni corrections (p>0.05).  
 
5.5.3. Pairwise FST estimates between the populations 
Apart from having different HWE and LE departure at different SNP markers for all 
three ethnic groups, the Malays, the Chinese and the Indians, the FST evaluations also 
show significant differences between these three groups. The Malays were found to be 
more closely related to the Chinese (with a FST of 0.007) than either was to the Indians 
(FST = 0.034 and 0.041 respectively).   
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5.5.4. The relationship between the Malays, the Chinese and the Indians 
Results obtained from this study indicate that the Malays are more closely related to 
the Chinese, compared to the Malays with the Indians or the Chinese with the Indians. 
The population assignment results also supported the above findings (table 5-9 and 
Figure 5-6). The HUGO Pan-Asian SNP Consortium having studied thousands of 
autosomal SNPs, suggested that the East Asians and Southeast Asians share a common 
origin, whilst the Central-South Asians share ancestry with the Europeans (Abdulla et al. 
2009). In addition, Hatin and colleagues have also revealed their findings after 
analyzing approximately 50, 000 autosomal SNPs and described the close connections 
between the Malays, the Chinese, the Indonesian and the Indigenous people in the 
phylogenetic tree (Hatin et al. 2011).  
Furthermore, Chang and colleagues have carried out a population study using 16 Y-STR 
markers on 980 male individuals from these three major ethnic groups and the results 
showed that the Malay and the Chinese populations were more closely related to each 
other than either was to the Indians (Chang et al. 2007). These findings were 
supported by Yong et al. (2006), who reported both groups, the Malays and the 
Chinese in Singapore as sharing most common Y-STR alleles than they did with the 
Indians (Yong et al. 2006). Even the frequency data reported in both countries 
correlates with those published for the Han Chinese (Hou et al. 2001) and the South 
Indian populations (Ballard et al. 2005).  
However, another interesting finding by Chang and colleagues (2007) that support the 
SNP population assignment in this study (Table 5-9 and Figure 5-6) was the Malays 
appeared to be more closely related to the Indians than the Chinese, when the 
samples were analyzed with the additional loci that were included in the Applied 
Biosystems Yfiler® kit. These additional loci in the Y-filer® system: DYS448, DYS635 and 
DYS458 are the three most diverse single loci for the three ethnic populations (Chang 
et al. 2007).  This finding shows that although Indians are quite different, they are 
somewhat closer to Malays than Chinese.  
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ANALYSIS OF 13-PLEX SNAPSHOT ASSAYS ON  
THE FORENSIC BIOLOGICAL SAMPLES 
 
 
6.1. INTRODUCTION 
There are many challenges involved with the amplification of crime-scene samples for 
forensic STR profiling. Samples may contain inhibitory substances, be heavily degraded, 
have only trace quantities of biological material, or be from multiple donors. Often 
minute quantities of DNA template will result partially amplified STR profiles. Partial 
profiles, amplification bias and allele drop-in can all be observed with compromised 
samples. While current multiplexes perform exceptionally well with a wide range of 
samples, new methods and technologies are being developed which could further 
increase the success rates of current STR profiling reactions from compromised 
samples (Ballantyne et al. 2011). 
The sole application of STR analysis in paternity testing can be problematic in various 
ways, and might lead to ambiguous results which due a low probability of relationship 
or when an exclusion of fatherhood is suggested by just 1 or 2 STR loci, e.g. when 
(unknowingly) testing close relatives of the alleged father. In addition, the STR results 
provide insufficient information for an exclusion because of the relatively frequently 
occurring germ-line step mutations in STR loci (addition or the decrease of 1 or 2 
repeats) that cannot be distinguished from exclusions (Schwark et al. 2012a).  
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6.2. RATIONALE OF THE STUDY 
In order to evaluate the reliability of the 13-plex assays for the real casework samples, 
several studies were conducted.  The studies included the relationship testing in the 
paternity cases, and the analysis of the simulated and real crime samples. All data 
obtained were analyzed with DNA.VIEWTM software. 
 
6.2.1. Section One: Kinship Analysis 
For this section, 10 real kinship cases samples and 2 known family samples were used. 
Seven of them were trios, four duos and a family of five (known control). In two of the 
cases, there are genetic inconsistencies at one or two loci, which could be due to 
mutation.  All these samples were previously amplified with AmpF1STR Identifiler® kit 
(Applied Biosysytems) and also were re-amplified with the Powerplex 16® System 
(Promega) for comparison study.  
 
6.2.2. Section Two: Crime Samples 
For this section, the 13-plex assays were subjected to two types of samples: 
environmental simulated samples and real crime casework samples. 
 
6.2.2.1.  Environmental simulated samples 
This simulated sample was tested under Malaysian temperate and humidity 
environment for 27 days continuously as described earlier in Chapter 2, section 2.1.2. 
The samples were collected every day (from Day 1 to Day 27) and were kept in the 
freezer. Throughout the experiment, the samples were covered with the plastic packet 
to avoid interferences from any insects or other smaller fauna.  
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6.2.2.2.  Real forensic biological samples 
In this study, the 13-plex assays were applied on 51 samples of 10 cases. Most of these 
samples are bloodstain type, which were obtained from either the crime scene or the 
victim’s belongings. The samples were selected from the casework that has both; 
failed and successfully amplified with the STR analysis. 
 
6.3. RESULTS 
 
6.3.1. Section One: Kinship Analysis 
 
6.3.1.1.  Analysis of different paternity cases (trio, duo and family) 
In Case 5, one mutation had occurred at the Child’s CSF1PO marker (Powerplex® 16 
system) as shown in Figure 6-1. In a control family, the Child E showed two mutations 
had occurred at two STR loci, D8S1179 and FGA (Figure 6-2).  Others are the normal 
trios and duos paternity/maternity investigations. In all cases, the putative father or 
mothers are found to be the biological mother or father of the child(s), including in 
Case 9 (from Table 6-1), AM1 is found to be the biological mother of the child, not 
AM2.  
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6.3.1.2.  Combined paternity index (CPI) and probability of paternity (%)  
The STR analysis results were compared to the SNP genotyping results as shown in 
Table 6-1.   
Overall, in both analyses, the trios showed higher combined paternity index (CPI) and 
probability of paternity (%) when compared to the duos. In addition, in most of the trio 
cases involving mother, child and alleged father, the STR gave higher CPI and % than 
SNP analysis as can be seen in Table 6-1.      
However, in cases with one or two mutation occurrences, SNP assays gave higher CPI 
and % than STR analysis. This demonstrates one of the advantages of SNP technology 
over the STR analysis. 
As for the control that comprised two alleged mothers of a child, the SNP-based 
probability of maternity gave 100% to AM1 compared to STRs 99.99991%.  
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Table 6-1: Paternity calculation using 16 STRs versus 52 SNPs markers in all kinship 
cases.  
Case Remarks Combined paternity index 
(CPI) 
Probability of paternity (%) 
16 STRs 52 SNPs 16 STRs 52 SNPs 
1 Trio 1.09e6 2.16e6 99.99991 99.99995 
2 Duo 179401 796.42 99.9994 99.9 
3 Trio 86.55e6 7.55e6 99.999999 99.99999 
4 Trio 43.41e6 9.46e6 99.999998 99.99999 
5 Trio- 1 mutation 87851 14.15e6 99.999 99.999993 
6 Trio 11.407e9 328.849e6 99.99999999 99.9999997 
7 Duo 108.978 5.14e6 99.09 99.99998 
8 Control 1-a family of 
5 (father and 
mother) with: 
Child C 
Child D 
Child E 
(2 mutations) 
 
 
 
 
516.24e6 
27.72e6  
54.44 
 
 
 
3.96e6 
325.84e6 
3.26e6 
 
 
 
99.9999998 
99.999996 
98.2 
 
 
 
99.99997 
99.9999997 
99.99997 
9 Control 2- 2 AM of a 
baby girl 
AM1(M) 
AM2(G) 
 
 
 
1.16e6 
30.08 
 
 
- 
1.27 
 
 
99.99991 
96.8 
 
 
100 
- 
 
10 Duo 275561 77.32 99.9996 98.7 
11 Duo 5.24e6 409.15 99.99998 99.8 
12 Trio 193.90e6 17.43e6 99.9999995 99.999994 
Notes: AM represents alleged mother.  
The DNA.VIEW calculation results are attached as Appendix F (52 SNPs) and Appendix G (STR).  
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Figure 6-1: Electropherograms of Paternity Case 5 (mentioned in Table 6-1) involving 
putative father, mother and child: (A) SNaPshot profiles of 13th multiplex assay of this trio, 
and (B) STR profile with one mutation occurrence at Child’s CSF1PO marker. 
  
A B 
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Figure 6-2: STR profile of a Control family (Case 8- Table 6-1) involving father, mother 
and Child E, where two mutations had occurred in Child E at locus D8S1179 and FGA 
(as shown by the arrows).  
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6.3.2. Section Two: Analysis of the crime samples  
 
6.3.2.1.  SNPs analysis of the simulated casework samples 
Total duration of samples collection was 27 days in the month of August/September.  
Data of average temperature, rainfall and relative humidity of each day involved 
(Figure 6-3) have been provided by the Meteorology Department of Malaysia (as 
shown in Appendix C).     
As shown in Figure 6-3, the temperature of all 27 days shows an average of 33°C, 
whilst the humidity varies from day 1 to day 27 and morning (a.m.) to evening (p.m.).  
Out of 27 days, rainfall was only observed in 11 days with the maximum rainfall 29.4 
mm (in Day 19).    
 
 
Figure 6-3: Shown above are the parameters such as temperature, rainfall and relative humidity 
values in the month of August/September (for 27 days).   
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CHAPTER 6                                                                     SNPs Genotyping on the Real Casework samples 
 
181 
 
From Day 22 until Day 27, no rainfall was received (Figure 6-3), however fungi were 
found surrounded the bloodstain spots on cloth taken from Day 21 to Day 27 as shown 
in Figure 6-4. This could be because dry temperature gave good conditions for the 
fungus to grow after the samples were exposed to the temperature, varying humidity 
and rainfall during the earlier days.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-4: Shown above are the simulated samples taken from Day 19 to Day 27. The 
arrows show the bloodstains on the cloths surrounded or covered by the fungi.  
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As for quantification results (Table 6-2), DNA was detected until Day 21, and a very 
minute amount in Day 23, Day 24 and Day 25.  Full STR and SNP profiles were obtained 
from Day 1 to Day 21. Starting from Day 22 to Day 27, only a few full alleles were 
detected. This might be because of the interference from the fungus. 
 
Table 6-2: Full alleles detected in Day 1, Day 21 to Day 27.  
Day samples were taken 
Quantification 
values (ng/μl) 
Full alleles detected 
Powerplex® 16 52 SNP markers 
Day 1 3.45 16 52 
Day 21 0.55 16 52 
Day 22 Undetermined 0 8 
Day 23 0.002 0 11 
Day 24 0.003 1 4 
Day 25 0.003 0 3 
Day 26 Undetermined 5 2 
Day 27 Undetermined 0 0 
 
 
As can be seen from Figure 6-5, only Day 1 and Day 21 have full complete profiles for 
13nd assays (SNPs) and STR analysis. Few alleles were detected for both analyses, but 
most of the alleles that generated from these samples (such as for Day 26 and Day 27) 
are not the true/correct allele(s).    
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Figure 6-5: A) SNaPshot profiles of 13nd multiplex assay of the simulated environmental 
samples from Day 1, Day 21 to Day 27, and (B) STR profiles of Powerplex® 16 system of these 
samples from Day 1, Day 21 to Day 27. 
  
400 RFU 
400 RFU 
400 RFU 
400 RFU 
400 RFU 
400 RFU 
6000 RFU 
6000 RFU 
DAY 1 
DAY  21 
DAY  22 
DAY  23 
DAY 24 
DAY 25 
DAY  26 
DAY 27 
DAY 1 
DAY  21 
DAY  22 
DAY  23 
DAY 24 
DAY 25 
DAY  26 
DAY 27 
A 
B 
CHAPTER 6                                                                     SNPs Genotyping on the Real Casework samples 
 
184 
 
6.3.2.2.  13-plex assays genotyping of the casework samples 
Fifty-one crime samples comprising bloodstains on cloths, swabs, and a mat and 2 
swabs of trace DNA from 10 crime scenes in Malaysia were profiled after extraction of 
DNA using a phenol-chloroform method. These samples were subjected to 13-plex 
assays and Powerplex® 16 System. Results obtained from both analyses were shown as 
in Table 6-3.   
Out of 51 selected samples; 17 full STR profiles were generated using conventional STR 
analysis; of the remaining 34 samples 9 gave partial profiles and 25 could not be 
amplified at all. In comparison, with 52 SNP markers, 36 full profiles were successfully 
amplified from the samples and only 15 were partially amplified or not amplified at all 
(with 5 partial profiles (with SNPs >26 loci had to be detected to be classed as a partial 
profile) and no DNA profile was obtained for 10 samples) (Figure 6-6). 
Two examples of results obtained from the casework samples are shown in Figure 6-7 
and Figure 6-8. In Figure 6-7, full STR and SNPs profiles were generated from the 
bloodstain on the cloth portion. The DNA concentration was 2.95 ng/μl with IPCCT 28. 
Whilst in Figure 6-8, no STR loci were amplified but a full SNP profile was produced 
from this sample. This sample DNA concentration was 15 ng/μl but the IPCCT was 
undetermined. In this case, the failure of STR loci to be amplified might be because of 
the presence of inhibitors. 
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Table 6-3: Results obtained from the analysis of 16 STRs and 52 SNPs on the casework 
samples.  
Case Samples In-house Labeled  52 SNPs Identifiler/Powerplex® Sytem 
1 
 
Bloodstains on pillow case F1 FP FP 
Bloodstains on bedsheet F2 FP PP-13 
Bloodstains on blanket F3 FP FP 
2 Bloodstains on mat F4 FP FP 
Bloodstains on T-shirt F5 FP FP 
Bloodstains on pair of jeans F6 FP PP-7 
Bloodstains on panties F7 FP FP 
3 Bloodstains on blouse F8 FP PP-8 
Bloodstains on skirt F9 FP FP 
Bloodstains on brassiere F10 FP PP-8 
4 Bloodstains on comforter 1 F11 FP FP 
Bloodstains on comforter 2 F12 FP FP 
5 Bloodstains on towel F13 PP-26 PP-8 
Bloodstains on pair of jeans F14 PP-39 NP 
Bloodstains on blouse F15 NP NP 
Bloodstains on camisole F16 FP FP 
Bloodstains on skirt F17 FP FP 
Bloodstains on sarong F18 FP FP 
6 Swab of cable 1 F19 NP NP 
Swab of cable 2 F20 NP NP 
7 Bloodstains on blanket 1 F21 NP NP 
Bloodstains on blanket 2 F22 FP FP 
Bloodstains on shirt 1 F23 FP NP 
Bloodstains on shirt 2 F24 FP NP 
Bloodstains on shirt 3 F25 FP NP 
Bloodstains on shirt 4 F26 FP NP 
Bloodstains on shirt 5 F27 FP PP-11 
Bloodstains on shirt 6 F28 FP PP-13 
Bloodstains on shirt 7 F29 FP FP 
Bloodstains on shirt 8 F30 FP Weak/Inconclusive 
8 Bloodstains on plastic bag 1 F31 PP-50 NP 
Bloodstains on shirt  F32 PP-47 NP 
Bloodstains on pair of jeans F33 FP FP 
Bloodstains on towel F34 FP FP 
Bloodstains on tissue paper F35 NP NP 
Bloodstains on string 1 F36 FP NP 
Bloodstains on string 2 F37 FP NP 
Bloodstains on plastic bag 2 F38 NP NP 
9 Bloodstains on pair of short pants F39 FP PP-7 
Bloodstains on T-shirt  F40 NP NP 
Bloodstains on underwear  F41 PP-33 PP-7 
Bloodstains on baton F42 FP FP 
10 Bloodstains on shirt 1 F43 FP FP 
Bloodstains on shirt 2 F44 FP FP 
Bloodstains on pairs of short pants F45 FP FP 
Bloodstains on underwear F46 FP NP 
Bloodstains on singlet F47 FP NP 
Bloodstains on pair of short pants F48 FP NP 
Bloodstains on panties F49 NP NP 
Bloodstains on brassiere F50 NP NP 
Bloodstains on slippers F51 NP NP 
Notes: FP- Full profile, PP- Partial profile and NP- No profile.  
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Notes: FP- Full profile, PP- Partial profile and NP- No profile. 
Figure 6-6: Number of profiles (STR and SNPs) that have been successfully developed 
or failed from the crime stains. For SNP, PP means sample developed more than 26 
markers.    
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Figure 6-7: Application of SNP and STR assays on the crime sample (with DNA concentration 
2.95 ng/μl and IPCCT 28). Full STR (16 markers) and SNaPshot (52 markers) profiles were 
generated from this sample.  
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Figure 6-8: Application of SNP and STR assays on the crime sample (with DNA concentration 
15 ng/μl and IPCCT undetermined). No STR loci was amplified but a full SNaPshot profile was 
generated from this sample (a portion of torn shirt bearing bloodstains).  
All samples that were successfully amplified using STR or SNP multiplex assays were found to 
come from the same source. Shown below, in Table 6-4, are the samples that were analysed 
using DNA.VIEW software. From the results obtained, all full profiles and even partial profiles 
gave higher match probability with theta () corrections (0.01 and 0.03) is incorporated. This 
shows the SNP multiplex assays have potential to be used in forensic casework analysis.  
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Table 6-4: Statistical evaluation of SNP data using DNA.VIEW software.  
 
  
Case Samples In-house 
Labeled  
Source of the samples 52 SNPs Theta () 
0.01 0.03 
1 
 
Bloodstains on pillow case F1 Samples are from the same source. FP 
1e18 720e15 Bloodstains on bedsheet F2 FP 
Bloodstains on blanket F3 FP 
2 Bloodstains on mat F4 Samples are from the same source. FP 
23e18 15e18 
Bloodstains on T-shirt F5 FP 
Bloodstains on pair of jeans F6 FP 
Bloodstains on panties F7 FP 
3 Bloodstains on blouse F8 Samples are from the same source. FP 
12e18 8.6e18 Bloodstains on skirt F9 FP 
Bloodstains on brassiere F10 FP 
4 Bloodstains on comforter 1 F11 Samples are from the same source. FP 
2.7e18 1.9e18 
Bloodstains on comforter 2 F12 FP 
5 Bloodstains on towel F13 Samples are from the same source. PP-26 1.7e12 1.2e12 
Bloodstains on pair of jeans F14 PP-39 17e15 11e15 
Bloodstains on blouse F15  NP   
Bloodstains on camisole F16 Samples are from the same source. FP 
3.2e21 1.9e21 Bloodstains on skirt F17 FP 
Bloodstains on sarong F18 FP 
6 Swab of cable 1 F19  NP   
Swab of cable 2 F20  NP   
7 Bloodstains on blanket 1 F21  NP   
Bloodstains on blanket 2 F22 Samples are from the same source. FP 
200e21 110e21 
Bloodstains on shirt 1 F23 FP 
Bloodstains on shirt 2 F24 FP 
Bloodstains on shirt 3 F25 FP 
Bloodstains on shirt 4 F26 FP 
Bloodstains on shirt 5 F27 FP 
Bloodstains on shirt 6 F28 FP 
Bloodstains on shirt 7 F29 FP 
Bloodstains on shirt 8 F30 FP 
8 Bloodstains on plastic bag 1 F31 Samples are from the same source. PP-50 41e18 28e18 
Bloodstains on shirt  F32 PP-47 51e18 30e18 
Bloodstains on pair of jeans F33 FP 
32e18 23e18 
Bloodstains on towel F34 FP 
Bloodstains on tissue paper F35  NP   
Bloodstains on string 1 F36 Samples are from the same source. FP 
32e18 23e18 
Bloodstains on string 2 F37 FP 
Bloodstains on plastic bag 2 F38  NP   
9 Bloodstains on pair of short pants F39 Samples are from the same source. FP 460e18 280e18 
Bloodstains on T-shirt  F40  NP   
Bloodstains on underwear  F41 Samples are from the same source. PP-33 28e9 23e9 
Bloodstains on baton F42 FP 460e18 280e18 
10 Bloodstains on shirt 1 F43  FP 
570e18 360e18 
Bloodstains on shirt 2 F44  FP 
Bloodstains on pairs of short pants F45  FP 
Bloodstains on underwear F46  FP 
Bloodstains on singlet F47  FP 
Bloodstains on pair of short pants F48  FP 
Bloodstains on panties F49  NP   
Bloodstains on brassiere F50  NP   
Bloodstains on slippers F51  NP   
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6.4. DISCUSSION 
In the case of natural and mass disasters, missing person’s cases and forensic casework, 
highly degraded biological samples are often encountered. Conventional methods of 
identification such as fingerprint, forensic anthropology and dental matching can be 
inadequate when remains are highly fragmented and decomposed. DNA typing using 
industry standard short tandem repeats (STRs) often becomes the principal means of 
identification (Brenner 2006, Hughes-Stamm et al. 2011). 
In this study 13-plex assays were applied to the simulated crime samples and paternity 
samples, in order to evaluate the usefulness of these SNP markers in handling 
problematic samples. As reported by Stamm and colleagues (2011), their results 
indicated mini-STRs and SNP markers are usually more successful in typing degraded 
samples and in cases of extreme DNA degradation (≤200 bp) and template amounts 
below 250 pg, mini-STR and SNP analysis yielded significantly more complete profiles 
and lower match probabilities than corresponding STR profiles (Hughes-Stamm et al. 
2011). 
 
6.4.1. Section One: Kinship studies  
One of the main aims of this chapter was to study the identification ability of these 
SNP markers. Therefore the first approach was applied these 13-plex assays on the 
paternity samples having different scenarios. Results obtained from this study showed 
that normal trio paternity cases gave higher CPI and probability % than normal duo 
cases. In addition, STR analysis also gave higher CPI and probability % than SNP analysis. 
However, in cases where STR mutation(s) were present SNP analysis gave higher CPI 
and probability % than STRs.  This phenomenon could be because in commonly used 
STR, one mutation is expected to occur in one of the loci typed in approximately 3% of 
all meioses. If one or two genetic inconsistencies are detected between a child and the 
alleged parents may not be the true biological parent. In contrast, mutations occur 
100,000 times less frequently in SNPs than in STRs, and inconsistencies caused by 
mutations in SNP loci are extremely rare (Borsting et al. 2012a). 
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6.4.2. Section Two: The analysis of forensic biological samples  
 
6.4.2.1.  Simulated casework samples 
Poor sample handling and storage may lead to further loss or degradation of samples 
and could impact obtaining useful results. Additional factors that may compromise 
sample integrity include high humidity, temperature, persistence of nucleases and 
other chemical agents as well as other sub-optimal conditions that may occur not only 
during transport, but also within storage facilities (Lee et al. 2012).  
 
In order to test whether these 13-plex assays will be suitable to be used on the 
Malaysian crime samples, simulated samples were exposed to typical Malaysian 
weather, very high humidity and temperature for 27 days. The extent of DNA 
degradation and inhibition can be seen as shown in Figure 6-4. Samples from Day 21 to 
Day 27 showed the presence of fungi on the bloodstain spot and on the cloth itself. 
The results obtained from STR and SNP analysis also demonstrate that samples from 
Day 22 to Day 27 failed to amplify.   
 
Spontaneous degradation by hydrolysis and oxidation will further modify DNA 
structure at a much slower speed. However, a fundamental knowledge of the types of 
DNA damage encountered in forensic stains that would lead to amplification failure 
has not been yet been provided. There are a few other factors that might lead to DNA 
degradation through environmental conditions or microbial activity such as radiation 
and oxidation processes, the availability of sufficient nutrients, pH and ionic 
concentration for the growth of microorganisms (Alaeddini et al. 2010).  
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6.4.2.2.  Real casework samples 
DNA becomes progressively more fragmented as biological tissue degrades resulting in 
a decreasing ability to gain a complete DNA profile. Successful identification of samples 
exhibiting very high levels of DNA degradation may be complicated by presenting in 
minute quantities. The industry standard method for human DNA identification 
utilizing short tandem repeats (STR) may produce partial or no DNA profiles with such 
samples (Hughes-Stamm et al. 2011). 
In this study, the results obtained demonstrate that in some instances the SNPs can 
generate full profiles from DNA extracts that yielded no or partial STR loci. The samples 
that were successfully typed have input DNA from undetermined up to 100 ng 
(quantified using the Quantifiler® kit), and this suggests that some of the samples were 
highly degraded or inhibited as STR profiles would have otherwise been expected. 
The DNAVIEW calculation shows that even the partial profiles such as 26 SNP markers 
and above gave a high power of discrimination. Overall, out of 51 crime samples, STR 
typing was able to amplify 17 full profiles and 9 partial profiles. By contrast, with SNP 
analysis, 36 full profiles and 5 partial profiles had been successfully amplified from the 
DNA extracts.  
Sanchez and colleagues (2006) reported that the full set of 52 SNP markers were 
successfully amplified from partially degraded DNA samples using 200 to 500 pg DNA 
input (Sanchez et al. 2006a).  Børsting and colleagues (2011) have also reported that in 
their study, complete SNP profiles were obtained in 80% of the highly degraded 
samples and at least 41 SNPs were typed in the last 20% (Børsting et al. 2011). 
The high sensitivity and the short amplicon sizes make the assay very suitable for 
typing of partially degraded DNA, and the low mutation rate of SNPs makes the assay 
very useful for relationship testing. Indirectly, these advantages make the assay well 
suited for disaster victim identifications, where the DNA from the victims may be 
highly degraded and the victims are identified via investigation of their relatives 
(Børsting et al. 2013).  
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GENERAL DISCUSSION AND FUTURE WORK 
 
 
7.1. GENERAL DISCUSSION 
SNPs have already proved to be valuable markers and SNPs are used by some 
laboratories in routine case work investigations. SNPs are mainly used as 
supplementary markers, but there are situations where SNPs may be the best choice 
of markers. If the DNA is highly degraded, there is a much higher chance of obtaining 
results with SNP markers than with short tandem repeat (STR) markers, because SNPs 
may be amplified on very short amplicons (<100 bp) (Sanchez et al. 2006a, Butler et al. 
2008, Phillips et al. 2008b) 
The performance of the 52plex SNP assay was recently compared to the use of STRs 
and VNTRs (variable number of tandem repeats) in paternity casework. The typical 
paternity indices (PIs) obtained based on the 52 SNPs were 5–50 times lower than the 
typical PIs based on 15 STRs or 7 VNTRs. However, the mutation rate of SNPs is 
expected to be approximately 100,000 times lower than the mutation rate of tandem 
repeats, and this makes the SNPforID 52plex SNP assay a valuable investigative tool in 
forensic casework where potential relatives are involved. This is especially true in cases 
where various family scenarios are possible or in cases where a possible mutation has 
been detected in one of the tandem repeat loci, and supplementary investigations are 
required. Furthermore, the SNPforID 52plex SNP assay may be highly useful in disaster 
victim investigations, because the assay can generate complete proﬁles from highly 
degraded DNA, where the commercial STR kits fail (Borsting et al. 2009). 
In developing multiplex assays, there are several crucial criteria that need to be 
carefully evaluated, especially primer-primer concentration and interactions, 
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concentrations used for PCR buffers and other components, thermal conditions and CE 
instruments used to analyze the samples.  
Few studies had been carried out involved the PCR/SBE primers, to adjust and obtain 
balanced SNP profile. In this study, four sets of 13-plex assays (13st, 13nd, 13rd and 13th) 
have been developed from the 52 SNP markers identified (Sanchez et al. 2006a) and 
the single base primer extension method has been chosen to be used with the 
SNaPshot Multiplex kit.  The main reason for the reduction of SNP markers from the 
original study is for easier interpretation and to accommodate the ABI 310 capability in 
detecting SNP alleles. These assays will also be applied to the forensic casework 
samples, therefore an easy and reliable tool is needed to interpret the SNP data.  
Any technology that is applied to forensic casework, such as CE systems must be 
rigorously evaluated through a comprehensive validation program (Moretti et al. 2001, 
Butler et al. 2004). The validation experiments reveal the operational parameters that 
are employed in the assessment of peaks detected during CE analysis (Butler et al. 
2004).  
In comparing the reproducibility of 13-plex assays generated from both genetic 
analyzers, a concordance study had been carried out using polymer, POP-7™ and 3500 
genetic analyzer, but the resolution of the profiles were found to be poor. Further 
experiments were undertaken and as a result, POP-6™ was decided to be the best 
polymer to be used in detecting SNP alleles using 3500 genetic analyzer.  
All these observations were very important because it gives new insight in SNP 
genotyping using the 3500 analyzer especially for profiles that would have many 
heterozygous alleles. The CE instruments should have a high resolving capability with 
high precision to be able to identify alleles that have one or two bases in size 
difference (Isenberg et al. 1998). 
Apart from different software and capabilities between ABI 310 and ABI 3500, overall, 
the four sets of 13-plex assays introduced in the study were reliable and could be used 
in the SNP genotyping of the population and casework samples. In fact, the sensitivity 
of these assays on both genetic analyzers was as low as 30 pg. In some profiles with 
only 30 pg input, the samples showed one or two allele drop-outs, especially in the 
 CHAPTER 7                                                                                              General Discussion & Future Work 
 
196 
 
heterozygous alleles. Therefore, the best SNP profile obtained with full amplification of 
52 alleles was at DNA input more than 60 pg. Full SNP profiles were also successfully 
amplified from DNA samples of more than 70 ng with no allele drop-out but the 
imbalanced peak heights were observed. Overall, as for forensic casework, these 
assays (13st, 13nd, 13rd and 13th) were reliable and could be useful tools in genotyping 
low template DNA less than 200 pg, and particularly degraded DNA. 
In forensic laboratories, an amount of DNA below a specific level (between 100 and 
200 pg) has been variously defined as low template DNA (Gill & Buckleton 2009). These 
13-plex assays provide useful and reliable tools in detecting alleles from samples with 
input DNA less than 30 pg or higher than 70 ng.   
Besides that, although these 52 SNP markers were meant to be used in forensic human 
identification and not ethnicity prediction, the results obtained using these 52 SNP 
markers could possibly differentiate between the Indians and the other two ethnic 
groups.  
The results obtained from this 52 SNPs study combined with those previously 
published suggest that a complex model of admixture could have occurred between 
the Malays, the Chinese and the Indians or even with the indigenous people. This is 
consistent with the hypothesis that human populations are not discrete groups, since 
admixture commonly occurs between neighbouring populations (Sanchez et al. 2006a, 
Serre & Paabo 2004). Therefore, it is necessary to take into account for the future 
studies especially regarding different ancestry origin among the populations.  
This study not only revealed least differences, FST for most markers between the three 
studied ethnic populations, the Malays, the Chinese and the Indians that indicates the 
closeness of these three ethnic groups, but also shows that the 52 SNP markers can 
provide a high discrimination capacity which is essential for forensic applications. 
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Limitations/Challenges of SNP Analysis 
There are a few limitations of SNP analysis was identified to be used as core forensic 
technology such as no commercial kits available, no widely established core loci, 
having mixture resolution issues/interpretation, large multiplexing assays are required, 
linkage studies very limited and substructure due to low mutation rate and there are 
multiple typing platforms that make universal SNP selection difficult (Butler et. 
al.2008). 
 
7.2. FUTURE WORK 
As for future work, marker sets that are based on small insertion/deletion (INDEL) 
alleles can serve as useful supplementary or stand-alone assays for human 
identification. The presence or absence of a small insertion or deletion (INDEL), 
technically a SNP, offers the value of a more simplified analytical process. In addition, 
the instrumentation for INDEL analyses is commonly found in forensic laboratories and 
essentially, INDELs perform analytically similar to that of STRs (Larue et al. 2012, 
Pereira, Gusmao 2012). 
 
Further population studies on variation in individual admixture proportions will be 
interesting for Malaysian’s multi-ethnic populations. Current interest that growing is 
establishing SNP tests that are able to predict hair, skin and eye colour variation 
(Kayser & Schneider 2009, Walsh et al. 2013) in populations, along with the ancestry 
informative markers (AIM) (Li et al. 2008, Fondevila et al. 2013, Pereira et al. 2012, 
Wall et al. 2013) that associate the genotypes detected in an individual to their genetic 
ancestry, where in this case, genetic ancestry is a characteristic defined by broadly 
based continental population group . 
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APPENDIX A: Approval letter of samples collection from Department of Chemistry 
Malaysia, Ministry of Science Technology and Innovation, Malaysia. 
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APPENDIX B: Approval notification from Health, Safety and Ethics Committee of the 
School of Forensic and Investigative Sciences. 
 
 200 
Appendix C 
 
APPENDIX C: Records of meteorological data. 
 
Year Month Day Temperature ( °C ) Rainfall 
( mm ) 
Relative Humidity ( % ) 
Maximum Minimum 8.00 a.m 2.00 p.m 
2011 08 08 33.9 23.9 0.0 92 61 
2011 08 09 33.6 24.5 0.0 92 58 
2011 08 10 31.8 23.7 0.0 92 86 
2011 08 11 34.2 22.8 0.0 91 53 
2011 08 12 33.3 24.8 12.1 89 55 
2011 08 13 33.4 22.7 13.4 91 59 
2011 08 14 32.0 23.4 1.2 92 70 
2011 08 15 33.2 23.4 0.0 96 61 
2011 08 16 33.0 23.2 0.0 93 58 
2011 08 17 33.9 23.5 0.0 91 51 
2011 08 18 33.9 24.6 0.0 84 51 
2011 08 19 34.6 24.2 3.7 92 53 
2011 08 20 30.2 23.4 16.3 91 88 
2011 08 21 33.7 24.4 13.5 92 53 
2011 08 22 33.0 23.9 2.0 92 90 
2011 08 23 32.6 23.4 13.1 92 81 
2011 08 24 32.4 24.0 1.2 88 66 
2011 08 25 32.5 23.3 0.0 96 83 
2011 08 26 30.2 23.4 29.4 92 93 
2011 08 27 32.4 23.9 0.0 88 67 
2011 08 28 31.0 24.8 17.0 92 69 
2011 08 29 30.6 23.0 0.0 96 64 
2011 08 30 33.1 24.0 0.0 87 56 
2011 08 31 31.1 25.5 0.0 89 66 
2011 09 01 33.4 22.4 0.0 87 52 
2011 09 02 31.4 24.7 0.0 92 75 
2011 09 03 32.6 23.4 0.0 85 58 
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APPENDIX D: Real forensic casework samples used in the study. 
 
 
Figure 1: Shown above are the casework samples from Case 1. 
 
Figure 2: Shown above are the casework samples from Case 2. 
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Figure 3: Shown above are the casework samples from Case 3. 
 
 
Figure 4: Shown above are the casework samples from Case 4.  
 203 
Appendix D 
 
 
Figure 5: Shown above are the casework samples from Case 5. 
 
Figure 6: Shown above are the casework samples from Case 6.  
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Figure 7: Shown above are the casework samples from Case 7.  
 205 
Appendix D 
 
 
 
Figure 8: Shown above are the casework samples from Case 8.  
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Figure 9: Shown above are the casework samples from Case 9.  
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Figure 10: Shown above are the casework samples from Case 10. 
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APPENDIX E: Documents set-up for Allelic Discrimination study 
 
Figure 11: An example of a Pre-Read document created. 
 
 
 
 
Figure 12: Detector was created and selected for targeted SNP markers in a Pre-Read 
document.  
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Figure 13: The sample plate was set-up with tasks and markers chosen in a Pre-Read 
document. 
 
Figure 14: An example of the Pre-Read template.   
 210 
Appendix E 
 
 
 
Figure 15: Selecting the assay type to create the Amplification document 
 
Figure 16: An example of the Amplification template with sample names, tasks, a 
specific marker and detector.  
 211 
Appendix E 
 
 
 
Figure 17: Creating an AD Post-Read document. 
 
Figure 18: An example of a Post-Read document with sample names, tasks, a marker 
and detector of targeted SNP.  
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Figure 19: Instrument conditions for a Pre-Read analysis. 
 
Figure 20: Instrument conditions for an Amplification analysis.  
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Figure 21: Instrument conditions for a Post-Read analysis. 
 
Figure 22: No allele was observed in the Allelic Discrimination tab.  
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Figure 23: No report of analysis was generated. 
 
Figure 24: The Allelic Discrimination tab of the AQ analysis. 
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APPENDIX F: DNA.VIEW calculation of 52 SNP markers for tested samples. 
Case  1 Scenario 1 
    
 
M       Mother 1000-0097  
   
 
C        Child 1000-0098   
   
 
F   Tested Man 1000-0099   
   C: M + F 
       /C: M+ ? 
       
 
────── 
      
 
Malay cumulative LR 2.16363e6 Posterior probability= 99.99995% assuming prior= 50% 
 
────── 
        ► Malay 
   
M C F 
 
A01       SNP 2.32979  1 / c c=0.429  C  C C 
 
A02       SNP  1.54225  1 / c  c=0.648  C  C C 
 
A03       SNP  1  1 / (a+t)  a=0.164 t=0.836  AT AT T 
 
A04       SNP  1  1 / (a+t)  a=0.564 t=0.436  A T AT A 
 
A05       SNP  1.86441  1 / 2g  g=0.268  A G A GA 
 
A06       SNP  1.46667  1 / 2a  a=0.341  A A AT 
 
A07       SNP  2.2  1 / 2a  a=0.227  G A A G A 
 
A08       SNP  2.31579  1 / c c=0.432   T CT T 
 
A09       SNP  0.873016  1 / 2c  c=0.573  G GC G C 
 
A10       SNP  1  1 /(c+t)  c=0.182 t=0.818  CT C T T 
 
A11       SNP  1.92982  1 / 2c  c=0.259  C T C C T 
 
A12       SNP  0.70677  1 / 2a  a=0.705  A  A G A 
 
A13       SNP  1  1 / (a+g)  g=0.855 a=0.145  G A G A G A 
 
A14       SNP  1.77419  1 / a  a=0.564  T AT A 
 
A15       SNP  1  1 / (c+t)  c=0.35 t=0.65  C T C T C T 
 
A16       SNP  1  1 / (g+t)  g=0.841 t=0.159  GT G T G 
 
A17       SNP  3.66667  1 / 2g  g=0.136  A GA GA 
 
A18       SNP  2.5  1 / t  t=0.4  G  G T T 
 
A19       SNP  1.5  1 / t  t=0.667  T T T 
 
A20       SNP  1.07843  1 / 2g  g=0.464 T G T GT 
 
A21       SNP  1.71094  1 / a  a=0.584   A A A 
 
A22       SNP  1.80328  1 / 2a  a=0.277  GA A GA 
 
A23       SNP  0.628571  1 / 2g  g=0.795  G  G GA 
 
A24       SNP  1.17021  1 / 2c  c=0.427  CT C CT 
 
A25       SNP  1.19022  1 / a  a=0.84   A A A 
 
A26       SNP  1.20879  1 / 2g  g=0.414  T G T G T 
 
A27       SNP  1.65414  1 / a  a=0.605  G G A A 
 
A28       SNP  1  1 / (a+g)  g=0.832  GA GA G 
 
A29       SNP  0.555556  1 / 2g  g=0.9  G G GA 
 
A30       SNP  1 1 / (a+c)  a=0.541 c=0.459  AC A C AC 
 
A32       SNP  0.866142  1 / 2t  t=0.577  C C T CT 
 
A33       SNP  1.74603 1 / 2c  c=0.286   T C T CT 
 
A34       SNP  1  1 / (c+g)  g=0.541 c=0.459  GC G C G 
 
A36       SNP  1.34146  1 / t  t=0.745  AT T  T 
 
A37       SNP  1.52778  1 / 2c  c=0.327  T C T CT 
 
A38       SNP  1.06796  1 / 2c  c=0.47  C C GC 
 
A39       SNP  1.22222  1 / 2a  a=0.409  A A A T 
 
A40       SNP  3.05556  1 / a  a=0.327  GA A A 
 
A41       SNP  0.601093  1 / 2c  c=0.832  C C C T 
 
A42       SNP  0.833333 1 / 2g  g=0.6  A GA GA 
 
A43       SNP  0.578947 1 / 2a  a=0.864   A A G A 
 
A44       SNP  1.69231 1 / 2t  t=0.295  CT T CT 
 
A45       SNP  1.3949  1 / c  c=0.717  C C C 
 
A46       SNP  4.58333 1 / a  a=0.218  G A  A A 
 
A48       SNP  2.97297  1 / c  c=0.336  T C T C 
 
A49       SNP  1  1 / (a+g)  g=0.804 a=0.2  GA GA GA 
 
A50       SNP  2.36559  1 / a  a=0.423  G A A A 
 
A51       SNP  1  1 / (a+g)  g=0.527 a=0.473  G A G A  A 
 
A52       SNP  0.700637  1 / 2a  a=0.714  AT A A T 
 
A54       SNP  1.05769  1 / 2g  g=0.473  G  G G A 
 
 A35      SNP  2.01835  1 / a  a=0.495  GA A A 
 
 A53      SNP  1.12245  1 / 2g  g=0.445  G G G A 
 
cumulative LR  2.16363e6 
     
 
────── 
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Case  2 Scenario 2 
    
 
M       Mother 1000-0100  
   
 
C        Child 1000-0101   
   
 
     
   C: M + ? 
       /C: ?+ ? 
       
 
────── 
      
 
Malay cumulative LR 796.423 Posterior probability= 99.9% assuming prior= 50% 
 
────── 
        ► Malay 
   
M C 
 
A01       SNP 0.8  1 / 2t t=0.573  T C T  
 
A02       SNP  0.774648  1 / 2c  c=0.645  C CT  
 
A03       SNP  1.19022  1 / t  t=0.84  T T  
 
A04       SNP  0.887097  1 / 2a  a=0.564  A AT  
 
A05       SNP  0.68323  1 / 2a  a=0.732 A G A  
 
A06       SNP  0.758621  1 / 2t  t=0.659  A T T  
 
A07       SNP  1.28824  1 / g  g=0.776 G G  
 
A08       SNP  0.88  1 /2 t  t=0.568  T CT  
 
A09       SNP  1.7381  1 / c  c=0.575  C C  
 
A10       SNP  2.75  1 /2c  c=0.182 CT CT  
 
A11       SNP  1.34356  1 / t  t=0.744  T T  
 
A12       SNP  1.4129  1 / a  a=0.708  A A  
 
A13       SNP  0.585106 1 / 2g  g=0.855   G G A  
 
A14       SNP  0.887097  1 / 2a  a=0.564  A AT  
 
A15       SNP  1.53147  1 / t  t=0.653  T T  
 
A16       SNP  1.18378  1 / g  g=0.845  G G  
 
A17       SNP  1.15263  1 / a  a=0.868  A A  
 
A18       SNP  2.48864  1 / t  t=0.402  T T  
 
A19       SNP  0.753425  1 / 2t  t=0.664  T C T  
 
A20       SNP 0.932203  1 / 2t  t=0.536  T G T  
 
A21       SNP  0.859375  1 / 2a  a=0.582  A G A  
 
A22       SNP  0.691824  1 / 2g  g=0.723  G GA  
 
A23       SNP  1.25143  1 / g  g=0.799  G  G   
 
A24       SNP  0.873016  1 /2t  t=0.573  T CT  
 
A25       SNP  1.19022  1 / a  a=0.84  A A  
 
A26       SNP  0.852713  1 / 2t  t=0.586  T G T  
 
A27       SNP  1.64662  1 / a  a=0.607  A A  
 
A28       SNP  1.19672  1 / g  g=0.836  G G  
 
A29       SNP  1.10606  1 / g  g=0.904  G G  
 
A30       SNP  1.84034 1 / a  a=0.543  A A  
 
A32       SNP  0.866142  1 / 2t  t=0.577  CT T  
 
A33       SNP  1.22333  (c+t) / 4ct  c=0.286 t=0.714  C T C T  
 
A34       SNP  0.92437  1 / 2g  g=0.541  GC G  
 
A36       SNP  1.96429  1 / 2a  a=0.255  AT A  
 
A37       SNP  1.47973  1 / t  t=0.676  T T  
 
A38       SNP  2.12621  1 / c  c=0.47  C C  
 
A39       SNP  0.846154  1 / 2t  t=0.591  A T T  
 
A40       SNP  0.743243  1 /2g  g=0.673  GA G  
 
A41       SNP  1.19672  1 / c  c=0.836  C C  
 
A42       SNP  1.65909  1 / g  g=0.603  G G  
 
A43       SNP  1.15263  1 / a  a=0.868  A A  
 
A44       SNP  1.4129  1 / c  c=0.708  C C  
 
A45       SNP  1.22333  (c+t) / 4ct  c=0.286 t=0.714 CT CT  
 
A46       SNP  0.639535  1 / 2g  g=0.782  G G A  
 
A48       SNP  0.753425  1 / 2t  t=0.664  T C T  
 
A49       SNP  1.24432  1 / g  g=0.804  G G  
 
A50       SNP  1.72441  1 / g  g=0.58  G G  
 
A51       SNP  1.05769  1 / 2a  a=0.473  G A A  
A52       SNP 1.3949  1 / a  a=0.717  A A  
 
A54       SNP  1.00298  (a+g) / 4ag  a=0.527 g=0.473 G A GA  
 
 A35      SNP  1.00917  1 / 2a  a=0.495  A GA  
 
 A53      SNP  1.79508  1 / a  a=0.557  A A  
 
cumulative LR  796.423 
     
 
────── 
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Case  3 Scenario 3 
    
 
M       Mother 1000-0102  
   
 
C        Child 1000-0103   
   
 
F   Tested Man 1000-0104   
   C: M + F 
       /C: M+ ? 
       
 
────── 
      
 
Malay cumulative LR 7.55221e6 Posterior probability= 99.99999% assuming prior= 50% 
 
────── 
        ► Malay 
   
M C F 
 
A01       SNP 1  1 / (c+t) c=0.427 t=0.573  C T C T T 
 
A02       SNP  2.82051  1 / t  t=0.355  C T T T 
 
A03       SNP  1.19022  1 / t  t=0.84  T T T 
 
A04       SNP  2.29167  1 / t  t=0.436  A T T T 
 
A05       SNP  3.72881  1 / g  g=0.268  A G A G 
 
A06       SNP  1.51724  1 / t  t=0.659  A T T T 
 
A07       SNP  1  1 / (a+g)  g=0.773 a=0.227  G A G A G A 
 
A08       SNP  1.76  1 / t  t=0.568  C T T T 
 
A09       SNP  0.873016  1 / 2c  c=0.573  C C G C 
 
A10       SNP  1.22222  1 / t  t=0.818  C C T T 
 
A11       SNP  1.92982  1 / 2c  c=0.259  C T C C T 
 
A12       SNP  1  1 / (a+g)  g=0.295 a=0.705  G A G A G A 
 
A13       SNP  1  1 / (a+g)  g=0.855 a=0.145  G A G A G A 
 
A14       SNP  1.14583  1 / 2t  t=0.436  T T A T 
 
A15       SNP  1  1 / (c+t)  c=0.35 t=0.65  C T C T C T 
 
A16       SNP  3.14286  1 / 2t  t=0.159  G G T G T 
 
A17       SNP  1.15263  1 / a  a=0.868  A A A 
 
A18       SNP  1  1 / (g+t)  g=0.6 t=0.4  G T G T G T 
 
A19       SNP  1.48649  1 / 2c  c=0.336  T C T C T 
 
A20       SNP  1  1 / (g+t)  g=0.464 t=0.536  G T G T T 
 
A21       SNP  1  1 / (a+g)  g=0.418 a=0.582  G A G A A 
 
A22       SNP  1.37736  1 / g  g=0.726  G G G 
 
A23       SNP  1  1 / (a+g)  g=0.795 a=0.205  G A G A A 
 
A24       SNP  1.7381  1 / t  t=0.575  T T T 
 
A25       SNP  1  1 / (a+g)  g=0.164 a=0.836  G A G A A 
 
A26       SNP  1.20879  1 / 2g  g=0.414  T G T G T 
 
A27       SNP  1.26437  1 / 2g  g=0.395  A G A G A 
 
A28       SNP  1.19672  1 / g  g=0.836  G G G 
 
A29       SNP  1.10606  1 / g  g=0.904  G G G 
 
A30       SNP  1.84874  1 / a  a=0.541  C A C A 
 
A32       SNP  2.36559  1 / c  c=0.423  T C T C 
 
A33       SNP  1  1 / (c+t)  c=0.286 t=0.714  C T C T T 
 
A34       SNP  1.84874  1 / g  g=0.541  C G C G 
 
A36       SNP  0.670732  1 / 2t  t=0.745  T T A T 
 
A37       SNP  1.48649  1 / t  t=0.673  C C T T 
 
A38       SNP  2.12621  1 / c  c=0.47  C C C 
 
A39       SNP  0.846154  1 / 2t  t=0.591  A T T A T 
 
A40       SNP  1.47973  1 / g  g=0.676  G G G 
 
A41       SNP  0.601093  1 / 2c  c=0.832  C C C T 
 
A42       SNP  2.5  1 / a  a=0.4  G A A A 
 
A43       SNP  3.66667  1 / 2g  g=0.136  G A G G A 
 
A44       SNP  1.4129  1 / c  c=0.708  C C C 
 
A45       SNP  3.47619  1 / t  t=0.288  T T T 
 
A46       SNP  1  1 / (a+g)  g=0.782 a=0.218  G A G A A 
 
A48       SNP  1.50685  1 / t  t=0.664  C C T T 
 
A49       SNP  1.24432  1 / g  g=0.804  G G G 
 
A50       SNP  1  1 / (a+g)  g=0.577 a=0.423  G A G A G 
 
A51       SNP  1  1 / (a+g)  g=0.527 a=0.473  G A G A G A 
 
A52       SNP  0.700637  1 / 2a  a=0.714  A A A T 
 
A54       SNP  0.948276  1 / 2a  a=0.527  G A A G A 
 
 A35      SNP  1.97297  1 / g  g=0.507  G G G 
 
 A53      SNP  1.12245  1 / 2g  g=0.445  G G G A 
 
cumulative LR  7.55221e6 
     
 
────── 
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Appendix F 
 
Case  4 Scenario 4 
    
 
M       Mother 1000-0105  
   
 
C        Child 1000-0106   
   
 
F   Tested Man 1000-0107   
   C: M + F 
       /C: M+ ? 
       
 
────── 
      
 
Malay cumulative LR 9.45636e6 Posterior probability= 99.99999% assuming prior= 50% 
 
────── 
        ► Malay 
   
M C F 
 
A01       SNP 1.74603  1 / t t=0.573  C T T T 
 
A02       SNP  1.54225  1 / c  c=0.648  C C C 
 
A03       SNP  1.19022  1 / t  t=0.84  T T T 
 
A04       SNP  2.29167  1 / t  t=0.436  A T T T 
 
A05       SNP  3.72881  1 / g  g=0.268  A G A G 
 
A06       SNP  1.46667  1 / 2a  a=0.341  T A T A T 
 
A07       SNP  1.28824  1 / g  g=0.776  G G G 
 
A08       SNP  1  1 / (c+t)  c=0.432 t=0.568  C T C T C T 
 
A09       SNP  2.32979  1 / g  g=0.429  G G G 
 
A10       SNP  1.21667  1 / t  t=0.822  T T T 
 
A11       SNP  1  1 / (c+t)  c=0.259 t=0.741  C T C T T 
 
A12       SNP  3.38462  1 / g  g=0.295  A G A G 
 
A13       SNP  1  1 / (a+g)  g=0.855 a=0.145  G A G A G 
 
A14       SNP  1  1 / (a+t)  a=0.564 t=0.436  A T A T T 
 
A15       SNP  0.769231  1 / 2t  t=0.65  C T T C T 
 
A16       SNP  3.14286  1 / 2t  t=0.159  G G T G T 
 
A17       SNP  1.15263  1 / a  a=0.868  A A A 
 
A18       SNP  1.66667  1 / g  g=0.6  T G T G 
 
A19       SNP  1.5  1 / t  t=0.667  T T T 
 
A20       SNP  1  1 / (g+t)  g=0.464 t=0.536  G T G T G T 
 
A21       SNP  1.71875  1 / a  a=0.582  G A A A 
 
A22       SNP  1  1 / (a+g)  g=0.723 a=0.277  G A G A G 
 
A23       SNP  1.25714  1 / g  g=0.795  G A G G 
 
A24       SNP  0.873016  1 / 2t  t=0.573  C T T C T 
 
A25       SNP  1  1 / (a+g)  g=0.164 a=0.836  G A G A A 
 
A26       SNP  1.20879  1 / 2g  g=0.414  T G T G T 
 
A27       SNP  1  1 / (a+g)  g=0.395 a=0.605  G A G A A 
 
A28       SNP  1.19672  1 / g  g=0.836  G G G 
 
A29       SNP  1.10606  1 / g  g=0.904  G G G 
 
A30       SNP  0.92437  1 / 2a  a=0.541  A A A C 
 
A32       SNP  1.1828  1 / 2c  c=0.423  T C T C T 
 
A33       SNP  0.700637  1 / 2t  t=0.714  C C T C T 
 
A34       SNP  1.84874  1 / g  g=0.541  G C G G 
 
A36       SNP  1  1 / (a+t)  a=0.255 t=0.745  A T A T A T 
 
A37       SNP  1  1 / (c+t)  c=0.327 t=0.673  C T C T C T 
 
A38       SNP  0.940171  1 / 2g  g=0.532  G C G G C 
 
A39       SNP  1  1 / (a+t)  a=0.409 t=0.591  A T A T A T 
 
A40       SNP  1  1 / (a+g)  g=0.673 a=0.327  G A G A G A 
 
A41       SNP  1  1 / (c+t)  c=0.832 t=0.168  C T C T C 
 
A42       SNP  2.5  1 / a  a=0.4  G A A A 
 
A43       SNP  1.15263  1 / a  a=0.868  A A A 
 
A44       SNP  1.4129  1 / c  c=0.708  C C C 
 
A45       SNP  1.74603  1 / 2t  t=0.286  C C T C T 
 
A46       SNP  1  1 / (a+g)  g=0.782 a=0.218  G A G A G 
 
A48       SNP  1.5  1 / t  t=0.667  T T T 
 
A49       SNP  5  1 / a  a=0.2  G G A A 
 
A50       SNP  1.73228  1 / g  g=0.577  A G A G 
 
A51       SNP  1  1 / (a+g)  g=0.527 a=0.473  G A G A G A 
 
A52       SNP  1.74603  1 / 2t  t=0.286  T T A T 
 
A54       SNP  0.948276  1 / 2a  a=0.527  A A G A 
 
 A35      SNP  1.98198  1 / g  g=0.505  G A G G 
 
 A53      SNP  2.2449  1 / g  g=0.445  A G A G 
 
cumulative LR  9.45636e6 
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Appendix F 
 
Case  5 Scenario 5 
    
 
M       Mother 1000-0108  
   
 
C        Child 1000-0109   
   
 
F   Tested Man 1000-0110   
   C: M + F 
       /C: M+ ? 
       
 
────── 
      
 
Malay cumulative LR 14.1494e6 Posterior probability= 99.999993% assuming prior= 50% 
 
────── 
        ► Malay 
   
M C F 
 
A01       SNP 1.74603  1 / t t=0.573  C C T T 
 
A02       SNP  1.54225  1 / c  c=0.648  C C C 
 
A03       SNP  0.597826  1 / 2t  t=0.836  T T A T 
 
A04       SNP  1  1 / (a+t)  a=0.564 t=0.436  A T A T A 
 
A05       SNP  3.72881  1 / g  g=0.268  A G A G 
 
A06       SNP  1.51034  1 / t  t=0.662  T T T 
 
A07       SNP  1  1 / (a+g)  g=0.773 a=0.227  G A G A G 
 
A08       SNP  1.15789  1 / 2c  c=0.432  T C T C T 
 
A09       SNP  1  1 / (c+g)  g=0.427 c=0.573  G C G C C 
 
A10       SNP  1.22222  1 / t  t=0.818  C C T T 
 
A11       SNP  1  1 / (c+t)  c=0.259 t=0.741  C T C T C T 
 
A12       SNP  1.4129  1 / a  a=0.708  A A A 
 
A13       SNP  6.875  1 / a  a=0.145  G A A A 
 
A14       SNP  1.14583  1 / 2t  t=0.436  T T A T 
 
A15       SNP  1.53846  1 / t  t=0.65  C T T T 
 
A16       SNP  3.14286  1 / 2t  t=0.159  G G T G T 
 
A17       SNP  1.15263  1 / a  a=0.868  A A A 
 
A18       SNP  2.5  1 / t  t=0.4  G G T T 
 
A19       SNP  1.48649  1 / 2c  c=0.336  C C C T 
 
A20       SNP  1.07843  1 / 2g  g=0.464  G T G G T 
 
A21       SNP  1.71094  1 / a  a=0.584  A A A 
 
A22       SNP  3.60656  1 / a  a=0.277  G G A A 
 
A23       SNP  1.25143  1 / g  g=0.799  G G G 
 
A24       SNP  1  1 / (c+t)  c=0.427 t=0.573  C T C T C T 
 
A25       SNP  0.597826  1 / 2a  a=0.836  A A G A 
 
A26       SNP  1  1 / (g+t)  g=0.414 t=0.586  G T G T G T 
 
A27       SNP  1  1 / (a+g)  g=0.395 a=0.605  G A G A A 
 
A28       SNP  1.19672  1 / g  g=0.836  G G G 
 
A29       SNP  10  1 / a  a=0.1  G G A A 
 
A30       SNP  1.08911  1 / 2c  c=0.459  C C A C 
 
A32       SNP  1  1 / (c+t)  c=0.423 t=0.577  C T C T C T 
 
A33       SNP  1.74603  1 / 2c  c=0.286  C C C T 
 
A34       SNP  1.08911  1 / 2c  c=0.459  C C G C 
 
A36       SNP  1.96429  1 / 2a  a=0.255  A T A A T 
 
A37       SNP  3.05556  1 / c  c=0.327  C T C C 
 
A38       SNP  2.13592  1 / c  c=0.468  G C C C 
 
A39       SNP  1  1 / (a+t)  a=0.409 t=0.591  A T A T A T 
 
A40       SNP  3.05556  1 / a  a=0.327  G G A A 
 
A41       SNP  0.601093  1 / 2c  c=0.832  C C C T 
 
A42       SNP  1.25  1 / 2a  a=0.4  A A G A 
 
A43       SNP  0.578947  1 / 2a  a=0.864  A A G A 
 
A44       SNP  1  1 / (c+t)  c=0.705 t=0.295  C T C T C T 
 
A45       SNP  1.3949  1 / c  c=0.717  C C C 
 
A46       SNP  1  1 / (a+g)  g=0.782 a=0.218  G A G A G 
 
A48       SNP  1  1 / (c+t)  c=0.336 t=0.664  C T C T C 
 
A49       SNP  0.625  1 / 2g  g=0.8  G G G A 
 
A50       SNP  0.866142  1 / 2g  g=0.577  G G G A 
 
A51       SNP  0.948276  1 / 2g  g=0.527  G G G A 
 
A52       SNP  1.74603  1 / 2t  t=0.286  T T A T 
 
A54       SNP  1  1 / (a+g)  g=0.473 a=0.527  G A G A A 
 
 A35      SNP  1.00917  1 / 2a  a=0.495  A A G A 
 
 A53      SNP  1.80328  1 / a  a=0.555  G G A A 
 
cumulative LR  14.1494e6 
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Appendix F 
 
Case  6 Scenario 6 
    
 
M       Mother 1000-0111  
   
 
C        Child 1000-0112   
   
 
F   Tested Man 1000-0113   
   C: M +F 
       /C: M+? 
       
 
────── 
      
 
Malay cumulative LR 328.849e6 Posterior probability= 
99.9999997
% assuming prior= 50% 
 
────── 
        ► Malay 
   
M C F 
 
A01       SNP 1.17021  1 / 2c c=0.427  T C T C T 
 
A02       SNP  1.5493  1 / c  c=0.645  C T C C 
 
A03       SNP  3.05556  1 / 2a  a=0.164  T A T A T 
 
A04       SNP  1.14583  1 / 2t  t=0.436  T T A T 
 
A05       SNP  1.36025  1 / a  a=0.735  A A A 
 
A06       SNP  1.51034  1 / t  t=0.662  T T T 
 
A07       SNP  0.647059  1 / 2g  g=0.773  G G G A 
 
A08       SNP  2.31579  1 / c  c=0.432  T C T C 
 
A09       SNP  2.34043  1 / g  g=0.427  C G C G 
 
A10       SNP  1.21667  1 / t  t=0.822  T T T 
 
A11       SNP  1.92982  1 / 2c  c=0.259  T C T C T 
 
A12       SNP  3.38462  1 / g  g=0.295  A G A G 
 
A13       SNP  1.16489  1 / g  g=0.858  G G G 
 
A14       SNP  1.77419  1 / a  a=0.564  T A T A 
 
A15       SNP  1.53846  1 / t  t=0.65  C C T T 
 
A16       SNP  1.18378  1 / g  g=0.845  G G G 
 
A17       SNP  1.15263  1 / a  a=0.868  A A A 
 
A18       SNP  1.66667  1 / g  g=0.6  T G T G 
 
A19       SNP  1.50685  1 / t  t=0.664  C T T T 
 
A20       SNP  1  1 / (g+t)  g=0.464 t=0.536  G T G T G 
 
A21       SNP  1  1 / (a+g)  g=0.418 a=0.582  G A G A A 
 
A22       SNP  1.37736  1 / g  g=0.726  G G G 
 
A23       SNP  4.88889  1 / a  a=0.205  G A A A 
 
A24       SNP  1.7381  1 / t  t=0.575  T T T 
 
A25       SNP  1.19022  1 / a  a=0.84  A A A 
 
A26       SNP  1  1 / (g+t)  g=0.414 t=0.586  G T G T G T 
 
A27       SNP  1.65414  1 / a  a=0.605  G A A A 
 
A28       SNP  1.19672  1 / g  g=0.836  G G G 
 
A29       SNP  1.11111  1 / g  g=0.9  G A G G 
 
A30       SNP  2.16832  1 / c  c=0.461  C C C 
 
A32       SNP  1  1 / (c+t)  c=0.423 t=0.577  C T C T T 
 
A33       SNP  1.40127  1 / t  t=0.714  C T T T 
 
A34       SNP  1.08911  1 / 2c  c=0.459  G C C G C 
 
A36       SNP  1.34146  1 / t  t=0.745  A T T T 
 
A37       SNP  1.47973  1 / t  t=0.676  T T T 
 
A38       SNP  1.06796  1 / 2c  c=0.468  G G C G C 
 
A39       SNP  1.68462  1 / t  t=0.594  T T T 
 
A40       SNP  1.52778  1 / 2a  a=0.327  G A A G A 
 
A41       SNP  1.19672  1 / c  c=0.836  C C C 
 
A42       SNP  1  1 / (a+g)  g=0.6 a=0.4  G A G A G A 
 
A43       SNP  3.66667  1 / 2g  g=0.136  A G A G A 
 
A44       SNP  1.4129  1 / c  c=0.708  C C C 
 
A45       SNP  1.74603  1 / 2t  t=0.286  C C T C T 
 
A46       SNP  1  1 / (a+g)  g=0.782 a=0.218  G A G A G A 
 
A48       SNP  1.5  1 / t  t=0.667  T T T 
 
A49       SNP  1.24432  1 / g  g=0.804  G G G 
 
A50       SNP  1.1828  1 / 2a  a=0.423  G G A G A 
 
A51       SNP  2.11538  1 / a  a=0.473  G A A A 
 
A52       SNP  0.700637  1 / 2a  a=0.714  A A A T 
 
A54       SNP  1.88793  1 / a  a=0.53  A A A 
 
 A35      SNP  1  1 / (a+g)  g=0.505 a=0.495  G A G A A 
 
 A53      SNP  2.2449  1 / g  g=0.445  A G A G 
 
cumulative LR  328.849e6 
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Appendix F 
 
Case  7 Scenario 7 
    
 
M       Mother 1000-0114  
   
 
C        Child 1000-0115   
   C: M+? 
       /C:?+ ? 
       
 
────── 
      
 
Malay cumulative LR 5.1389e6 Posterior probability= 
99.99998
% assuming prior= 50% 
 
────── 
        ► Malay 
   
M C 
 
 
A01       SNP 0.873016  1 / 2t t=0.573  C T T 
 
 
A02       SNP  1.09245  (c+t) / 4ct  c=0.645 t=0.355  C T C T 
 
 
A03       SNP  6.08333  1 / a  a=0.164  A A 
 
 
A04       SNP  0.887097  1 / 2a  a=0.564  A A T 
 
 
A05       SNP  0.68323  1 / 2a  a=0.732  G A A 
 
 
A06       SNP  0.758621  1 / 2t  t=0.659  A T T 
 
 
A07       SNP  1.28824  1 / g  g=0.776  G G 
 
 
A08       SNP  1.752  1 / t  t=0.571  T T 
 
 
A09       SNP  1.02161  (c+g) / 4cg  g=0.427 c=0.573  G C G C 
 
 
A10       SNP  0.611111  1 / 2t  t=0.818  C T T 
 
 
A11       SNP  1.92982  1 / 2c  c=0.259  C T C 
 
 
A12       SNP  1.20099  (a+g) / 4ag  g=0.295 a=0.705  G A G A 
 
 
A13       SNP  1.16489  1 / g  g=0.858  G G 
 
 
A14       SNP  0.887097  1 / 2a  a=0.564  A T A 
 
 
A15       SNP  1.53147  1 / t  t=0.653  T T 
 
 
A16       SNP  3.14286  1 / 2t  t=0.159  T G T 
 
 
A17       SNP  1.15263  1 / a  a=0.868  A A 
 
 
A18       SNP  1.65909  1 / g  g=0.603  G G 
 
 
A19       SNP  1.11996  (c+t) / 4ct  c=0.336 t=0.664  C T C T 
 
 
A20       SNP  1.07843  1 / 2g  g=0.464  G G T 
 
 
A21       SNP  0.859375  1 / 2a  a=0.582  G A A 
 
 
A22       SNP  1.37736  1 / g  g=0.726  G G 
 
 
A23       SNP  2.44444  1 / 2a  a=0.205  G A A 
 
 
A24       SNP  0.873016  1 / 2t  t=0.573  T C T 
 
 
A25       SNP  1.82669  (a+g) / 4ag  g=0.164 a=0.836  G A G A 
 
 
A26       SNP  1.03075  (g+t) / 4gt  g=0.414 t=0.586  G T G T 
 
 
A27       SNP  1.64662  1 / a  a=0.607  A A 
 
 
A28       SNP  1.19672  1 / g  g=0.836  G G 
 
 
A29       SNP  5  1 / 2a  a=0.1  G A A 
 
 
A30       SNP  1.84034  1 / a  a=0.543  A A 
 
 
A32       SNP  1.1828  1 / 2c  c=0.423  C T C 
 
 
A33       SNP  1.3949  1 / t  t=0.717  T T 
 
 
A34       SNP  1.00674  (c+g) / 4cg  g=0.541 c=0.459  G C G C 
 
 
A36       SNP  0.670732  1 / 2t  t=0.745  T A T 
 
 
A37       SNP  1.13551  (c+t) / 4ct  c=0.327 t=0.673  C T C T 
 
 
A38       SNP  1.87179  1 / g  g=0.534  G G 
 
 
A39       SNP  1.03419  (a+t) / 4at  a=0.409 t=0.591  A T A T 
 
 
A40       SNP  1.47973  1 / g  g=0.676  G G 
 
 
A41       SNP  2.97297  1 / 2t  t=0.168  T C T 
 
 
A42       SNP  0.833333  1 / 2g  g=0.6  G G A 
 
 
A43       SNP  0.578947  1 / 2a  a=0.864  G A A 
 
 
A44       SNP  1.20099  (c+t) / 4ct  c=0.705 t=0.295  C T C T 
 
 
A45       SNP  1.3949  1 / c  c=0.717  C C 
 
 
A46       SNP  2.29167  1 / 2a  a=0.218  G A A 
 
 
A48       SNP  2.95946  1 / c  c=0.338  C C 
 
 
A49       SNP  1.24432  1 / g  g=0.804  G G 
 
 
A50       SNP  1.72441  1 / g  g=0.58  G G 
 
 
A51       SNP  1.88793  1 / g  g=0.53  G G 
 
 
A52       SNP  1.3949  1 / a  a=0.717  A A 
 
 
A54       SNP  1.00298  (a+g) / 4ag  g=0.473 a=0.527  G A G A 
 
 
 A35      SNP  0.990991  1 / 2g  g=0.505  G A G 
 
 
 A53      SNP  1.79508  1 / a  a=0.557  A A 
 
 
cumulative LR  5.1389e6 
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Appendix F 
 
Case  8C Scenario Control1 
      
 
M       Mother 1000-0116  
     
 
C     Child #1 1000-0117   
     
 
D     Child #2 1000-0118   
     
 
E     Child #3 1000-0119   
     
 
F   Tested Man 1000-0120   
     C : M +F 
         /C: M+? 
         
 
Malay 
cumulative 
LR 3.96072e6 
Posterior 
probability= 99.99997% 
assuming 
prior= 50% 
  
 
────── 
          ► Malay 
   
M C D E F 
 
A01       SNP 2.32979  1 / c c=0.429  C C C C C 
 
A02       SNP  1.5493  1 / c  c=0.645  C T C C T C C 
 
A03       SNP  6.11111  1 / a  a=0.164  T A T A T A T A 
 
A04       SNP  1.14583  1 / 2t  t=0.436  T T T A T A T 
 
A05       SNP  0.68323  1 / 2a  a=0.732  G A A G G A G A 
 
A06       SNP  1.51724  1 / t  t=0.659  A T T A T T T 
 
A07       SNP  1  1 / (a+g)  g=0.773 a=0.227  G A G A G A G A G A 
 
A08       SNP  2.31579  1 / c  c=0.432  T C T C T C T C 
 
A09       SNP  2.32979  1 / g  g=0.429  G G G G G 
 
A10       SNP  1.22222  1 / t  t=0.818  C T T T T T 
 
A11       SNP  1  1 / (c+t)  c=0.259 t=0.741  C T C T C T C C 
 
A12       SNP  1.4129  1 / a  a=0.708  A A A A A 
 
A13       SNP  1.16489  1 / g  g=0.858  G G G G G 
 
A14       SNP  1  1 / (a+t)  a=0.564 t=0.436  A T A T T T A T 
 
A15       SNP  1.53147  1 / t  t=0.653  T T T T T 
 
A16       SNP  1.18378  1 / g  g=0.845  G G G G G 
 
A17       SNP  1  1 / (a+g)  g=0.136 a=0.864  G A G A G A G A 
 
A18       SNP  1  1 / (g+t)  g=0.6 t=0.4  G T G T G G T G 
 
A19       SNP  1.5  1 / t  t=0.667  T T T T T 
 
A20       SNP  1.85593  1 / t  t=0.539  T T T T T 
 
A21       SNP  1.19565  1 / 2g  g=0.418  G G G G A G A 
 
A22       SNP  0.691824  1 / 2g  g=0.723  G G G A G G A 
 
A23       SNP  1.25714  1 / g  g=0.795  G A G G G G 
 
A24       SNP  1.17021  1 / 2c  c=0.427  C T C C T C T 
 
A25       SNP  3.05556  1 / 2g  g=0.164  A G A G A G A G A 
 
A26       SNP  0.852713  1 / 2t  t=0.586  T T T T G T 
 
A27       SNP  1.26437  1 / 2g  g=0.395  A G A G A G A G A 
 
A28       SNP  1.19672  1 / g  g=0.836  G G G G G 
 
A29       SNP  1.10606  1 / g  g=0.904  G G G G G 
 
A30       SNP  1.84034  1 / a  a=0.543  A A A A A 
 
A32       SNP  1  1 / (c+t)  c=0.423 t=0.577  C T C T C T C T C T 
 
A33       SNP  3.49206  1 / c  c=0.286  C T C C T C C 
 
A34       SNP  0.92437  1 / 2g  g=0.541  G G G G G C 
 
A36       SNP  1.96429  1 / 2a  a=0.255  A T A A T A T A T 
 
A37       SNP  1.48649  1 / t  t=0.673  C T T T C T T 
 
A38       SNP  0.940171  1 / 2g  g=0.532  C G C C G G C 
 
A39       SNP  1.22222  1 / 2a  a=0.409  A A A A T A T 
 
A40       SNP  0.743243  1 / 2g  g=0.673  G A G G A G A G A 
 
A41       SNP  0.601093  1 / 2c  c=0.832  C C C T C T C T 
 
A42       SNP  2.5  1 / a  a=0.4  G A A A G A A 
 
A43       SNP  0.578947  1 / 2a  a=0.864  A A G A A G A 
 
A44       SNP  1  1 / (c+t)  c=0.705 t=0.295  C T C T C T C C 
 
A45       SNP  1.74603  1 / 2t  t=0.286  T T C T T C T 
 
A46       SNP  1.27326  1 / g  g=0.785  G G G G G 
 
A48       SNP  1.50685  1 / t  t=0.664  C C T C T C T T 
 
A49       SNP  1  1 / (a+g)  g=0.8 a=0.2  G A G A A G A G A 
 
A50       SNP  1.1828  1 / 2a  a=0.423  G G A G A G A G A 
 
A51       SNP  2.11538  1 / a  a=0.473  G G A G A G A A 
 
A52       SNP  1.3949  1 / a  a=0.717  A A A A A 
 
A54       SNP  1.89655  1 / a  a=0.527  G G A G A G A A 
 
 A35      SNP  1.00917  1 / 2a  a=0.495  A A A A G A 
 
 A53      SNP  1.80328  1 / a  a=0.555  G A A G A G A A 
 
cumulative 
LR  3.96072e6 
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Appendix F 
 
Case  8D Scenario Control1 
      
 
M       Mother 1000-0116  
     
 
C     Child #1 1000-0117   
     
 
D     Child #2 1000-0118   
     
 
E     Child #3 1000-0119   
     
 
F   Tested Man 1000-0120   
     D:M + F 
         /D:M+ ? 
         
 
Malay cumulative LR 325.836e6 Posterior probability= 99.9999997% 
assuming 
prior= 50% 
  
 
────── 
          ► Malay 
   
M C D E F 
 
A01       SNP 2.32979  1 / c c=0.429  C C C C C 
 
A02       SNP  1  1 / (c+t)  c=0.645 t=0.355  C T C C T C C 
 
A03       SNP  6.11111  1 / a  a=0.164  T A T A T A T A 
 
A04       SNP  1.14583  1 / 2t  t=0.436  T T T A T A T 
 
A05       SNP  1.86441  1 / 2g  g=0.268  G A A G G A G A 
 
A06       SNP  1  1 / (a+t)  a=0.341 t=0.659  A T T A T T T 
 
A07       SNP  1  1 / (a+g)  g=0.773 a=0.227  G A G A G A G A G A 
 
A08       SNP  2.31579  1 / c  c=0.432  T C T C T C T C 
 
A09       SNP  2.32979  1 / g  g=0.429  G G G G G 
 
A10       SNP  1.22222  1 / t  t=0.818  C T T T T T 
 
A11       SNP  1  1 / (c+t)  c=0.259 t=0.741  C T C T C T C C 
 
A12       SNP  1.4129  1 / a  a=0.708  A A A A A 
 
A13       SNP  1.16489  1 / g  g=0.858  G G G G G 
 
A14       SNP  1.14583  1 / 2t  t=0.436  A T A T T T A T 
 
A15       SNP  1.53147  1 / t  t=0.653  T T T T T 
 
A16       SNP  1.18378  1 / g  g=0.845  G G G G G 
 
A17       SNP  3.66667  1 / 2g  g=0.136  G A G A G A G A 
 
A18       SNP  1.66667  1 / g  g=0.6  G T G T G G T G 
 
A19       SNP  1.5  1 / t  t=0.667  T T T T T 
 
A20       SNP  1.85593  1 / t  t=0.539  T T T T T 
 
A21       SNP  1.19565  1 / 2g  g=0.418  G G G G A G A 
 
A22       SNP  1.80328  1 / 2a  a=0.277  G G G A G G A 
 
A23       SNP  1.25714  1 / g  g=0.795  G A G G G G 
 
A24       SNP  1.17021  1 / 2c  c=0.427  C T C C T C T 
 
A25       SNP  3.05556  1 / 2g  g=0.164  A G A G A G A G A 
 
A26       SNP  0.852713  1 / 2t  t=0.586  T T T T G T 
 
A27       SNP  1.26437  1 / 2g  g=0.395  A G A G A G A G A 
 
A28       SNP  1.19672  1 / g  g=0.836  G G G G G 
 
A29       SNP  1.10606  1 / g  g=0.904  G G G G G 
 
A30       SNP  1.84034  1 / a  a=0.543  A A A A A 
 
A32       SNP  1  1 / (c+t)  c=0.423 t=0.577  C T C T C T C T C T 
 
A33       SNP  1  1 / (c+t)  c=0.286 t=0.714  C T C C T C C 
 
A34       SNP  0.92437  1 / 2g  g=0.541  G G G G G C 
 
A36       SNP  1  1 / (a+t)  a=0.255 t=0.745  A T A A T A T A T 
 
A37       SNP  1.48649  1 / t  t=0.673  C T T T C T T 
 
A38       SNP  1.06796  1 / 2c  c=0.468  C G C C G G C 
 
A39       SNP  1.22222  1 / 2a  a=0.409  A A A A T A T 
 
A40       SNP  1  1 / (a+g)  g=0.673 a=0.327  G A G G A G A G A 
 
A41       SNP  2.97297  1 / 2t  t=0.168  C C C T C T C T 
 
A42       SNP  2.5  1 / a  a=0.4  G A A A G A A 
 
A43       SNP  3.66667  1 / 2g  g=0.136  A A G A A G A 
 
A44       SNP  1  1 / (c+t)  c=0.705 t=0.295  C T C T C T C C 
 
A45       SNP  0.700637  1 / 2c  c=0.714  T T C T T C T 
 
A46       SNP  1.27326  1 / g  g=0.785  G G G G G 
 
A48       SNP  1.50685  1 / t  t=0.664  C C T C T C T T 
 
A49       SNP  2.5  1 / 2a  a=0.2  G A G A A G A G A 
 
A50       SNP  1.1828  1 / 2a  a=0.423  G G A G A G A G A 
 
A51       SNP  2.11538  1 / a  a=0.473  G G A G A G A A 
 
A52       SNP  1.3949  1 / a  a=0.717  A A A A A 
 
A54       SNP  1.89655  1 / a  a=0.527  G G A G A G A A 
 
 A35      SNP  1.00917  1 / 2a  a=0.495  A A A A G A 
 
 A53      SNP  1  1 / (a+g)  g=0.445 a=0.555  G A A G A G A A 
 
cumulative LR  325.836e6 
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Appendix F 
 
Case  8E Scenario Control1 
      
 
M       Mother 1000-0116  
     
 
C     Child #1 1000-0117   
     
 
D     Child #2 1000-0118   
     
 
E     Child #3 1000-0119   
     
 
F   Tested Man 1000-0120   
     E: M + F 
         /E:M+ ? 
         
 
Malay cumulative LR 3.25562e6 
Posterior 
probability= 99.99997% 
assuming 
prior= 50% 
  
 
────── 
          ► Malay 
   
M C D E F 
 
A01       SNP 2.32979  1 / c c=0.429  C C C C C 
 
A02       SNP  1.5493  1 / c  c=0.645  C T C C T C C 
 
A03       SNP  6.11111  1 / a  a=0.164  T A T A T A T A 
 
A04       SNP  0.887097  1 / 2a  a=0.564  T T T A T A T 
 
A05       SNP  1  1 / (a+g)  g=0.268 a=0.732  G A A G G A G A 
 
A06       SNP  1.51724  1 / t  t=0.659  A T T A T T T 
 
A07       SNP  1  1 / (a+g)  g=0.773 a=0.227  G A G A G A G A G A 
 
A08       SNP  2.31579  1 / c  c=0.432  T C T C T C T C 
 
A09       SNP  2.32979  1 / g  g=0.429  G G G G G 
 
A10       SNP  1.22222  1 / t  t=0.818  C T T T T T 
 
A11       SNP  3.85965  1 / c  c=0.259  C T C T C T C C 
 
A12       SNP  1.4129  1 / a  a=0.708  A A A A A 
 
A13       SNP  1.16489  1 / g  g=0.858  G G G G G 
 
A14       SNP  1.14583  1 / 2t  t=0.436  A T A T T T A T 
 
A15       SNP  1.53147  1 / t  t=0.653  T T T T T 
 
A16       SNP  1.18378  1 / g  g=0.845  G G G G G 
 
A17       SNP  0.578947  1 / 2a  a=0.864  G A G A G A G A 
 
A18       SNP  1  1 / (g+t)  g=0.6 t=0.4  G T G T G G T G 
 
A19       SNP  1.5  1 / t  t=0.667  T T T T T 
 
A20       SNP  1.85593  1 / t  t=0.539  T T T T T 
 
A21       SNP  0.859375  1 / 2a  a=0.582  G G G G A G A 
 
A22       SNP  0.691824  1 / 2g  g=0.723  G G G A G G A 
 
A23       SNP  1.25714  1 / g  g=0.795  G A G G G G 
 
A24       SNP  0.873016  1 / 2t  t=0.573  C T C C T C T 
 
A25       SNP  3.05556  1 / 2g  g=0.164  A G A G A G A G A 
 
A26       SNP  0.852713  1 / 2t  t=0.586  T T T T G T 
 
A27       SNP  1.26437  1 / 2g  g=0.395  A G A G A G A G A 
 
A28       SNP  1.19672  1 / g  g=0.836  G G G G G 
 
A29       SNP  1.10606  1 / g  g=0.904  G G G G G 
 
A30       SNP  1.84034  1 / a  a=0.543  A A A A A 
 
A32       SNP  1  1 / (c+t)  c=0.423 t=0.577  C T C T C T C T C T 
 
A33       SNP  3.49206  1 / c  c=0.286  C T C C T C C 
 
A34       SNP  0.92437  1 / 2g  g=0.541  G G G G G C 
 
A36       SNP  1  1 / (a+t)  a=0.255 t=0.745  A T A A T A T A T 
 
A37       SNP  1  1 / (c+t)  c=0.327 t=0.673  C T T T C T T 
 
A38       SNP undefined 0 / 0 
 
C G C C G G C 
 
A39       SNP  0.846154  1 / 2t t=0.591  A A A A T A T 
 
A40       SNP  1  1 / (a+g)  g=0.673 a=0.327  G A G G A G A G A 
 
A41       SNP  2.97297  1 / 2t  t=0.168  C C C T C T C T 
 
A42       SNP  1  1 / (a+g)  g=0.6 a=0.4  G A A A G A A 
 
A43       SNP  0.578947  1 / 2a  a=0.864  A A G A A G A 
 
A44       SNP  1.41935  1 / c  c=0.705  C T C T C T C C 
 
A45       SNP  1.74603  1 / 2t  t=0.286  T T C T T C T 
 
A46       SNP  1.27326  1 / g  g=0.785  G G G G G 
 
A48       SNP  1.50685  1 / t  t=0.664  C C T C T C T T 
 
A49       SNP  1  1 / (a+g)  g=0.8 a=0.2  G A G A A G A G A 
 
A50       SNP  1.1828  1 / 2a  a=0.423  G G A G A G A G A 
 
A51       SNP  2.11538  1 / a  a=0.473  G G A G A G A A 
 
A52       SNP  1.3949  1 / a  a=0.717  A A A A A 
 
A54       SNP  1.89655  1 / a  a=0.527  G G A G A G A A 
 
 A35      SNP  1.00917  1 / 2a  a=0.495  A A A A G A 
 
 A53      SNP  1  1 / (a+g)  g=0.445 a=0.555  G A A G A G A A 
 
cumulative LR  3.25562e6 
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Appendix F 
 
Case  9 Scenario Control 2 C  : M + ? 
   
 
M       Mother 1000-0121 /C:  G + ? 
   
 
C        Child 1000-0122   
   
 
G       Man #2 1000-0123   
   
 
Malay LR=inf.inf..... 1.26564 Posterior probability= 100% 
assuming 
prior= 50% 
       
   ► Malay 
   
M C G 
 
A01       SNP 1  1 / 1 
 
T T T 
 
A02       SNP  0.709091  2t / (c+t) c=0.645 t=0.355  C C T C T 
 
A03       SNP  1  1 / 1 
 
A T A T A T 
 
A04       SNP  1  1 / 1 
 
T T T 
 
A05       SNP  1  1 / 1 
 
A G A A 
 
A06       SNP  0.758621  (a+t) / 2t a=0.341 t=0.659  A T A T A 
 
A07       SNP  1  1 / 1 
 
G G A G 
 
A08       SNP infinite 1 / 0 
 
T T C 
 
A09       SNP  1  1 / 1 
 
G C G C G C 
 
A10       SNP  1  1 / 1 
 
T T T 
 
A11       SNP  1  1 / 1 
 
T T T 
 
A12       SNP  1  1 / 1 
 
A A A 
 
A13       SNP  1  1 / 1 
 
G G G 
 
A14       SNP  0.887097  (a+t) / 2a a=0.564 t=0.436  A T A T T 
 
A15       SNP infinite 1 / 0 
 
C T C T 
 
A16       SNP  1  1 / 1 
 
G T T G T 
 
A17       SNP  1  1 / 1 
 
G A A G A 
 
A18       SNP  1.2  2g / (g+t) g=0.6 t=0.4  T G T G T 
 
A19       SNP  1  1 / 1 
 
T T T 
 
A20       SNP  1.07273  2t / (g+t) g=0.464 t=0.536  G G T G T 
 
A21       SNP  0.859375  (a+g) / 2a  g=0.418 a=0.582  G A G A G 
 
A22       SNP  1  1 / 1 
 
G G A G 
 
A23       SNP  1  1 / 1 
 
G G G 
 
A24       SNP  1  1 / 1 
 
C C C 
 
A25       SNP infinite 1 / 0 
 
G A A G 
 
A26       SNP  0.852713  (g+t) / 2t g=0.414 t=0.586  G T G T G 
 
A27       SNP infinite 1 / 0 
 
A A G 
 
A28       SNP  1  1 / 1 
 
G G G 
 
A29       SNP  1  1 / 1 
 
G G G 
 
A30       SNP  1  1 / 1 
 
A C A C A C 
 
A32       SNP  1.15455  2t / (c+t) c=0.423 t=0.577  C C T C T 
 
A33       SNP  1  1 / 1 
 
C T T C T 
 
A34       SNP  0.92437  (c+g) / 2g g=0.541 c=0.459  G C G C C 
 
A36       SNP  1  1 / 1 
 
T A T T 
 
A37       SNP  1  1 / 1 
 
C T T C T 
 
A38       SNP  0.5  1 / 2 
 
G C C C 
 
A39       SNP infinite 1 / 0 
 
A A T 
 
A40       SNP  1  1 / 1 
 
G A G A G A 
 
A41       SNP  1  1 / 1 
 
C C T C 
 
A42       SNP infinite 1 / 0 
 
G A A G 
 
A43       SNP  2  2 / 1 
 
A A G A 
 
A44       SNP  2  2 / 1 
 
C C C T 
 
A45       SNP  1  1 / 1 
 
C C C 
 
A46       SNP  2.29167  (a+g) / 2a g=0.782 a=0.218  G A G A G 
 
A48       SNP  1.32727  2t / (c+t)  c=0.336 t=0.664  C C T C T 
 
A49       SNP  1  1 / 1 
 
G G G 
 
A50       SNP  0.866142  (a+g) / 2g g=0.577 a=0.423  G A G A A 
 
A51       SNP infinite 1 / 0 
 
G A G A 
 
A52       SNP  1  1 / 1 
 
A A T A 
 
A54       SNP  1  1 / 1 
 
G A G G A 
 
 A35      SNP  0.5  1 / 2 
 
G A G G 
 
 A53      SNP  1  1 / 1 
 
G A G A G A 
 
LR=inf.inf.....  1.26564 
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Appendix F 
 
Case  10 Scenario 10 
    
 
C        Child 1000-00124  
   
 
F   Tested Man 1000-00125   
   C: F + ? 
       /C: ? + ? 
       
 
────── 
      
 
Malay cumulative LR 77.3155 Posterior probability= 98.7% 
assuming 
prior= 50% 
 
────── 
        ► Malay 
   
C F 
 
 
A01       SNP 1.17021  1 / 2c c=0.427  C T C 
 
 
A02       SNP  1.54225  1 / c  c=0.648  C C 
 
 
A03       SNP  1.19022  1 / t  t=0.84  T T 
 
 
A04       SNP  2.28125  1 / t  t=0.438  T T 
 
 
A05       SNP  0.68323  1 / 2a  a=0.732  A G A 
 
 
A06       SNP  1.51034  1 / t  t=0.662  T T 
 
 
A07       SNP  1.42353  (a+g) / 4ag  g=0.773 a=0.227  G A G A 
 
 
A08       SNP  1.15789  1 / 2c  c=0.432  C T C 
 
 
A09       SNP  1.7381  1 / c  c=0.575  C C 
 
 
A10       SNP  0.611111  1 / 2t  t=0.818  T C T 
 
 
A11       SNP  0.674847  1 / 2t  t=0.741  T C T 
 
 
A12       SNP  1.20099  (a+g) / 4ag  g=0.295 a=0.705  G A G A 
 
 
A13       SNP  0.585106  1 / 2g  g=0.855  G G A 
 
 
A14       SNP  1.01647  (a+t) / 4at  a=0.564 t=0.436  A T A T 
 
 
A15       SNP  1.0989  (c+t) / 4ct  c=0.35 t=0.65  C T C T 
 
 
A16       SNP  0.594595  1 / 2g  g=0.841  G G T 
 
 
A17       SNP  1.15263  1 / a  a=0.868  A A 
 
 
A18       SNP  1.25  1 / 2t  t=0.4  T G T 
 
 
A19       SNP  1.5  1 / t  t=0.667  T T 
 
 
A20       SNP  1.00532  (g+t) / 4gt  g=0.464 t=0.536  G T G T 
 
 
A21       SNP  1.19565  1 / 2g  g=0.418  G A G 
 
 
A22       SNP  0.691824  1 / 2g  g=0.723  G A G 
 
 
A23       SNP  1.25143  1 / g  g=0.799  G G 
 
 
A24       SNP  1.02161  (c+t) / 4ct  c=0.427 t=0.573  C T C T 
 
 
A25       SNP  1.19022  1 / a  a=0.84  A A 
 
 
A26       SNP  1.03075  (g+t) / 4gt  g=0.414 t=0.586  G T G T 
 
 
A27       SNP  1.04572  (a+g) / 4ag  g=0.395 a=0.605  G A G A 
 
 
A28       SNP  1.78703  (a+g) / 4ag  g=0.832 a=0.168  G A G A 
 
 
A29       SNP  1.10606  1 / g  g=0.904  G G 
 
 
A30       SNP  1.08911  1 / 2c  c=0.459  C A C 
 
 
A32       SNP  1.02447  (c+t) / 4ct  c=0.423 t=0.577  C T C T 
 
 
A33       SNP  1.22333  (c+t) / 4ct  c=0.286 t=0.714  C T C T 
 
 
A34       SNP  1.08911  1 / 2c  c=0.459  C G C 
 
 
A36       SNP  1.31751  (a+t) / 4at  a=0.255 t=0.745  A T A T 
 
 
A37       SNP  0.743243  1 / 2t  t=0.673  C T T 
 
 
A38       SNP  0.940171  1 / 2g  g=0.532  G C G 
 
 
A39       SNP  1.03419  (a+t) / 4at  a=0.409 t=0.591  A T A T 
 
 
A40       SNP  1.13551  (a+g) / 4ag  g=0.673 a=0.327  G A G A 
 
 
A41       SNP  1.19672  1 / c  c=0.836  C C 
 
 
A42       SNP  1.04167  (a+g) / 4ag  g=0.6 a=0.4  G A G A 
 
 
A43       SNP  0.578947  1 / 2a  a=0.864  A G A 
 
 
A44       SNP  1.4129  1 / c  c=0.708  C C 
 
 
A45       SNP  1.3949  1 / c  c=0.717  C C 
 
 
A46       SNP  0.639535  1 / 2g  g=0.782  G G A 
 
 
A48       SNP  1.11996  (c+t) / 4ct  c=0.336 t=0.664  C T C T 
 
 
A49       SNP  1.24432  1 / g  g=0.804  G G 
 
 
A50       SNP  2.35484  1 / a  a=0.425  A A 
 
 
A51       SNP  0.948276  1 / 2g  g=0.527  G A G 
 
 
A52       SNP  1.22333  (a+t) / 4at  a=0.714 t=0.286  A T A T 
 
 
A54       SNP  0.948276  1 / 2a  a=0.527  G A A 
 
 
 A35      SNP  1.00008  (a+g) / 4ag  g=0.505 a=0.495  G A G A 
 
 
 A53      SNP  0.901639  1 / 2a  a=0.555  G A A 
 
 
cumulative LR  77.3155 
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Appendix F 
 
Case  11 Scenario 11 
    
 
M       Mother 1000-0126  
   
 
C        Child 1000-0127   
   C: M + ? 
       /C: ? + ? 
       
 
────── 
      
 
Malay cumulative LR 409.145 Posterior probability= 99.8% assuming prior= 50% 
 
────── 
        ► Malay 
   
M C 
 
 
A01       SNP 1.7381  1 / t t=0.575  T T 
 
 
A02       SNP  1.54225  1 / c  c=0.648  C C 
 
 
A03       SNP  1.19022  1 / t  t=0.84  T T 
 
 
A04       SNP  1.14583  1 / 2t  t=0.436  A T T 
 
 
A05       SNP  1.36025  1 / a  a=0.735  A A 
 
 
A06       SNP  0.758621  1 / 2t  t=0.659  A T T 
 
 
A07       SNP  1.28824  1 / g  g=0.776  G G 
 
 
A08       SNP  1.15789  1 / 2c  c=0.432  C C T 
 
 
A09       SNP  0.873016  1 / 2c  c=0.573  G C C 
 
 
A10       SNP  1.21667  1 / t  t=0.822  T T 
 
 
A11       SNP  0.674847  1 / 2t  t=0.741  T C T 
 
 
A12       SNP  1.69231  1 / 2g  g=0.295  G A G 
 
 
A13       SNP  1.16489  1 / g  g=0.858  G G 
 
 
A14       SNP  0.887097  1 / 2a  a=0.564  A A T 
 
 
A15       SNP  0.769231  1 / 2t  t=0.65  C T T 
 
 
A16       SNP  1.18378  1 / g  g=0.845  G G 
 
 
A17       SNP  0.578947  1 / 2a  a=0.864  A G A 
 
 
A18       SNP  1.25  1 / 2t  t=0.4  T G T 
 
 
A19       SNP  1.11996  (c+t) / 4ct  c=0.336 t=0.664  C T C T 
 
 
A20       SNP  1.07843  1 / 2g  g=0.464  G G T 
 
 
A21       SNP  0.859375  1 / 2a  a=0.582  G A A 
 
 
A22       SNP  0.691824  1 / 2g  g=0.723  G A G 
 
 
A23       SNP  0.628571  1 / 2g  g=0.795  G G A 
 
 
A24       SNP  1.17021  1 / 2c  c=0.427  C C T 
 
 
A25       SNP  1.19022  1 / a  a=0.84  A A 
 
 
A26       SNP  1.03075  (g+t) / 4gt  g=0.414 t=0.586  G T G T 
 
 
A27       SNP  1.26437  1 / 2g  g=0.395  G A G 
 
 
A28       SNP  1.19672  1 / g  g=0.836  G G 
 
 
A29       SNP  0.555556  1 / 2g  g=0.9  G G A 
 
 
A30       SNP  1.08911  1 / 2c  c=0.459  A C C 
 
 
A32       SNP  1.72441  1 / t  t=0.58  T T 
 
 
A33       SNP  1.3949  1 / t  t=0.717  T T 
 
 
A34       SNP  0.92437  1 / 2g  g=0.541  G G C 
 
 
A36       SNP  1.31751  (a+t) / 4at  a=0.255 t=0.745  A T A T 
 
 
A37       SNP  0.743243  1 / 2t  t=0.673  C T T 
 
 
A38       SNP  0.940171  1 / 2g  g=0.532  G C G 
 
 
A39       SNP  1.03419  (a+t) / 4at  a=0.409 t=0.591  A T A T 
 
 
A40       SNP  1.52778  1 / 2a  a=0.327  A G A 
 
 
A41       SNP  1.19672  1 / c  c=0.836  C C 
 
 
A42       SNP  1.25  1 / 2a  a=0.4  G A A 
 
 
A43       SNP  2.12281  (a+g) / 4ag  g=0.136 a=0.864  G A G A 
 
 
A44       SNP  1.4129  1 / c  c=0.708  C C 
 
 
A45       SNP  1.3949  1 / c  c=0.717  C C 
 
 
A46       SNP  1.27326  1 / g  g=0.785  G G 
 
 
A48       SNP  0.753425  1 / 2t  t=0.664  C T T 
 
 
A49       SNP  1.24432  1 / g  g=0.804  G G 
 
 
A50       SNP  1.72441  1 / g  g=0.58  G G 
 
 
A51       SNP  0.948276  1 / 2g  g=0.527  G A G 
 
 
A52       SNP  1.74603  1 / 2t  t=0.286  A T T 
 
 
A54       SNP  1.05769  1 / 2g  g=0.473  G G A 
 
 
 A35      SNP  2.00917  1 / a  a=0.498  A A 
 
 
 A53      SNP  1.01204  (a+g) / 4ag  g=0.445 a=0.555  G A G A 
 
 
cumulative LR  409.145 
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Appendix F 
 
Case  12 Scenario 12 
    
 
M       Mother 1000-0220  
   
 
C        Child 1000-0221   
   
 
F   Tested Man 1000-0222   
   C: M + F 
       /C:M+ ? 
       
 
────── 
      
 
Malay cumulative LR 17.426e6 Posterior probability= 
99.999994
% assuming prior= 
50
% 
 
────── 
        ► Malay 
   
M C F 
 
A01       SNP 0.873016  1 / 2t t=0.573  T T C T 
 
A02       SNP  1  1 / (c+t)  c=0.645 t=0.355  C T C T T 
 
A03       SNP  1.19022  1 / t  t=0.84  T T T 
 
A04       SNP  2.29167  1 / t  t=0.436  A A T T 
 
A05       SNP  1.36025  1 / a  a=0.735  A A A 
 
A06       SNP  1.51724  1 / t  t=0.659  A A T T 
 
A07       SNP  1.28824  1 / g  g=0.776  G G G 
 
A08       SNP  1  1 / (c+t)  c=0.432 t=0.568  C T C T T 
 
A09       SNP  0.873016  1 / 2c  c=0.573  C C G C 
 
A10       SNP  2.75  1 / 2c  c=0.182  T C T C T 
 
A11       SNP  1.34356  1 / t  t=0.744  T T T 
 
A12       SNP  0.709677  1 / 2a  a=0.705  G A A G A 
 
A13       SNP  1.17021  1 / g  g=0.855  G A G G 
 
A14       SNP  1.77419  1 / a  a=0.564  A T A A 
 
A15       SNP  1.53147  1 / t  t=0.653  T T T 
 
A16       SNP  1.18378  1 / g  g=0.845  G G G 
 
A17       SNP  1.15263  1 / a  a=0.868  A A A 
 
A18       SNP  1.25  1 / 2t  t=0.4  T T G T 
 
A19       SNP  1.48649  1 / 2c  c=0.336  C T C C T 
 
A20       SNP  1.07843  1 / 2g  g=0.464  G G G T 
 
A21       SNP  2.3913  1 / g  g=0.418  A G A G 
 
A22       SNP  3.60656  1 / a  a=0.277  G G A A 
 
A23       SNP  2.44444  1 / 2a  a=0.205  G G A G A 
 
A24       SNP  2.34043  1 / c  c=0.427  T C T C 
 
A25       SNP  1.19022  1 / a  a=0.84  A A A 
 
A26       SNP  1  1 / (g+t)  g=0.414 t=0.586  G T G T G T 
 
A27       SNP  1.26437  1 / 2g  g=0.395  G A G G A 
 
A28       SNP  1.19672  1 / g  g=0.836  G G G 
 
A29       SNP  0.555556  1 / 2g  g=0.9  G A G G A 
 
A30       SNP  1.84034  1 / a  a=0.543  A A A 
 
A32       SNP  1.72441  1 / t  t=0.58  T T T 
 
A33       SNP  1  1 / (c+t)  c=0.286 t=0.714  C T C T C T 
 
A34       SNP  1.84034  1 / g  g=0.543  G G G 
 
A36       SNP  1.96429  1 / 2a  a=0.255  T A T A T 
 
A37       SNP  1.52778  1 / 2c  c=0.327  T C T C T 
 
A38       SNP  2.12621  1 / c  c=0.47  C C C 
 
A39       SNP  1.22222  1 / 2a  a=0.409  A A A T 
 
A40       SNP  1  1 / (a+g)  g=0.673 a=0.327  G A G A G 
 
A41       SNP  1.19672  1 / c  c=0.836  C C C 
 
A42       SNP  0.833333  1 / 2g  g=0.6  A G A G A 
 
A43       SNP  3.66667  1 / 2g  g=0.136  A G A G A 
 
A44       SNP  1  1 / (c+t)  c=0.705 t=0.295  C T C T T 
 
A45       SNP  1.3949  1 / c  c=0.717  C C C 
 
A46       SNP  1.27326  1 / g  g=0.785  G G G 
 
A48       SNP  1.48649  1 / 2c  c=0.336  T C T C T 
 
A49       SNP  1.24432  1 / g  g=0.804  G G G 
 
A50       SNP  1.73228  1 / g  g=0.577  G A G G 
 
A51       SNP  0.948276  1 / 2g  g=0.527  G A G G A 
 
A52       SNP  1.40127  1 / a  a=0.714  A T A A 
 
A54       SNP  1  1 / (a+g)  g=0.473 a=0.527  G A G A G A 
 
 A35      SNP  1.98198  1 / g  g=0.505  A G A G 
 
 A53      SNP  1.12245  1 / 2g  g=0.445  G A G G A 
 
cumulative LR  17.426e6 
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Appendix G 
 
APPENDIX G: DNA.VIEW calculation of 16 STR markers (Powerplex® System) for tested  
samples.. 
 
Case  1 Scenario 1 
    
 
M       Mother 1000-00186  
   
 
C        Child 1000-00187   
   
 
F   Tested Man 1000-00188   
   C: M + F 
       /C : M + ? 
       
 
────── 
      
 
Malay cumulative LR 1.09112e6 Posterior probability= 99.99991% assuming prior= 50% 
 
────── 
         ► Malay 
   
M C F 
 
D3S1358   2.01004  1 / 2q q=0.249  16 17 17 16 17 
 
VWA        2.33333  1 / (p+q)  p=0.149 q=0.28  16 17 16 17 16 17 
 
D16S539    2.06818  1 / 2q  q=0.242  11 12 12 11 12 
 
D8S1179    2.96154  1 / 2t  t=0.169  11 15 15 12 15 
 
D21S11     2.19518  1 / 2q  q=0.228  29 31.2 29 30 30 34 
 
D18S51     1.91031  1 / 2r  r=0.262  14 16 14 15 13 15 
 
TH01       1.10486  1 / (2p+2s)  p=0.104 s=0.349  6 9 6 9 7 9 
 
FGA        4.20588  1 / 2c  c=0.119  21.2 22 22 24 23 24 
 
D7S820     3.06116  1 / s  s=0.327  8 11 11 11 
 
CSF1PO     1.52591  1 / 2q  q=0.328  11 11 10 11 
 
D13S317    1.99402  1 / 2s  s=0.251  8 11 11 8 11 
 
TPOX       1.49626  1 / (p+q)  p=0.536 q=0.132  8 9 8 9 8 
 
D5S818     4.13636  1 / q  q=0.242  10 11 11 11 
 
Penta E    16.2692  1 / s  s=0.0615  13 22 16 22 16 
 
Penta D    2.07831  1 / 2s  s=0.241  9 14 9 12 10 12 
 
cumulative LR  1.09112e6 
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Case  2 Scenario 1 
    
 
M       Mother 1000-00189   
   
 
C        Child 1000-00190   
   
C: M + ? 
       
/C : ? + ? 
       
 
────── 
      
 
Malay cumulative LR 179401 Posterior probability= 99.9994% assuming prior= 50% 
 
────── 
      
   ► Malay 
   
M C 
 
 
D3S1358    6.42137  (p+r) / 4pr  p=0.044 r=0.341  14 16 14 16 
 
 
VWA        1.15323  1 / 4s  s=0.217  17 18 15 18 
 
 
D16S539    1.84007  1 / 2p  p=0.272  11 11 12 
 
 
D8S1179    5.92308  1 / p  p=0.169  15 15 
 
 
D21S11     9.26852  1 / p  p=0.108  31 31 
 
 
D18S51     1.2703  1 / 4p  p=0.197  14 23 14 24 
 
 
TH01       2.70316  (p+q) / 4pq  p=0.126 q=0.349  8 9 8 9 
 
 
FGA        3.25  1 / 4p  p=0.0769  19 22 19 23 
 
 
D7S820     1.80036  1 / 4t  t=0.139  11 12 8 12 
 
 
CSF1PO     0.697075  1 / 4s  s=0.359  10 12 9 12 
 
 
D13S317    1.59395  1 / 4t  t=0.157  8 12 10 12 
 
 
TPOX       1.86406  1 / p  p=0.536  8 8 
 
 
D5S818     1.08804  1 / 4r  r=0.23  11 12 10 12 
 
 
Penta E    2.51786  1 / 4q  q=0.0993  10 11 11 15 
 
 
Penta D    2.10366  1 / 4q  q=0.119  9 10 10 12 
 
 
cumulative LR  179401 
       
 Appendix G 
231 
 
Case  3 Scenario 1 
    
 
M       Mother 1000-00223  
   
 
C        Child 1000-00224   
   
 
F   Tested Man 1000-00225   
   C: M + F 
       /C: M + ? 
       
 
────── 
      
 
Malay cumulative LR 86.551e6 Posterior probability= 99.999999% assuming prior= 50% 
 
────── 
         ► Malay 
   
M C F 
 
D3S1358   8.62931  1 / 2s s=0.0579  15 16 15 18 17 18 
 
VWA        3.575  1 / r  r=0.28  15 18 15 17 17 
 
D16S539    2.52778  1 / (p+r)  p=0.272 r=0.124  11 13 11 13 11 
 
D8S1179    10.1111  1 / p  p=0.0989  12 15 10 15 10 
 
D21S11     3.76316  1 / 2a  a=0.133  29 30 30 32.2 32.2 34.2 
 
D18S51     2.89306  1 / 2s  s=0.173  13 15 13 16 15 16 
 
TH01       1.72586  1 / 2p  p=0.29  8 9 7 9 7 9 
 
FGA        2.31713  1 / 2p  p=0.216  25 26 22 25 22 23 
 
D7S820     1.53058  1 / 2r  r=0.327  9 13 11 13 10 11 
 
CSF1PO     1.39415  1 / 2r  r=0.359  12 12 10 12 
 
D13S317    1.91396  1 / (p+s)  p=0.272 s=0.251  8 11 8 11 8 
 
TPOX       20.02  1 / 2r  r=0.025  8 11 10 11 10 11 
 
D5S818     1.60417  1 / 2p  p=0.312  11 10 11 10 12 
 
Penta E    2.89726  1 / 2p  p=0.173  16 18 7 16 7 13 
 
Penta D    6.63462  1 / r  r=0.151  9 9 11 11 
 
cumulative LR  86.551e6 
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Case  4 Scenario 1 
    
 
M       Mother 1000-00194  
   
 
C        Child 1000-00195   
   
 
F   Tested Man 1000-00196   
   C: M + F 
       /C: M + ? 
       
 
────── 
      
 
Malay cumulative LR 43.4064e6 Posterior probability= 99.999998% assuming prior= 50% 
 
────── 
         ► Malay 
   
M C F 
 
D3S1358   1.46774  1 / 2p p=0.341  17 16 17 16 17 
 
VWA        1.7875  1 / 2p  p=0.28  17 20 17 17 21 
 
D16S539    2.28539  1 / (p+q)  p=0.166 q=0.272  10 11 10 11 10 
 
D8S1179    10.1111  1 / p  p=0.0989  10 14 10 10 
 
D21S11     1.97047  1 / 2p  p=0.254  31 34.2 29 34.2 29 31 
 
D18S51     4.67757  1 / (2p+2x)  p=0.0939 x=0.013  13 21 13 21 13 16 
 
TH01       1.72586  1 / 2q  q=0.29  6 10 6 7 7 10 
 
FGA        2.90988  1 / 2p  p=0.172  24 25.2 21 24 21 22 
 
D7S820     1.76232  1 / (p+s)  p=0.241 s=0.327  8 11 8 11 11 
 
CSF1PO     3.4878  1 / (p+s)  p=0.219 s=0.0679  10 13 10 13 10 
 
D13S317    1.99402  1 / 2s  s=0.251  9 12 11 12 8 11 
 
TPOX       1.75614  1 / 2s  s=0.285  8 8 11 8 11 
 
D5S818     2.06818  1 / 2r  r=0.242  12 11 12 9 11 
 
Penta E    60.4286  1 / u  u=0.0165  14 16 16 19 19 
 
Penta D    5.75  1 / p  p=0.174  10 11 9 11 9 
 
cumulative LR  43.4064e6 
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Case  5 Scenario 1 
    
 
M       Mother 1000-00197  
   
 
C        Child 1000-00198   
   
 
F   Tested Man 1000-00199   
   C: M + F 
       /C: M + ? 
       
 
────── 
      
 
Malay cumulative LR 87851 Posterior probability= 99.999% assuming prior= 50% 
 
────── 
         ► Malay 
   
M C F 
 
D3S1358   11.375  1 / 2p p=0.044  15 18 14 15 14 15 
 
VWA        3.35906  1 / 2q  q=0.149  17 18 16 18 15 16 
 
D16S539    2.52778  1 / (p+r)  p=0.272 r=0.124  11 13 11 13 11 13 
 
D8S1179    4.46875  1 / 2p  p=0.112  15 16 11 15 11 15 
 
D21S11     11.6395  1 / 2a  a=0.043  29 29 33.2 31 33.2 
 
D18S51     5.32447  1 / 2p  p=0.0939  15 21 13 21 13 14 
 
TH01       1.4341  1 / 2s  s=0.349  7 9 9 6 9 
 
FGA        1.70819  1 / (2p+2s)  p=0.0769 s=0.216  19 22 19 22 20 22 
 
D7S820     1.76232  1 / (p+s)  p=0.241 s=0.327  8 11 8 11 11 
 
CSF1PO     0.0022  µ  µ=0.0022  11 11 10 12 
 
D13S317    11.1222  1 / 2r  r=0.045  12 12 13 11 13 
 
TPOX       1.86406  1 / p  p=0.536  9 8 9 8 
 
D5S818     2.06818  1 / 2r  r=0.242  9 10 9 11 11 12 
 
Penta E    2.43103  1 / 2p  p=0.206  15 16 12 15 12 13 
 
Penta D    3.31731  1 / 2q  q=0.151  10 12 10 11 11 12 
 
cumulative LR  87851 
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Case  6 Scenario 1 
    
 
M       Mother 1000-00200  
   
 
C        Child 1000-00201   
   
 
F   Tested Man 1000-00202   
   C: M + F 
       /C: M + ? 
       
 
────── 
      
 
Malay cumulative LR 11.407e9 Posterior probability= 99.99999999% assuming prior= 50% 
 
────── 
         ► Malay 
   
M C F 
 
D3S1358   2.01004  1 / 2r r=0.249  15 18 17 18 16 17 
 
VWA        3.35906  1 / 2r  r=0.149  14 17 16 17 16 17 
 
D16S539    4.03629  1 / 2r  r=0.124  11 13 13 12 13 
 
D8S1179    2.42961  1 / 2r  r=0.206  11 15 13 15 13 15 
 
D21S11     4.63426  1 / 2q  q=0.108  30 33.2 31 33.2 31 32 
 
D18S51     7.15  1 / 2t  t=0.0699  13 18 17 18 15 17 
 
TH01       3.97222  1 / 2q  q=0.126  7 8 8 7 8 
 
FGA        100.1  1 / 2p  p=0.005  22 23 18 23 18 24 
 
D7S820     4.15353  1 / p  p=0.241  8 12 8 8 
 
CSF1PO     4.57078  1 / p  p=0.219  12 10 12 10 
 
D13S317    3.98805  1 / s  s=0.251  8 13 8 11 11 
 
TPOX       3.79167  1 / 2q  q=0.132  9 9 8 9 
 
D5S818     2.17609  1 / 2q  q=0.23  11 12 12 11 12 
 
Penta E    10.0714  1 / p  p=0.0993  11 16 11 11 
 
Penta D    2.07831  1 / 2s  s=0.241  9 9 12 9 12 
 
cumulative LR  11.407e9 
     
  
 Appendix G 
235 
 
Case  7 Scenario 1 
    
 
M       Mother 1000-00203  
   
 
C        Child 1000-00204   
   C: M + ? 
       /C: ? + ? 
       
 
────── 
      
 
Malay cumulative LR 108.978 Posterior probability= 99.09% assuming prior= 50% 
 
────── 
         ► Malay 
   
M C 
 
 
D3S1358   1.68519  1 / 2p p=0.297  15 16 15 
 
 
VWA        1.67953  1 / 4p  p=0.149  16 18 16 19 
 
 
D16S539    1.43822  1 / 4p  p=0.174  9 10 9 13 
 
 
D8S1179    1.31021  1 / 4t  t=0.191  14 16 10 14 
 
 
D21S11     0.985236  1 / 4q  q=0.254  28 29 29 32.2 
 
 
D18S51     1.44653  1 / 4r  r=0.173  14 16 16 19 
 
 
TH01       0.717049  1 / 4s  s=0.349  6 9 7 9 
 
 
FGA        1.15856  1 / 4p  p=0.216  22 23 22 24 
 
 
D7S820     1.80036  1 / 4t  t=0.139  8 12 10 12 
 
 
CSF1PO     0.762957  1 / 4r  r=0.328  9 11 11 12 
 
 
D13S317    0.997012  1 / 4r  r=0.251  9 11 10 11 
 
 
TPOX       1.75614  1 / 2s  s=0.285  8 11 11 
 
 
D5S818     1.83617  (p+q) / 4pq  p=0.312 q=0.242  10 11 10 11 
 
 
Penta E    1.44863  1 / 4p  p=0.173  7 16 7 19 
 
 
Penta D    2.69781  (p+q) / 4pq  p=0.151 q=0.241  11 12 11 12 
 
 
cumulative LR  108.978 
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Case  8C Scenario 1 
      
 
M       Mother 
1000-
00205   
     
 
C     Child #1 
1000-
00206   
     
 
D     Child #2 
1000-
00207   
     
 
E     Child #3 
1000-
00208   
     
 
F   Tested Man 
1000-
00209   
     
C: M + F 
         
/C: M + ? 
         
 
────── 
        
 
Malay cumulative LR 516.24e6 
Posterior 
probability= 99.9999998% 
assuming 
prior= 50% 
  
 
────── 
        
   ► Malay 
   
M C D E F 
 
D3S1358    2.01004  1 / 2s  s=0.249  14 16 16 17 16 16 16 17 
 
VWA        10.01  1 / 2q  q=0.05  15 17 15 14 17 
14 
15 14 15 
 
D16S539    1.84007  1 / 2r  r=0.272  9 10 10 11 9 11 9 11 9 11 
 
D8S1179    2.42961  1 / 2p  p=0.206  13 13 13 
13 
16 13 15 
 
D21S11     11.6395  1 / 2a  a=0.043  30 31 31 33.2 30 33.2 
28 
31 28 33.2 
 
D18S51     2.89306  1 / 2t  t=0.173  15 19 16 19 12 15 
16 
19 12 16 
 
TH01       8.20492  1 / 2a  a=0.0609  9 9 9.3 9 9 9.3 9 9.3 
 
FGA        2.90988  1 / 2p  p=0.172  23 27 21 23 23 24 
25 
27 21 24 
 
D7S820     2.54061  1 / 2p  p=0.197  11 12 10 12 10 11 
10 
12 10 12 
 
CSF1PO     3.05183  1 / q  q=0.328  10 11 11 10 11 11 11 
 
D13S317    11.1222  1 / 2u  u=0.045  8 11 8 13 11 13 8 13 8 13 
 
TPOX       1.21776  1 / (p+s)  p=0.536 s=0.285  8 11 8 11 8 11 8 11 8 11 
 
D5S818     1.60417  1 / 2p  p=0.312  10 13 10 10 10 10 13 
 
Penta E    5.03571  1 / 2p  p=0.0993  14 19 11 19 11 19 
12 
19 11 12 
 
Penta D    8.41463  1 / q  q=0.119  9 11 9 10 9 10 
10 
11 10 
 
cumulative LR  516.24e6 
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Case  8D Scenario 1 
      
 
M       Mother 1000-00205  
     
 
C     Child #1 1000-00206   
     
 
D     Child #2 1000-00207   
     
 
E     Child #3 1000-00208   
     
 
F   Tested Man 1000-00209   
     D: M + F 
         /D: M + ? 
         
 
────── 
        
 
Malay cumulative LR 27.719e6 
Posterior 
probability= 99.999996% 
assuming 
prior= 50% 
  
 
────── 
           ► Malay 
   
M C D E F 
 
D3S1358   1.46774  1 / 2r r=0.341  14 16 16 17 16 16 16 17 
 
VWA        2.52778  1 / 2p  p=0.198  15 17 15 14 17 14 15 14 15 
 
D16S539    1.84007  1 / 2r  r=0.272  9 10 10 11 9 11 9 11 9 11 
 
D8S1179    2.42961  1 / 2p  p=0.206  13 13 13 13 16 13 15 
 
D21S11     11.6395  1 / 2a  a=0.043  30 31 31 33.2 30 33.2 28 31 28 33.2 
 
D18S51     5.56111  1 / 2p  p=0.0899  15 19 16 19 12 15 16 19 12 16 
 
TH01       1.4341  1 / 2p  p=0.349  9 9 9.3 9 9 9.3 9 9.3 
 
FGA        4.20588  1 / 2s  s=0.119  23 27 21 23 23 24 25 27 21 24 
 
D7S820     2.54061  1 / 2p  p=0.197  11 12 10 12 10 11 10 12 10 12 
 
CSF1PO     1.82998  1 / (p+q)  p=0.219 q=0.328  10 11 11 10 11 11 11 
 
D13S317    11.1222  1 / 2u  u=0.045  8 11 8 13 11 13 8 13 8 13 
 
TPOX       1.21776  1 / (p+s)  p=0.536 s=0.285  8 11 8 11 8 11 8 11 8 11 
 
D5S818     1.60417  1 / 2p  p=0.312  10 13 10 10 10 10 13 
 
Penta E    5.03571  1 / 2p  p=0.0993  14 19 11 19 11 19 12 19 11 12 
 
Penta D    8.41463  1 / q  q=0.119  9 11 9 10 9 10 10 11 10 
 
cumulative LR  27.719e6 
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Case  8E Scenario 1 
      
 
M       Mother 1000-00205  
     
 
C     Child #1 1000-00206   
     
 
D     Child #2 1000-00207   
     
 
E     Child #3 1000-00208   
     
 
F 
  Tested 
Man 1000-00209   
     E: M + F 
         /E: M + ? 
         
 
────── 
        
 
Malay 
cumulative 
LR 54.4425 
Posterior 
probability= 98.2% 
assuming 
prior= 50% 
  
 
────── 
           ► Malay 
   
M C D E F 
 
D3S1358   1.46774  1 / 2r r=0.341  14 16 16 17 16 16 16 17 
 
VWA        2.52778  1 / 2p  p=0.198  15 17 15 14 17 14 15 14 15 
 
D16S539    1.84007  1 / 2r  r=0.272  9 10 10 11 9 11 9 11 9 11 
 
D8S1179    0.0028  µ  µ=0.0028  13 13 13 13 16 13 15 
 
D21S11     7.25362  1 / 2p  p=0.0689  30 31 31 33.2 30 33.2 28 31 28 33.2 
 
D18S51     2.89306  1 / 2t  t=0.173  15 19 16 19 12 15 16 19 12 16 
 
TH01       8.20492  1 / 2a  a=0.0609  9 9 9.3 9 9 9.3 9 9.3 
 
FGA        0.0048  µ  µ=0.0048  23 27 21 23 23 24 25 27 21 24 
 
D7S820     2.54061  1 / 2p  p=0.197  11 12 10 12 10 11 10 12 10 12 
 
CSF1PO     3.05183  1 / q  q=0.328  10 11 11 10 11 11 11 
 
D13S317    11.1222  1 / 2u  u=0.045  8 11 8 13 11 13 8 13 8 13 
 
TPOX       1.21776  1 / (p+s)  p=0.536 s=0.285  8 11 8 11 8 11 8 11 8 11 
 
D5S818     1.60417  1 / 2p  p=0.312  10 13 10 10 10 10 13 
 
Penta E    2.43103  1 / 2q  q=0.206  14 19 11 19 11 19 12 19 11 12 
 
Penta D    8.41463  1 / q  q=0.119  9 11 9 10 9 10 10 11 10 
 
cumulative LR  54.4425 
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Case  9G Scenario 1 
    
 
M       Mother 1000-00210   
   
 
C        Child 1000-00211   
   
 
G       Man #2 1000-00212   
   
C: G + ? 
       
/C: ? + ? 
       
 
────── 
      
 
Malay cumulative LR 30.0776 Posterior probability= 96.8% assuming prior= 50% 
 
────── 
      
   ► Malay 
   
M C G 
 
D3S1358    1.46774  1 / 2p  p=0.341  16 16 17 16 
 
VWA        2.83276  (p+r) / 4pr  p=0.149 r=0.217  18 16 18 16 18 
 
D16S539    1.84007  1 / 2p  p=0.272  11 12 11 13 11 
 
D8S1179    1.48077  1 / 4t  t=0.169  11 14 11 15 14 15 
 
D21S11     0.0022  µ  µ=0.0022  28 31 28 31 29 32 
 
D18S51     7.37182  (p+s) / 4ps  p=0.262 s=0.039  15 18 15 18 15 18 
 
TH01       1.98611  1 / 4p  p=0.126  8 9 8 9 8 10 
 
FGA        2.61351  (p+q) / 4pq  p=0.172 q=0.216  21 22 21 22 21 22 
 
D7S820     1.2703  1 / 4r  r=0.197  10 12 8 10 10 12 
 
CSF1PO     1.39415  1 / 2q  q=0.359  12 12 11 12 
 
D13S317    3.82061  1 / 2p  p=0.131  9 9 11 9 
 
TPOX       0.466015  1 / 4p  p=0.536  9 10 8 9 8 11 
 
D5S818     2.06818  1 / 2p  p=0.242  11 11 12 11 
 
Penta E    2.29891  1 / 4r  r=0.109  11 13 11 13 13 16 
 
Penta D    2.10366  1 / 4p  p=0.119  10 11 10 12 10 11 
 
cumulative LR  30.0776 
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Case  9M Scenario 1 
    
 
M       Mother 1000-00210   
   
 
C        Child 1000-00211   
   
 
G       Man #2 1000-00212   
   
C: M + ? 
       
/C: ? + ? 
       
 
────── 
      
 
Malay cumulative LR 1.15824e6 Posterior probability= 99.99991% assuming prior= 50% 
 
────── 
      
   ► Malay 
   
M C G 
 
D3S1358    1.46774  1 / 2p  p=0.341  16 16 17 16 
 
VWA        2.30645  1 / 2r  r=0.217  18 16 18 16 18 
 
D16S539    0.920037  1 / 4p  p=0.272  11 12 11 13 11 
 
D8S1179    2.23438  1 / 4p  p=0.112  11 14 11 15 14 15 
 
D21S11     5.94394  (p+s) / 4ps  p=0.0689 s=0.108  28 31 28 31 29 32 
 
D18S51     7.37182  (p+s) / 4ps  p=0.262 s=0.039  15 18 15 18 15 18 
 
TH01       2.70316  (p+q) / 4pq  p=0.126 q=0.349  8 9 8 9 8 10 
 
FGA        2.61351  (p+q) / 4pq  p=0.172 q=0.216  21 22 21 22 21 22 
 
D7S820     1.2703  1 / 4r  r=0.197  10 12 8 10 10 12 
 
CSF1PO     2.7883  1 / q  q=0.359  12 12 11 12 
 
D13S317    3.82061  1 / 2p  p=0.131  9 9 11 9 
 
TPOX       1.89583  1 / 4q  q=0.132  9 10 8 9 8 11 
 
D5S818     2.06818  1 / 2p  p=0.242  11 11 12 11 
 
Penta E    4.81677  (p+r) / 4pr  p=0.0993 r=0.109  11 13 11 13 13 16 
 
Penta D    2.10366  1 / 4p  p=0.119  10 11 10 12 10 11 
 
cumulative LR  1.15824e6 
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Case  10 Scenario 1 
    
 
C        Child 1000-00231   
   
 
F   Tested Man 1000-00232   
   
C: ? + F 
       
/C: ? + ? 
       
 
────── 
      
 
Malay cumulative LR 275561 Posterior probability= 99.9996% assuming prior= 50% 
 
────── 
      
   ► Malay 
   
C F 
 
 
D3S1358    2.01004  1 / 2r  r=0.249  17 15 17 
 
 
VWA        2.63421  1 / 4s  s=0.0949  18 19 16 19 
 
 
D16S539    1.50753  1 / 4p  p=0.166  10 11 10 13 
 
 
D8S1179    4.76667  1 / 2u  u=0.105  10 16 16 
 
 
D21S11     6.76351  1 / 4a  a=0.037  30 30.2 30.2 31 
 
 
D18S51     3.82061  1 / p  p=0.262  15 15 
 
 
TH01       0.862931  1 / 4p  p=0.29  7 9 7 10 
 
 
FGA        3.20833  1 / 2p  p=0.156  23 23 24 
 
 
D7S820     3.06116  1 / p  p=0.327  11 11 
 
 
CSF1PO     0.697075  1 / 4r  r=0.359  11 12 10 12 
 
 
D13S317    0.997012  1 / 4s  s=0.251  8 11 10 11 
 
 
TPOX       1.75614  1 / 2r  r=0.285  11 9 11 
 
 
D5S818     1.60417  1 / 2p  p=0.312  10 11 10 
 
 
Penta E    5.875  1 / 4t  t=0.0426  11 15 15 20 
 
 
Penta D    2.875  1 / 2p  p=0.174  9 10 9 
 
 
cumulative LR  275561 
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Case  11 Scenario 1 
    
 
M       Mother 1000-00215   
   
 
C        Child 1000-00216   
   
C: M + ? 
       
/C: ? + ? 
       
 
────── 
      
 
Malay cumulative LR 5.2374e6 Posterior probability= 99.99998% assuming prior= 50% 
 
────── 
      
   ► Malay 
   
M C 
 
 
D3S1358    5.31968  (p+q) / 4pq  p=0.249 q=0.0579  17 18 17 18 
 
 
VWA        5.005  1 / 4q  q=0.05  14 15 15 19 
 
 
D16S539    1.50753  1 / 4q  q=0.166  10 12 9 10 
 
 
D8S1179    2.52778  1 / 4p  p=0.0989  10 16 10 15 
 
 
D21S11     7.15  1 / 4u  u=0.035  31 32 27 32 
 
 
D18S51     5.08122  1 / p  p=0.197  14 14 
 
 
TH01       3.45172  1 / p  p=0.29  7 7 
 
 
FGA        1.60417  1 / 4b  b=0.156  22 23 21.2 23 
 
 
D7S820     3.47569  1 / 4q  q=0.0719  8 9 9 10 
 
 
CSF1PO     0.762957  1 / 4r  r=0.328  9 11 11 14 
 
 
D13S317    0.920037  1 / 4p  p=0.272  8 10 8 11 
 
 
TPOX       0.93203  1 / 2q  q=0.536  8 7 8 
 
 
D5S818     2.59815  (p+r) / 4pr  p=0.242 r=0.16  11 13 11 13 
 
 
Penta E    7.55357  1 / 2p  p=0.0662  5 5 12 
 
 
Penta D    5.75  1 / p  p=0.174  9 9 
 
 
cumulative LR  5.2374e6 
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Case  12 Scenario 1 
    
 
M       Mother 1000-00233   
   
 
C        Child 1000-00234   
   
 
F   Tested Man 1000-00235   
   
C: M + F 
       
/C: M + ? 
       
 
────── 
      
 
Malay cumulative LR 193.895e6 Posterior probability= 99.9999995% assuming prior= 50% 
 
────── 
      
   ► Malay 
   
M C F 
 
D3S1358    4.02008  1 / q  q=0.249  16 17 17 17 
 
VWA        1.7875  1 / 2s  s=0.28  14 17 17 16 17 
 
D16S539    1.84007  1 / 2q  q=0.272  10 11 11 11 13 
 
D8S1179    2.42961  1 / 2s  s=0.206  10 14 13 14 13 16 
 
D21S11     14.3  1 / 2s  s=0.035  29 29 32 32 32.2 
 
D18S51     5.32447  1 / 2p  p=0.0939  14 19 13 19 13 14 
 
TH01       3.45172  1 / p  p=0.29  9 7 9 7 
 
FGA        4.20588  1 / 2q  q=0.119  23 26 24 26 23 24 
 
D7S820     3.60072  1 / 2t  t=0.139  11 11 12 8 12 
 
CSF1PO     1.39415  1 / 2r  r=0.359  11 11 12 10 12 
 
D13S317    3.98805  1 / q  q=0.251  10 11 11 11 
 
TPOX       1.86406  1 / p  p=0.536  10 11 8 11 8 
 
D5S818     6.25625  1 / s  s=0.16  10 13 13 13 
 
Penta E    8.13462  1 / 2u  u=0.0615  11 16 16 14 16 
 
Penta D    2.875  1 / 2p  p=0.174  10 13 9 10 9 10 
 
cumulative LR  193.895e6 
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The analysis of degraded DNA is one of the biggest challenges in forensic casework. SNPs, which can be
ampliﬁed using small amplicons, have previously been successfully applied to the proﬁling of forensic
evidence that could not be analyzed using conventional STRs. Here we selected the 52 SNPforID SNP
markers, with amplicons that ranged in size from 59 bp to 115 bp, and used them to proﬁle a range of
casework samples from Malaysia. DNA degradation is a common problem in Malaysia due to the high
temperatures and humidity. To carry out the study we modiﬁed the 52 SNPforID markers into four 13-
plex SNaPshot assays to enable easier interpretation of proﬁles on the ABI PRISM1 310 and 3500.
Fifty-one crime samples comprising bloodstains on cloth, swabs, and a mat and 2 swabs of trace DNA
from 10 crime scenes in Malaysia were proﬁled after DNA extraction using a phenol–chloroform method.
The samples were also subjected to STR analysis using the Powerplex1 16 system (Promega), which
resulted in only 17 full proﬁles and 9 partial proﬁles; using SNPs, 36 full proﬁles and 5 partial proﬁles
could be generated.
 2013 Elsevier Ireland Ltd. All rights reserved.
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jo ur n al ho mep ag e: www .e lsev ier . c om / lo cate /FSIG SS52 SNPs
15 STRs
51 
casework 
samples
34 Samples:
- 9 PP
- 25 NP
19 FP
15  samples:
- 5 PP
- 10 NP
17 FP
17 FP1. Introduction
SNPs have received a lot of attention in recent years due to their
abundance throughout the human genome and have been widely
used in medical studies. Their use in forensic DNA analysis is
limited, but is becoming more widespread. Applying SNPs to the
analysis of degraded DNA is of particular interest as SNPs have the
advantage over short tandem repeats (STRs) that the amplicon size
is generally much shorter and therefore they have the potential to
be successfully proﬁled in degraded samples. Crime scene samples
in Malaysia often display signs of degradation as the environmen-
tal is hot and humid.
The main objective of the study was to assess the success rate in
proﬁling crime scene samples using the SNPs designed by the
SNPforID project [1,2] in comparison to a conventional STR system.
2. Process
Fifty-one real crime samples (2 swabs and bloodstains from
clothing and a mat) were provided by Forensic DNA/Serology
Section, Department of Chemistry, Malaysia. DNA was extracted
using a phenol–chloroform method and then was quantiﬁed using* Corresponding author. Tel.: +44 1772 894254; fax: +44 1772 894981.
E-mail addresses: SAlimat@uclan.ac.uk (S. Alimat), SHadi@uclan.ac.uk (S. Hadi),
whgoodwin@uclan.ac.uk (W. Goodwin).
1875-1768/$ – see front matter  2013 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.fsigss.2013.10.092Quantiﬁler1 Kit. All crime scene samples had been processed and
reported and the cases processed through the courts in Malaysia
prior to this work.
In this study, four sets of 13-PCR & SBE (single base extension)-
plexes were designed and evaluated before analyzing the crime
samples. All samples (1 ml of DNA input ranged from undeter-
mined up to 100 ng) were genotyped using four separate 13-plex
PCR assays. PCR products were puriﬁed with ExoSAP enzymes. The
13-plex SBE ampliﬁcation of the puriﬁed samples was carried out
using SNaPshot Multiplex1 kit. The SBE products were puriﬁed
with SAP enzyme. STR analysis using the Powerplex1 16 SystemFig. 1. Success rate of STR and SNP proﬁles developed from casework samples.
FP = full proﬁle; PP = partial proﬁle; NP = no proﬁle. A SNP partial proﬁle required
more than 26 markers to have been called and for STR partial proﬁles seven or more
loci were needed.
Fig. 2. Proﬁling of a crime scene sample using (a) STR markers and (b) SNP markers. A full proﬁle could be generated using the SNP markers whereas no loci were successful
ampliﬁed using STRs.
S. Alimat et al. / Forensic Science International: Genetics Supplement Series 4 (2013) e178–e179 e179(Promega) was also carried out on all the samples. Samples from
both analyses were subjected to capillary electrophoresis using the
Applied Biosystems 310 and 3500 Genetic Analyzers and analyze
using GeneMapper software with peak thresholds set to a
minimum of 120 RFUs (blue colour), 60 RFUs (green colour) and
30 RFUs (yellow, red and orange colours). The criteria for
acceptable peak height ratio for heterozygotes allele calls and
homozygotes allele calls for each locus were as previously
described [1].
3. Results
Out of 51 selected samples; 17 full STR proﬁles were generated
using conventional STR analysis; of the remaining 34 samples 9
gave partial proﬁles with 7 or more loci successfully analyzed; 25
could not be ampliﬁed at all. In comparison, with 52 SNP markers,
36 full proﬁles were successfully ampliﬁed from the samples and
only 15 were partially or not ampliﬁed at all (with 5 partial proﬁles
where more than 26 loci had been ampliﬁed) and no DNA proﬁle
was obtained for 10 samples (Fig. 1)
An example of proﬁles from a poor quality sample is given in
Fig. 2.
4. Discussion
We have demonstrated with casework samples that in some
instances the SNPs can generate full proﬁles from DNA extracts
that yielded no or few STR loci. The increased success rate will be
partially due to the reduced amplicon sizes and may also be due to
greater resistance to inhibitors as the chemistries used to amplify
the two types of marker were slightly different. In the example
shown in Fig. 2 we would expect some of the STR loci which have
shorter amplicons to be proﬁled and inhibition may have impacted
more on the STR typing.The increase in success rate is notable; from approximately 50%
of samples proﬁled using STRs to over 80% successfully proﬁled
using SNPs. Further work needs to be done to assess whether the
increased success rate can be achieved using less labour intensive
systems, such as mini STRs [3] and INDELS [4].
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Research Article
Development of a multiplex system to
assess DNA persistence in taphonomic
studies
In this study, we have developed a PCRmultiplex that can be used to assess DNA degrada-
tion and at the same time monitor for inhibition: primers have been designed to amplify
human, pig, and rabbit DNA, allowing pig and rabbit to be used as experimental models
for taphonomic research, but also enabling studies on humanDNA persistence in forensic
evidence. Internal amplified controls have been added to monitor for inhibition, allowing
the effects of degradation and inhibition to be differentiated. Sequence data for single-copy
nuclear recombination activation gene (RAG-1) from human, pig, and rabbit were aligned
to identify conserved regions and primers were designed that targeted amplicons of 70,
194, 305, and 384 bp. Robust amplification in all three species was possible using as little
as 0.3 ng of template DNA. These have been combined with primers that will amplify a
bacterial DNA template within the PCR. The multiplex has been evaluated in a series of
experiments to gain more knowledge of DNA persistence in soft tissues, which can be
important when assessing what material to collect following events such as mass disasters
or conflict, when muscle or bone material can be used to aid with the identification of
human remains. The experiments used pigs as a model species. When whole pig bodies
were exposed to the environment in Northwest England, DNA in muscle tissue persisted
for over 24 days in the summer and over 77 days in the winter, with full profiles generated
from these samples. In addition to time, accumulated degree days (ADD) were also used as
a measure that combines both time and temperature—24 days was in summer equivalent
to 295 ADD whereas 77 days in winter was equivalent to 494 ADD.
Keywords:
DNA degradation / DNA persistence / DNA profiling / Forensic genetics
DOI 10.1002/elps.201300240
 Additional supporting information may be found in the online version of thisarticle at the publisher’s web-site
1 Introduction
Different experimental approaches have been utilized to esti-
mate the level of DNA degradation in postmortem tissue and
body fluids. These include comet assays [1], the development
of species-specific PCR primers and agarose gel electrophore-
sis [2–5], species-specific primers and real-time PCR [6–8],
Southern blotting and hybridization [9, 10], competitive PCR
[11], and profiling of DNA extracts with polymorphicmarkers
systems [12–14].
Correspondence: Dr. Will Goodwin, School of Forensic and In-
vestigative Sciences, University of Central Lancashire, PR1 2HE
Preston, UK
E-mail: whgoodwin@uclan.ac.uk
Abbreviations: ADD, accumulated degree days; IAC, internal
amplification control; RAG-1, recombination activation gene
Understanding DNA degradation is important when un-
dertaking forensic analysis [15]. For example, the level of
degradation dictates which tissues to sample from human
remains when using DNA to assist with the identification
[16, 17]. Bone and teeth are preferred over soft tissues when
dealingwithhighly degraded remains; however, processing of
hard tissues takes longer and ismore expensive thanwhenus-
ingmuscle tissues. Assessing the level of degradation can also
be important in deciding which DNA profiling systems are
most appropriate for the analysis of different sample types.
While most laboratories will have a standard STR-based pro-
filing system thatwill typically amplifyDNAup to 400–500 bp,
highly degraded samplesmaybenefit fromanalysis using spe-
cialized assays that either amplify STR markers using short
amplicons [18–20], target SNPs [21–24], or insertion-deletion
polymorphisms (indels) [25, 26].
Colour Online: See the article online to view Figs. 1 and 2 in colour.
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In previous studies, the reported persistence of DNA in
soft muscle has varied: experiments in Western Australia us-
ing pig muscle from whole animals could amplify DNA after
ten days in winter [3], in Thailand pigmuscle yielded DNA for
up to four days when exposed to the environment (eight days
when immersed in water) [5], rat brain tissue yielded DNA
when stored at 20C for up to 42 days [8], human brain and
thyroid tissue yielded DNA for over 100 days when stored in
a container or immersed in water at 21C [14]. Of the above
studies, only Larkin et al. [3] took into account the level of
DNA degradation in relation to both time and temperature
(accumulated degree days (ADD)) for the purpose of estimat-
ing postmortem interval [3, 27–29].
Here we describe the development of a PCR multi-
plex that targets loci with amplicons over a similar range
to that seen inmany commercial PCR amplification kits used
for forensic DNA profiling. We have combined the multi-
plex with previously described internal amplification controls
(IACs) that can monitor for PCR inhibition [30, 31]. We have
used the optimized multiplex to work with human, pig, and
rabbit DNA, allowing it to be used as a tool to assess the per-
sistence/degradation of DNA in soft muscle tissue using pigs
or rabbits as an experimental model. We describe an applica-
tion of the multiplex assessing the persistence of DNA in pig
muscle tissue in a series of field experiments.
2 Materials and methods
2.1 Design of PCR primers
Sequence data for a nuclear recombination activation gene
(RAG-1) from human, rabbit, and pig were downloaded
from GenBank and aligned using Bioedit (http://www.mbio.
ncsu.edu/bioedit/bioedit.html) to identify conserved regions:
primers that would amplify 70, 194, 305, and 384 bp ampli-
cons from the three species were identified (Table 1). These
primers were designed using the publicly available software
Primer3 [32, 33] and the oligonucleotide property calculator
software [34].
Primer pairs with 5′ fluorescein-labeled or ROX-labeled
forward primers were synthesized (Life TechnologiesTM, UK)
and were delivered desalted and lyophilized: 100 M stock
solutions were prepared by adding the appropriate volume of
1× TE buffer (0.1 M Tris HCl, 0.01 M EDTA, pH 8.0; Sigma,
UK) and stored at−20C,while an aliquot of a 10Mworking
solution was kept at 4C.
2.2 DNA samples
DNA extraction was carried out using DNeasy R© Blood and
Tissue kit (Qiagen, UK) according to the manufacturer’s in-
structions using 25–30 mg of tissue. Pig and rabbit positive
control DNA samples were extracted from soft muscle tissue
samples collected at day 0.
2.3 DNA quantification
Extracts used in the sensitivity study were quantified in trip-
licate using real-time PCR of the 70 bp fragment with two
unlabeled primers. GoTaq R© qPCR Master Mix (Promega R©,
UK) was used following the manufacturer’s recommended
protocol with an ABI 7500 real-time PCR machine (Life
TechnologiesTM).
Field samples were extracted as above, but quantified
using the Quant-iTTM PicoGreen R© dsDNA Assay Kit (Life
TechnologiesTM). Samples were prepared by mixing 3 L
DNA with 147 L 1× TE and 150 L PicoGreen and pipetted
(300 L) into microplate wells—all samples were prepared in
triplicate. Fluorescence was determined using TECAN GE-
nios Pro plate reader at absorption and emission wavelengths
of 485 and 535 nm, respectively. Data were obtained in the
form of relative fluorescent unit.
2.4 Multiplex PCR
The primer mix and thermal cycler conditions were prepared
according to the optimized PCR condition (Table 1). In a total
reaction volume of 10.0 L, 5.0 L 2× Platinum Multiplex
PCR Master Mix (Applied Biosystems), 0.6 L of primers
mix, 2.5 L of dH2O, 1 L of DNA template, and 1 L of
IAC template, prepared as described by Zahra et al. [30], were
added. PCR was carried out in a thermal cycler GeneAmp R©
2700 (Life TechnologiesTM) using following conditions: 95C
for 5 min; 30 cycles of 94C for 1 min, 60C for 1 min, 72C
for 1 min, and a final extension at 72C for 10 min.
For sensitivity studies dilutions (2.80, 0.93, 0.31, 0.10,
and 0.03 ng) were made for human, pig, and rabbit day DNA.
Human genomicDNAG3041 (273 ng/L)was obtained from
Promega R©.
2.5 Capillary electrophoresis
Each sample for fragment analysis was prepared by adding
1 L of PCR product to 10 L of Hi-DiTM formamide (Life
TechnologiesTM) containing 0.7LGS500 ROX size standard
(Life TechnologiesTM). The samples were heated at 95C for
5 min and snap-cooled for at least 3 min.
Optimization of the multiplex PCR was performed using
an ABI 310 Prism R© Genetic Analyzer (Life TechnologiesTM).
DNA fragment analysis was carried out using a 47 cm-long
capillary using POP-4
TM
polymer (Life TechnologiesTM). Elec-
trophoresis running bufferwas used at 1× concentration. The
GSPOP 4 (1mL) F.md4 runmodule with dye set DS-32 (filter
set F) was used with the following parameters: run temper-
ature 60C, syringe pump time 150 s, prerun voltage 15 kV,
prerun time 120 s, injection time 5 s, injection voltage 15 kV,
run voltage 15 kV, and run time 30 min.
Due to the ability to increase throughput DNA fragment,
analysis for the field samples was performed using an ABI
3500 Genetic Analyzer (Life Technologies) using a 50 cm
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Table 1. Shown below are four PCR primer sets for conserved regions of pig, rabbit, and human
Nuclear gene Forward and reverse primers (5′-3′) Primer conc. (M) Amplicon (bp)
RAG-1 NCBI reference M77666.1 CCT CAA AGT CAT GGG CAG C 0.08 70
GAC TCT CCA GGT CAG TAG G (0.05)
GCT GTT TGC TTG GCC ATC CG 0.19 194
GTG CTG GAA GAC ACA TTC TTC (0.1)
ATG AGG TCT GGC GTT CCA AC 0.15 305
TGG TCA TGA GCT TCC TGG CA (0.15)
GAG CAA TCT CCA GCA GTC CT 0.56 384
GCT AAA CTT CCT GTG CAT GA (0.4)
IAC 90 CTG TCA AAT CTA AAC ACC CTG ATG CGa) 0.60a) 90
GTC AGC TTG CAT AAT ATC GAG ATA ACG C 0.15
IAC 410 CTG TCA AAT CTA AAC ACC CTG ATG CGa) 0.60a) 410
GTA CAA TGT TGA CGT TCC TCG CTG 0.45
The sequence and concentration of the IAC primers are also given. The primer concentrations shown in brackets are used when the IAC
primers are not included.
a) The same forward primer is used for both the IAC 90 and 410; 0.6 M is the total primer concentration.
capillary array and 3500 POP-6
TM
polymer. The Fragment-
Analysis50_POP6 runmodule was used in combination with
the dye set DS-32 (filter set F with the following parameters:
run temperature 60C, prerun voltage 15 kV, prerun time
180 s, injection time 10 s, injection voltage 1.6 kV, run voltage
15 kV, and run time 2700 s).
The data obtained from CE were analyzed using
GeneMapperTM ID version 3.2 (ABI 310) and GeneMapper R©
Software v4.1 (ABI 3500) (both Life TechnologiesTM).
2.6 Simulated DNA degradation
The exposure of forensic evidence samples to environmen-
tal insult, fragmentation of full-length genomic DNA, and
the reduction of overall concentration of amplifiable DNA
are observed. Therefore, the effect of DNA degradation on
the amplification efficiency of the multiplex (4-plex) was ex-
amined according to the protocol described by Swango et al.
[35]. A degradation series was prepared by digesting high
molecular weight (177 g/mL) DNA with DNase I (Applied
Biosystems) for a progressive length of time. A reaction con-
taining 15.7 g DNA, 10× DNase buffer (100 mM Tris,
25mMMgCl2, 5 mMCaCl2, pH 7.6), and nuclease-free water
to bring the reaction volume to 110 L, was prepared. Ten
microliters were removed and used as a control sample. DNA
in the remaining solution was digested by adding 1.25 L
of DNase I (2 U/L), and then the mixture was incubated
at 24C. From this solution, 10 L was removed at specific
time points (5, 10, 15, 20, 30, 45, 60, 90, 120, and 180 min),
DNase I activity was stopped by mixing 2 L of DNase in-
activation reagent, and incubating at 65C for 15 min. After
incubation, samples were centrifuged at 10 000 × g for 2 min
and supernatant was transferred to a fresh tube. The degree
of DNA degradation was assessed by running 2 L of di-
gested products on 2% agarose gel using 100 bp DNA ladder
(BioLabs R©, UK). DNA quantification was performed using
Human Quantifiler R© kit (Life TechnologiesTM) according to
the manufacturer’s instruction.
2.7 Field studies
In order to assess the degradation of DNA in soft muscle
tissue whole pig carcasses were laid out at the University of
Central Lancashire’s Taphonomic Research in Anthropology:
Centre for Experimental Studies (TRACES), which comprises
13 acres of field facilities in the Northwest of England [36];
carcasses were covered by a wire mesh cage to prevent scav-
enging by large mammals. Field experiments were carried
out in February–May 2010, May–June 2010, and September–
October 2010. Muscle samples of approximately 1 g were
taken from the upper hind limb at regular intervals until
either no DNA could be recovered (this was based on an
assessment of the DNA extract on an agarose gel and was
only relevant for the February series) or no muscle tissue
remained for analysis (as occurred with both the May and
September experiments). The muscle tissues remain moist
throughout all experiments described here and samples were
taken from below the tissue surface, avoiding the complica-
tions that could be introduced by muscle tissues becoming
desiccated, which would have enhanced the preservation of
DNA. In a preliminary series of experiments related to this
study, different regions of muscles were sampled: the hind
and fore legs, both upper and lower (i.e. in contact with the
ground) and the neck, no significant difference was seen in
the rates of degradation [37]. Samples were collected in all
cases from three separate pig carcasses and were transported
on ice and frozen at−20Cuntil DNAwas extracted. Ambient
temperatures were measured at the field site using HDT-200
and HDT-250 USB data loggers (Thermosense, UK). When
analyzing the field samples with themultiplex, 0.6 ng of DNA
template were added to each PCR and the CE undertaken us-
ing a 3500 Genetic Analyzer.
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3 Results
3.1 Selection of loci and primer design
Single-copy RAG-1 is involved in somatic (V(D)J) re-
arrangement of B- and T-cell lymphocytes, which
is essential for the development of a normal im-
mune system and its functions. The RAG-1 gene is
found throughout higher vertebrates and comprises a
3.1 kb exon without introns. It evolves slowly, has minimal
saturation at the third position of codons, and a low fre-
quency of indels [38–40]. Multiple conserved regions could be
identified in the alignment between human, pig, and rabbit
sequence, allowing a range of amplicons sizes from the
same gene (Supporting Information Fig. 1). Additional sites
were available allowing amplicons be added at a later stage, if
desired.
3.2 Multiplex sensitivity and specificity
The four primer pairs were found to be optimum at working
concentrations of 0.05, 0.1, 0.15, and 0.4 M for 70, 194, 305,
and 384 bp, respectively (Table 1). The MgCl2 concentration
was kept at 2.5mMfor all PCR. The optimized 4-plex PCRwas
assessed for any nonspecific amplification that would lead to
extra peaks and could interfere with target peaks. Positive
control DNA samples of all three species were evaluated on
ABI Prism R© 310 and 3500 Genetic Analyzers.
DNA fragment analysis for multiplex PCR was carried
out using serial dilutions of positive control DNA samples
of human (Promega R©), rabbit, and pig extracted from day 0
postmortem soft muscle tissues and quantified using real-
time PCR. The 4-plex PCR was found to work efficiently
in triplicate samples of all three species between 2.80 and
0.1 ng of DNA template (Supporting Information Fig. 2); no
extra peaks were observed in any of the amplifications and
full amplification was observed in all three species with tem-
plate amounts as low as 0.3 ng; when the template amount
dropped below 0.3 ng allele dropout, which is typical of low-
template PCR [41, 42], was observed in some profiles. The
multiplex was also tested with DNA from insects that would
commonly be found on the carcasses [43]; no amplification
was seen with DNA from Calliphora vomitoria, Protophormia
terraenovae, Lucilia sericata, Lucilia caesar, or Lucilia illustris.
Addition of the IAC template and primers did not alter the
sensitivity of specificity of the multiplex.
To assess the ability of the multiplex (4-plex) assay to
quantify DNA in degraded samples, a ten-point degradation
series was prepared by treating aliquots of high molecular
weight genomic DNA (Promega R©) with DNase I for increas-
ing periods of time ranging from 5 to 180 min. The result
was, as expected, a degradation series exhibiting incremental
increase in the extent of DNA degradation. Full 4-plex profiles
were obtained reproducibly until 30min ofDNase I digestion,
but with a decline in overall peak height and a relative decline
in the amplification of large loci. There was complete failure
Figure 1. Shown above is the PicoGreen R©-based DNA quantifi-
cation of samples collected from pig carcasses in February 2010.
The error bars indicate the standard error from three replicates.
A total of 200 L was extracted from each sample and 3 L was
used for quantification.
of amplification in all DNA samples digested with DNase I
for a period of 45 min or above (Supporting Information
Fig. 3).
The standard deviation of the amplicon sizes for mul-
tiple runs of the same and different samples was be-
low 1 bp for all amplicons. The sizing of fragments
varied in accuracy: 70 bp (64.32 ± 0.69 bp); 194 bp
(194.54 ± 0.04 bp), 305 bp (305 ± 0.5 bp), and 384 bp (383.9
± 0.05 bp) on the ABI 310 Genetic Analyzer. Slightly differ-
ent values were seen when using the 3500 Genetic Analyzer;
70 bp (65.17 ± 0.02 bp), 194 bp (195.66 ± 0.03 bp), 305 bp
(307.38 ± 0.60 bp), and 384 bp (384.69 ± 0.15 bp).
3.3 Taphonomic study using field DNA samples
Three separate repeats of an experiment to assess the persis-
tence of DNA in soft tissue were undertaken over the course
of a year (2010), with experiments covering winter–spring,
spring–summer, and autumn. Sampling time points varied
depending on the season and the temperatures: in May sam-
ples were taken at between three and six day intervals whereas
in February samples were only taken approximately once a
week.
The breakdown of soft tissues was much more rapid, as
would be expected, in summer and samplingwas not possible
after day 27 in theMay–June experiment. Following collection
of soft muscle tissue DNA was extracted and quantified us-
ing PicoGreen R©. The values obtained from the quantification
were used as a guide for adding DNA to the multiplex. An ex-
ample of the quantification results from the February series is
shown in Fig. 1. PicoGreen R© is nonspecific and so will quan-
tify bacterial and fungal DNA. However, this did not appear
to confound the quantification of the endogenous DNA as the
values went down to zero over time, before then increasing as
bacterial and fungus colonized the remaining tissues. Based
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Figure 2. (A) Examples of electropherograms generated from 1 L of DNA extract (from a total of 200 L) extracted from pig soft muscle
tissues collected during May 2010 project at (b) 159 ADD, (c) 203 ADD, (d) and (e) 338 ADD. Human positive control (a) is also shown
(0.5 ng). The amount of DNA in 1 L of each extract was quantified using real-time PCR: (b) 0.82 ng, (c) 0.73 ng, (d) 0.32 ng, (e) 0.59 ng.
(B) Electropherograms with the same samples as in (A) with the addition of the IAC 90 and 410 internal amplification controls.
on the quantifications, 0.6 ng was added to the PCR multi-
plex and the absence or presence of each of the amplicons
was noted. The PCRs were generally well balanced, which in-
dicated that the quantification using PicoGreen R© was reason-
ably accurate. An example of electropherograms taken from
theMay series is shown inFig. 2 (February andSeptember are
shown in Supporting Information Figs. 4 and 5)—input DNA
was kept constant for these using 1 L of extract in each PCR
(i.e. 0.5% of the total extract) and the amount of DNA added
was assessed by real-time PCR. As time/ADD increase, the
larger amplicons show a relative decline in abundance. This
is expected, but somewhat surprisingly amplicons can still be
amplified up to day 90/603 ADD in the February experiment.
The IAC primers shown in Fig. 2B produce two peaks of 90
and 410 bp; these are well balanced in all of the electrophero-
grams, indicating the absence of PCR inhibitors (had PCR
inhibitors been present then we would expect the 410 bp IAC
to decrease with respect to the 90 bp IAC). Table 2 contains
the data from all three field experiments—0.6 ng was used as
template in each of the reactions. As expected, DNA persists
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
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Figure 2. Continued.
for fewer days as the average temperature increases.However,
full profiles could be obtained from all samples in the May
series (average daily temperature 12.3C) up to and including
day 24 (ADD 295) and in September series (average daily tem-
perature 11.4C) up to and including day 30 (ADD 342). We
could have potentially increased the number of loci amplified
in some of the degraded samples by adding more template
DNA, but in the context of this series of experiments were
more interested in the general pattern of degradation and
providing a conservative estimate of DNA persistence—with
casework samples it may be appropriate to carry out further
analysis.
The data were analyzed using the generalized linear
mixed model fit by the Laplace approximation to measure
analysis of deviance using the software R (R Development
Core Team. http://www.R-project.org). The analysis demon-
strated that the relationship between ADD and amplification
success was not different for the 305 and 384 bp amplicons (Z
= 0.96, p = 0.76), but was different for pairwise comparisons
of all other amplicons. At time zero there was no difference
in amplification success of the four amplicons, but with
increased ADD the probability of getting the 194, 305, and
384 bp amplicons was 4, 6.15, and 5.92 times lower than
getting the 70 bp amplicons (p <0.001 for all permutations).
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Table 2. Shown below are the results of 4-plex multiplex
amplification of pig soft muscle tissues project
Days ADD Pig whole carcasses
70 bp 194 bp 305 bp 384 bp
(A) February 2010
14 34 +++ +++ +++ +++
21 57 +++ +++ +++ +++
29 88 +++ +++ +++ +++
41 185 +++ +++ +++ +++
57 302 +++ +++ +++ +++
64 367 +++ +++ +++ +++
71 418 +++ +++ +++ +++
77 494 +++ +++ +++ +++
84 554 +++ ++− +−− +−−
90 603 +++ ++− +−− +−−
(B) May 2010 project
6 77 +++ +++ +++ +++
13 159 +++ +++ +++ +++
16 203 +++ +++ +++ +++
24 295 +++ +++ +++ +++
27 338 +++ +++ +−− +−−
(C) September 2010
9 106 +++ +++ +++ +++
11 137 +++ +++ +++ +++
15 210 +++ +++ +++ +++
18 254 +++ +++ +++ +++
22 288 +++ +++ +++ +++
30 342 +++ +++ +++ +++
38 420 +++ −−− −−− −−−
44 490 +++ +−− −−− −−−
“+” denotes the presence and “−” represents the absence of a
PCR amplicon.
The probability of getting 305 and 384 bp was 1.54 and 1.58
times less than the 194 bp amplicons (p < 0.001 for both
permutations).
4 Discussion
A multiplex has been designed that will amplify four am-
plicons between 70 and 384 bp, which is a size range typi-
cally analyzed using commercial kits for forensic DNA pro-
filing. The primers work robustly using between 2.80 and
0.3 ng of template DNA from humans, pigs, and rabbits,
which gives the multiplex more utility than one that is spe-
cific to human DNA. In addition, the addition of the IACs to
the multiplex allows for the simultaneous detection of PCR
inhibitors. Similar multiplexes have been described in the
literature previously for carrying out persistence studies, but
to our knowledge this is the first system described that will
work with humans and other mammalian species that can
be used as model systems. The system was designed, in part,
to be used for taphonomic studies at the University of Cen-
tral Lancashire’s TRACES facility, where pigs and rabbits are
used as experimental models [29, 36, 44]. Designing a multi-
plex that can also be used with human DNA does offer some
advantages to making it species-specific. When using it in
the field experiment described, an advantage was that com-
mercial human DNA standards could be obtained—these are
routinely supplied as components of commercial quantifica-
tion kits and PCR amplification kits. This allowed accurate
quantification standards to be used in real-time PCR and also
gives more confidence when assessing the sensitivity of the
assay than using only in-house standards.
The utility of the multiplex has been tested in a series of
taphonomic experiments to assess the persistence of DNA in
muscle tissues. The trends seen in the results are as expected,
with warmer temperatures leading to higher rates of DNA
degradation. What is somewhat surprising is the time that
DNA is present in the muscle tissues—even in summer;
with daytime temperatures frequently exceeding 20C, DNA
over 384 bp long could be detected up to 24 days. In May a
factor limiting the retrieval of DNA was the availability of soft
muscle tissue, which was not present after 27 days. In the
February series, the muscle tissue maintained its mechanical
integrity and did not change much in appearance; in the
May and September experiments, the muscle tissue again
maintained its physical properties until the very last stages
of the experiment (typically the penultimate or final sample)
where the mechanical integrity of the muscle broke down
with the muscle becoming soft and sticky—once the muscle
reached this state it did not persist for more than 3–4 days. In
all studies we did not see significant changes in muscle color
with only slight fluctuations between pink and red.
The persistence of DNA inmuscle tissue could influence
practices in sampling of cadavers for the purpose of human
identification, at least in temperate climates, with DNA suc-
cessfully extracted from muscle recovered from what would
be considered by most to be highly decomposed bodies. The
results presented here can be compared with other studies,
but direct comparison is difficult. A similar experiment car-
ried out in Australia presented unusual results in that DNA
could not be recovered and amplified from samples on day 2,
and in several cases on day 0 [3], which suggest that either
the PCR assay or extractions were not robust. Other exper-
iments used excised tissues rather than whole animals [5],
and in some cases these were not exposed to the environ-
ment [8,14], which will have affected the DNA persistence. It
is necessary to carry out more detailed studies in warmer cli-
mates before making any generalized statements about how
long DNA might be available in muscle tissue. When apply-
ing the conclusions of these experiments to forensic casework
care also has to be taken not to overinterpret the results as
these are based on an experimental animal model. However,
pigs have been used in many taphonomic studies as they
have several features, such as size, anatomy and metabolic
rate similar to humans and have been used extensively as a
model in taphonomic research in Europe [29, 44–46].
Another utility of the multiplex is that it can be used for
studying factors that affect persistence in other types of foren-
sic evidence. Several studies have been described that have
used commercial PCR kits to assess the level of degradation
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[12–14]. Thismultiplex offers advantages over the commercial
kits in that it is much less expensive and it is also amplifying
homozygous nonvariable loci, removing the complication of
samples from different donors having different sized alleles
and combinations of homozygous and heterozygous loci. The
addition of the IACs enhances the utility of this system over
commercial systems in that the effect of inhibitors over the
range of the multiplex can be assessed.
There is also the potential to use a multiplex such as
this one as a screening tool for forensic analysis of material
that is believed to be degraded, because such multiplex can
potentially provide valuable information and minimize the
waste of expensive reagents. Looking at the results in Table 2,
it is possible to see samples where there is only amplifica-
tion of the 70 and 194 bp amplicons, which would indicate
that the use of a kit that is optimized to amplify small am-
plicons would be most beneficial. In other cases, the 70 bp
amplicon had persisted after the other amplicons failed to be
amplified—this would highlight the benefit of analyzing the
samples with an alternative markers system that could uti-
lize smaller amplicons, such as the SNPs and indels, where
amplicons can be as small as 70 bp. The addition of internal
amplified controls [30,31] allows detection of PCR inhibitors
and differentiation between DNA degradation and PCR inhi-
bition, thereby enhancing themultiplex’s ability to be used as
a tool to assess degradation in different types of forensic evi-
dence and to be used as a screening tool for complex forensic
samples. However, if the system is used for screening com-
plex samples to assess for inhibitors, it should be considered
that different commercial PCR kits have different sensitivi-
ties, for example the Minifiler kit is more robust to inhibitors
than the Identifiler kit [19] and in general later generations of
commercial kits have higher resistance to inhibitors. There-
fore, the relative impact of inhibition on this multiplex and
the commercial kit of choice would have to be assessed to
avoid overinterpretation. It should be noted that this same
limitation exists with real-time PCR detection of inhibition in
commercial kits, where the sensitivity of the detection varies
between the real-time systems, for example Quantifiler and
PCR multiplexes [30]. The best approach would be to incor-
porate the IACs into the commercial multiplex kit, however,
this is a complex process [30, 31] and may not be practical in
a commercial environment.
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